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Abstract
The macroscale network structure of the brain is fundamental to the pathophysiology and treatment of
several neuropsychiatric diseases, including epilepsy, neurodegenerative disease, depression, and
psychosis. Functional interactions at this scale index disease symptoms and guide exogenous
interventions, such as brain stimulation or pharmacology. However, a lack of tools for measuring the
underlying neurobiological drivers of these functional interactions, as well as phenotypic heterogeneity
within disorders, hinders the ability to expand upon existing treatments and target them to the appropriate
populations.
Dynamical systems models have the potential to move beyond a statistical description of neural systems
by positing mechanisms that link the physical form of a system with its emergent function. A subset of
dynamical systems models, linear network spreading models, have proved especially useful for capturing
activity fluctuations in neural systems. Existing tools allow these models to be studied through the lens of
network control theory, which captures the system’s response to external inputs. Here, we use network
spreading models and other computational tools to study structure-function relationships in the human
brain and the mechanisms of Parkinson’s disease pathophysiology.
First, we employed a network spreading model to characterize the neural substrates of individual
differences in impulse control throughout development. Second, we incorporated external inputs into
those models in order to explain the temporal progression of large- scale cortical activity patterns. Third,
we used a network spreading model to confirm that endogenous levels of α-synuclein, along with both
anterograde and retrograde transsynaptic diffusion drive Parkinson’s disease progression. Finally, we
identify latent patterns of co- occurring pathologies in neuropathological autopsy data that can be
predicted from in vivo biomarkers using statistical models.
This collection of studies expands our understanding of how brain activity and misfolded proteins spread
throughout the brain’s white matter connections and provides a computational framework for addressing
heterogeneity in neurologic diseases. These findings are complementary to the aim of developing
network-oriented therapies and lay a general framework for parsing disease heterogeneity across multiple
fields of medicine.
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ABSTRACT
Eli J. Cornblath
Danielle S. Bassett
The macroscale network structure of the brain is fundamental to the pathophysiology and
treatment of several neuropsychiatric diseases, including epilepsy, neurodegenerative disease, depression, and psychosis. Functional interactions at this scale index disease symptoms
and guide exogenous interventions, such as brain stimulation or pharmacology. However, a
lack of tools for measuring the underlying neurobiological drivers of these functional interactions, as well as phenotypic heterogeneity within disorders, hinders the ability to expand
upon existing treatments and target them to the appropriate populations.
Dynamical systems models have the potential to move beyond a statistical description
of neural systems by positing mechanisms that link the physical form of a system with its
emergent function. A subset of dynamical systems models, linear network spreading models,
have proved especially useful for capturing activity fluctuations in neural systems. Existing
tools allow these models to be studied through the lens of network control theory, which
captures the system’s response to external inputs. Here, we use network spreading models
and other computational tools to study structure-function relationships in the human brain
and the mechanisms of Parkinson’s disease pathophysiology.
First, we employed a network spreading model to characterize the neural substrates of
individual differences in impulse control throughout development. Second, we incorporated
external inputs into those models in order to explain the temporal progression of largescale cortical activity patterns. Third, we used a network spreading model to confirm that
endogenous levels of α-synuclein, along with both anterograde and retrograde transsynaptic
diffusion drive Parkinson’s disease progression. Finally, we identify latent patterns of cooccurring pathologies in neuropathological autopsy data that can be predicted from in vivo
biomarkers using statistical models.
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This collection of studies expands our understanding of how brain activity and misfolded
proteins spread throughout the brain’s white matter connections and provides a computational framework for addressing heterogeneity in neurologic diseases. These findings are
complementary to the aim of developing network-oriented therapies and lay a general framework for parsing disease heterogeneity across multiple fields of medicine.
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CHAPTER 1: General introduction
NETWORK SCIENCE OF NEUROPSYCHIATRIC ILLNESS
The human brain is often considered to be the most complex object in the known universe,
with around 100 billion neurons and 100 trillion synapses. It is because of this complexity that physicians have struggled to adequately treat many diseases affecting brain circuit
function (Insel 2014), while highly effective precision therapies for cancer (Jackson et al.
2016) and genetic disorders (Boye et al. 2013) have gained momentum in the last decade.
In order to usher in a similar era for clinical neurology and psychiatry, our understanding
of pathophysiology and arsenal of treatments must grow to accommodate the macroscale
structural and functional networks that exist within the brain. Neuroimaging and electrophysiology have been instrumental in understanding brain networks consisting of neuroanatomical structures, each comprised of neuronal populations connected by white matter
fibers or synchronous oscillations. In this dissertation, I will discuss the use of neuroimaging
and network science to understand the neurophysiology of cognition and demonstrate how
network models and computational tools can reveal insights into the pathophysiology of
neuropsychiatric illnesses.
In clinical neurology, the macroscale network architecture of the brain is fundamentally
relevant to the pathophysiology of stroke, epilepsy, and neurodegenerative disease. The
symptoms of ischemic stroke are best explained not only by local injury, but by the disruption of functional circuits that include the damaged tissue (Boes et al. 2015). Focal epileptic
seizures are characterized by the spreading of synchronous activity from a seizure onset zone
(SOZ) along white matter tracts (Shah et al. 2019). Furthermore, resection of tissue in the
SOZ is often insufficient for seizure freedom due to a latent network of regions that confer
epileptogenicity to the SOZ (Rosenow and Lüders 2001). Patients with advanced dementia
often show widespread aggregation of misfolded proteins on cerebral autopsy (Arnold et al.
2013), which can be explained by network spread of such proteins along the white matter
fibers that connect distant areas of the brain (Raj et al. 2012). Animal models have further
1

validated that transsynaptic spread of misfolded proteins from an initial seed site explains
the progression of neurodegenerative disease beyond the effects of regional vulnerability
(Henderson et al. 2019). Novel treatments for these conditions will need to address how
pathology spreads along or interacts with macroscale brain networks.
Psychiatrists have begun to move away from symptom-driven diagnostic frameworks in favor
of those that emphasize neural circuitry (Insel 2014), in search of neurodevelopmental and
neurophysiologic mechanisms of depression, anxiety, and psychosis. It has become clear that
these symptoms are characterized by distributed dysfunction in the interactions between
brain areas, rather than a reliable focal injury. The efficacies of transcranial magnetic
stimulation (Dichter et al. 2015; Drysdale et al. 2017) and pharmacotherapy (Dichter et al.
2015) for depression are related to patterns of interregional synchrony in spontaneous brain
activity, particularly involving frontal and limbic areas. Schizophrenia is characterized
by widespread frontotemporal and subcortical gray matter loss (Haijma et al. 2013), and
psychotic episodes with hallucinations are thought to arise from transient dysfunction of
frontolimbic interactions (Nakazawa et al. 2012). However, current pharmacotherapies for
psychosis and depression target neurotransmitter receptors that are distributed throughout
the brain. The ability to modulate frontolimbic interactions in a principled manner will be
tantamount to developing targeted therapies for affective dysfunction and psychosis.

MACROSCALE STRUCTURE-FUNCTION RELATIONSHIPS IN THE
HUMAN BRAIN
The brain is frequently modeled as a complex network at the macroscale as a set of anatomically or functionally defined brain areas, each containing millions of neurons (Bassett and
Sporns 2017). At this scale, one can study both structural and functional connections between regions. Structural connections are most commonly defined as white matter fibers
joining each pair regions, which can be detected by applying tractography algorithms to
diffusion weighted magnetic resonance imaging data (Dyrby et al. 2007; Mukherjee et al.
2008). On the other hand, functional connections are most commonly defined as the pair-

2

wise temporal correlation in spontaneous blood oxygenation level dependent (BOLD) signals measured through resting state functional magnetic resonance imaging (fMRI) (Fox and
Raichle 2007; van den Heuvel and Hulshoff Pol 2010). The network framework is widely
used in studies of cognition and disease, and will be used throughout this dissertation.
At the level of individual neurons, it is known that the topology of synaptic connections
constrains spontaneous firing patterns of small circuits (Shein Idelson et al. 2010; Marconi et al. 2012). The same is true of the human brain, where the strength of functional
connections is correlated with the strength of structural connections (Honey et al. 2009;
Greicius et al. 2009). Another study found that considering multiple measures of interregional communication derived from structural connectivity could better explain functional
connectivity (Goni et al. 2014). An individual region’s functional connections can be more
easily explained by its structural connections if that region belongs to unimodal cortex
as opposed to transmodal cortex, suggesting that evolution has favored a decoupling of
structure and function in areas responsible for complex cognitive processes (Baum et al.
2020; Vázquez-Rodrı́guez et al. 2019). Furthermore, the latency and amplitude of regional
responses to direct electrical stimulation are explained by structural connectivity and functional connectivity (Keller et al. 2014; Stiso et al. 2019; Solomon et al. 2018), suggesting
that white matter pathways support transmission of neuronal population activity between
macroscopic cortical areas.
Notably, it is known that “static” functional connectivity patterns depend on the analyzed
window of the BOLD time series (Chang and Glover 2010; Zalesky et al. 2014), a phenomenon known as“dynamic” functional connectivity (Preti et al. 2017), which complicates
the interpretation of correlations between structural connectivity and functional connectivity. An even more fine-grained analysis can identify recurring patterns of coactivation at
single time points, a smaller temporal unit than sliding windows (Cornblath et al. 2019a;
Liu et al. 2018; Cabral et al. 2017; Karahanoğlu and Van De Ville 2015). These studies
reveal that a small number of “bursty” activity patterns are sufficient to explain much of
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the information held in static functional connectivity (Tagliazucchi et al. 2012; Thompson
and Fransson 2016; Cabral et al. 2017; Vidaurre et al. 2017b; Betzel et al. 2019). The observation of event-like dynamics raises the question of how to interpret a pairwise correlation
between two regions in isolation, given that signals from those two regions fluctuate atop
a backdrop of temporally sparse expression of discrete spatial activity patterns. Notably,
the observation of time-varying connectivity and coactivation patterns does not necessitate
non-stationarity of the underlying system (Laumann et al. 2017; Liégeois et al. 2017), but
still likely captures an important aspect of large-scale cortical physiology. In fact, a subset of these time-varying activity and connectivity patterns have been shown to align with
structural connectivity (Fukushima et al. 2018; Cabral et al. 2017), suggesting that brain
activity is constrained but not tightly bound by the organization of white matter tracts,
allowing for transient flexible reconfiguration that supports cognition.

DYNAMICAL SYSTEMS MODELS OF BRAIN ACTIVITY
Most studies have attempted to quantify how white matter connections constrain functional communication between brain regions by computing the Pearson correlation between
structural connection strengths and resting state BOLD functional connectivity strengths
(Wang et al. 2015). However, this approach simply describes a property of an underlying system, the nature of which is unknown and difficult to identify. A more promising
alternative for gleaning generalizable insights into structure-function relationships lies in
dynamical systems models. When applied to the human brain at the macroscale, dynamical systems models generally describe how some property (usually activity) associated with
brain regions, x, changes over time as a function of some network parameters θ and the
current state of the brain, such that ẋ = f (x, θ). Because static and dynamic functional
connectivity are directly computed from x, the time series of brain activity, dynamical
systems models can simultaneously explain brain activity, dynamic functional connectivity,
and static functional connectivity. Additionally, these models can test for the plausibility
of specific structure-function relationships by explicitly incorporating biophysical features
of the brain, such as white matter tracts or individual neurons (Izhikevich and Edelman
4

2008).
The simplest dynamical systems model used to study brain activity assumes that the rate
of change in the vector of brain activity x is determined by a set of network connections
in a matrix A multiplied by x, such that ẋ = Ax. Linear network models where A
is defined by white matter connectivity can explain functional connectivity (Abdelnour
et al. 2014, 2018), implicating spreading of activity along structural pathways in creating
functional connectivity patterns. Data-driven approaches can be used to identify a matrix A
from the BOLD time series that recapitulate both static functional connectivity and major
aspects of dynamic functional connectivity (Liégeois et al. 2017). More complex dynamical
systems models of large-scale cortical activity have attempted to incorporate biophysical
realism by modeling neuronal populations linked by white matter fibers (Friston et al. 2003;
Izhikevich and Edelman 2008; Breakspear 2017). These neural mass models can recapitulate
static functional connectivity in held out data in individuals (Wang et al. 2019; Demirtaş
et al. 2019), and hold significant promise for linking parameters of neuronal dynamics to
disruptions of functional connectivity observed in clinical populations. However, compared
to linear models, the mathematical complexity and computational demands of neural mass
models currently limits their utility for data-driven discovery of clinical interventions.
Linear network models have shown initial promise as a tool for understanding and treating neuropsychiatric illness. Data-driven identification of linear systems has been used to
successfully decode mood fluctuations from implanted electrode grids in patients with intractable epilepsy (Sani et al. 2018), which may inform the development of adaptive brain
stimulation for treatment resistant depression. Similar techniques can synthesize speech by
decoding neural signals in face motor cortex during spoken speech, a key first step towards
restoring speech in patients with brainstem strokes or neurodegeneration (Anumanchipalli
et al. 2019). Linear diffusion models have also confirmed that white matter fibers serve as
a scaffold for the spread of misfolded proteins in multiple neurodegenerative diseases (Raj
et al. 2012; Pandya et al. 2017, 2019; Mezias et al. 2020). Instead of a state space of brain
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activity, the variable x captures the amount of pathology in each brain region as the disease
progresses. Application of these tools to Parkinson’s disease has revealed that misfolded
α-synuclein spreads bidirectionally across synapses although primarily from axon to dendrite, traverses synaptic connections rather than following distance-dependent bulk tissue
diffusion, and interacts with endogenous protein (Henderson et al. 2019; Mezias et al. 2020).
These findings collectively demonstrate the power of dynamical systems models for probing
network mechanisms of disease and extracting pertinent information from the brain.

NETWORK CONTROL THEORY
In recent years, the application of dynamical systems models in neuroscience has broadened to include techniques from network control theory, which allows one to identify inputs
necessary to drive specific state transitions in a dynamical system. Network control models
are a subset of dynamical systems models that define the rate of change of x as a function of x, some internal dynamics θ, and some external inputs u, such that ẋ = f (x, θ, u).
These tools are highly promising for the management of epilepsy, psychosis, and affective
disorders, where transiently aberrant network states define seizures, psychotic episodes, or
depressive episodes. Using this framework, the latent inputs driving brain activity across
multiple cognitive tasks can be recovered (Becker et al. 2018; Ashourvan et al. 2019). By
solving for external inputs required to oppose the linear spread of brain activity along white
matter fibers, the temporal progression between whole-brain coactivation patterns (Liu and
Duyn 2013) at rest can be explained (Cornblath et al. 2019a). Similarly, accounting for
both external inputs and internal linear dynamics provides an accurate, patient-specific
estimation of the neural response to direct electrical stimulation (Chang et al. 2012). A
combination of open loop and optimal control techniques can explain how exogenous electrical stimulation drives the brain into activity states favorable for episodic memory recall
(Stiso et al. 2019). Optimal control techniques have also been used to identify the inputs
needed to halt a seizure as a function of the internal dynamics observed at different stages
of seizure progression (Scheid et al. 2020). Models that explicitly incorporate the dynamic
interplay between the brain’s intrinsic dynamics and the external environment are highly
6

promising both for understanding physiology and developing new therapeutic interventions.

CLINICAL PREDICTIVE MODELS IN NEUROLOGY AND PSYCHIATRY
While network models of brain activity are promising for informing the mechanisms of targeted therapies, predictive modeling using multimodal information sources can help identify
groups of patients that may benefit from those therapies at a particular time. This relationship is evident in the increasing emphasis on the collection of large neuroimaging and
behavioral datasets (Calkins et al. 2015; Van Essen et al. 2013; Miller et al. 2016), which
have allowed researchers to validate network insights about the brain’s functional organization through the study of individual differences. Individual differences play a critical role in
extending these insights into the clinical realm, because many neuropsychiatric disorders are
phenotypically heterogeneous under their current definitions (Scheffer and Berkovic 1997;
Insel 2014; Robinson et al. 2018). In theory, the purpose of a clinical diagnosis is to use
the co-occurrence of symptoms to infer underlying pathophysiology that can then be targeted with a mechanistically justified therapy. However, clinical diagnoses are often defined
phenotypically and later fractionated into subtypes with putatively distinct etiologies (Insel
2014; Nelson et al. 2019; Josephs et al. 2019). To address this issue, studies have applied
data-driven approaches to large samples with the aim of automatically linking biological
findings with symptoms to resolve heterogeneity. In patients with clinical depression, covarying patterns of symptoms and behavior were found to predict response to transcranial
magnetic stimulation (Drysdale et al. 2017). In a heterogeneous developmental sample,
separable dimensions of fear and psychosis were found to covary with distinct patterns of
functional connectivity between the default mode and frontoparietal systems (Xia et al.
2018). Gold standard definitions of neurodegenerative diseases require the presence of 1-2
misfolded proteins on autopsy, but 3 or more proteins are frequently detected (Robinson
et al. 2018; Cornblath et al. 2019), suggesting that these disease definitions may not map to
distinct pathophysiologies or maximize the utility of clinical tests (Cornblath et al. 2019).
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Another important application of data-driven tools lies in the development of clinical decision support tools, which automatically integrate clinical data to provide physicians with
predictions about patient outcomes. In the field of internal medicine, these tools have been
shown to predict clinical outcomes in both acute and chronic care settings, providing physicians with the foresight to carry out early interventions or prepare for negative outcomes.
Machine learning models have been used to accurately predict the development of acute
kidney injury (Tomašev et al. 2019) or sepsis (Desautels et al. 2016) in hospitalized patients, as well as long term outcomes such as rheumatoid arthritis flares (Norgeot et al.
2019) or all-cause mortality (Harris et al. 2014). In psychiatry, extracting features from
location data and text input smartphone data can index ongoing disease state and potentially forecast episodic worsening of symptoms (Saeb et al. 2015; Cao et al. 2018), relying on
behavior as a read out of dysfunctional neural activity, rather than brain activity itself. In
neurology, efforts are underway to provide early warnings of upcoming seizures using signals
from implanted electrode, but despite the significant practical utility, the most successful
tools rely on “black box” models that do not point to any network mechanisms of seizure
onset (Brinkmann et al. 2016; Dumanis et al. 2017). As our understanding of the principles
governing brain networks grows, so too will the efficacy of clinical decision support tools in
neurology and psychiatry.

ARCHITECTURE OF THIS THESIS
In this dissertation, the overarching goal is to derive network level insights about brain
function and dysfunction by studying the structural organization of the brain, and to explore
the utility of data-driven models in developing biomarkers of neuropsychiatric disease.
In Chapter 2, we employed a dynamic network model based on estimates of white matter
connectivity from diffusion tensor imaging to measure the theoretical importance of several
macroscale structures in the brain for controlling whole-brain dynamics. We used this model
to study the neurobiological underpinnings of sex differences in impulsivity.
In Chapter 3, we identified recurring, whole-brain activation patterns from functional mag8

netic resonance imaging data and compared the temporal sequences of these activity patterns observed during a task-free resting state and during a cognitively demanding working
memory task. Next, we found that a combination of external inputs and activity spreading
along white matter tracts explained the temporal sequences of brain activity at rest.
In Chapter 4, we used structural connectivity data obtained from the Allen Brain Institute
to model the spread of alpha-synuclein in a mouse model of Parkinson’s disease. We found
that spatial patterns of pathology accumulation are explained by spread along structural
pathways and intrinsic regional vulnerability conferred by variation in levels of endogenous
alpha-synuclein expression.
In Chapter 5, we applied data-driven clustering analysis to histopathology data to resolve
the heterogeneous copathology found across multiple neurodegenerative diseases. This analysis identified new biologically defined subtypes of concomitant neurodegenerative diseases
that cross boundaries of traditional diagnoses, and allowed for a more faithful prediction of
pathology from in vivo data.
In Chapter 6, we provided an outlook on similar data-driven approaches to neuropsychiatric
illness more broadly, and emphasized the utility of machine learning techniques and rich
longitudinal data for developing patient-specific, clinical predictive models that monitor
disease symptoms in a biotype-specific fashion.

9

References
Abdelnour, F., Dayan, M., Devinsky, O., Thesen, T., and Raj, A. (2018). Functional brain
connectivity is predictable from anatomic network’s Laplacian eigen-structure. NeuroImage, 172:728–739.
Abdelnour, F., Voss, H. U., and Raj, A. (2014). Network diffusion accurately models the
relationship between structural and functional brain connectivity networks. NeuroImage,
90:335–347.
Anumanchipalli, G. K., Chartier, J., and Chang, E. F. (2019). Speech synthesis from neural
decoding of spoken sentences. Nature, 568(7753):493–498.
Arnold, S. E., Toledo, J. B., Appleby, D. H., Xie, S. X., Wang, L.-S., Baek, Y., Wolk,
D. A., Lee, E. B., Miller, B. L., Lee, V. M.-Y., and Trojanowski, J. Q. (2013). Comparative survey of the topographical distribution of signature molecular lesions in major
neurodegenerative diseases. The Journal of comparative neurology, 521(18):4339–55.
Ashourvan, A., Pequito, S., Bertolero, M., Kim, J. Z., Bassett, D. S., and Litt, B. (2019).
A dynamical systems framework to uncover the drivers of large-scale cortical activity.
bioRxiv, page 638718.
Bassett, D. S. and Sporns, O. (2017).
20(3):353–364.

Network neuroscience.

Nature Neuroscience,

Baum, G. L., Cui, Z., Roalf, D. R., Ciric, R., Betzel, R. F., Larsen, B., Cieslak, M.,
Cook, P. A., Xia, C. H., Moore, T. M., Ruparel, K., Oathes, D. J., Alexander-Bloch,
A. F., Shinohara, R. T., Raznahan, A., Gur, R. E., Gur, R. C., Bassett, D. S., and
Satterthwaite, T. D. (2020). Development of structure–function coupling in human brain
networks during youth. Proceedings of the National Academy of Sciences of the United
States of America, 117(1):771–778.
Becker, C. O., Bassett, D. S., and Preciado, V. M. (2018). Large-scale dynamic modeling
of task-fMRI signals via subspace system identification. Journal of Neural Engineering,
15(6):066016.
Betzel, R. F., Faskowitz, J., and Sporns, O. (2019). High-amplitude co-fluctuations in
cortical activity drive resting-state functional connectivity. bioRxiv, (October):800045.
Boes, A. D., Prasad, S., Liu, H., Liu, Q., Pascual-Leone, A., Caviness Jr, V. S., and Fox,
M. D. (2015). Network localization of neurological symptoms from focal brain lesions.
Brain, 138(10):3061–3075.
Boye, S. E., Boye, S. L., Lewin, A. S., and Hauswirth, W. W. (2013). A comprehensive
review of retinal gene therapy. Molecular Therapy, 21(3):509–519.

10

Breakspear, M. (2017). Dynamic models of large-scale brain activity. Nature Neuroscience,
20(3):340–352.
Brinkmann, B. H., Wagenaar, J., Abbot, D., Adkins, P., Bosshard, S. C., Chen, M.,
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Cabral, J., Vidaurre, D., Marques, P., Magalhães, R., Silva Moreira, P., Miguel Soares, J.,
Deco, G., Sousa, N., and Kringelbach, M. L. (2017). Cognitive performance in healthy
older adults relates to spontaneous switching between states of functional connectivity
during rest. Scientific Reports, 7(1):5135.
Calkins, M. E., Merikangas, K. R., Moore, T. M., Burstein, M., Behr, M. A., Satterthwaite,
T. D., Ruparel, K., Wolf, D. H., Roalf, D. R., Mentch, F. D., Qiu, H., Chiavacci, R.,
Connolly, J. J., Sleiman, P. M., Gur, R. C., Hakonarson, H., and Gur, R. E. (2015). The
Philadelphia Neurodevelopmental Cohort: Constructing a deep phenotyping collaborative. Journal of Child Psychology and Psychiatry and Allied Disciplines, 56(12):1356–
1369.
Cao, B., Zheng, L., Zhang, C., Yu, P. S., Piscitello, A., Zulueta, J., Ajilore, O., Ryan,
K., and Leow, A. D. (2018). DeepMood: Modeling Mobile Phone Typing Dynamics
for Mood Detection. Proceedings of the ACM SIGKDD International Conference on
Knowledge Discovery and Data Mining, Part F1296:747–755.
Chang, C. and Glover, G. H. (2010). Time-frequency dynamics of resting-state brain connectivity measured with fMRI. NeuroImage, 50(1):81–98.
Chang, J.-Y., Pigorini, A., Massimini, M., Tononi, G., Nobili, L., and Van Veen, B. D.
(2012). Multivariate autoregressive models with exogenous inputs for intracerebral responses to direct electrical stimulation of the human brain. Frontiers in Human Neuroscience, 6:317.
Cornblath, E. J., Ashourvan, A., Kim, J. Z., Betzel, R. F., Ciric, R., Adebimpe, A., Baum,
G. L., He, X., Ruparel, K., Moore, T. M., Gur, R. C., Gur, R. E., Shinohara, R. T., Roalf,
D. R., Satterthwaite, T. D., and Bassett, D. S. (2019a). Temporal sequences of brain
activity at rest are constrained by white matter structure and modulated by cognitive
demands. Communications biology, in press.
Cornblath, E. J., Robinson, J. L., Lee, V. M.-Y., Trojanowski, J. Q., and Bassett, D. S.
(2019b). Defining and predicting transdiagnostic categories of neurodegenerative disease.
bioRxiv, 25:664250.
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Karahanoğlu, F. I. and Van De Ville, D. (2015). Transient brain activity disentangles fMRI
resting-state dynamics in terms of spatially and temporally overlapping networks. Nature
Communications, 6(1):7751.
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Vázquez-Rodrı́guez, B., Suárez, L. E., Markello, R. D., Shafiei, G., Paquola, C., Hagmann,
P., Van Den Heuvel, M. P., Bernhardt, B. C., Spreng, R. N., and Misic, B. (2019).
Gradients of structure–function tethering across neocortex. Proceedings of the National
Academy of Sciences of the United States of America, 116(42):21219–21227.
Vidaurre, D., Smith, S. M., and Woolrich, M. W. (2017). Brain network dynamics are
hierarchically organized in time. Proceedings of the National Academy of Sciences,
114(48):12827–12832.
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CHAPTER 2: Sex differences in network controllability as a predictor of
executive function in youth
This chapter contains work from Cornblath, E.J., Tang, E., Baum, G.L., Moore, T.M.,
Adebimpe, A., Roalf, D.R., Gur, R.C., Gur, R.E., Pasqualetti, F., Satterthwaite, T.D. and
Bassett, D.S (2019). “Sex differences in network controllability as a predictor of executive
function in youth.” Neuroimage, 188, 122-134.
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Abstract

Executive function is a quintessential human capacity that emerges late in
development and displays different developmental trends in males and females.
Sex differences in executive function in youth have been linked to vulnerability
to psychopathology as well as to behaviors that impinge on health, wellbeing,
and longevity. Yet, the neurobiological basis of these differences is not well understood, in part due to the spatiotemporal complexity inherent in patterns of
brain network maturation supporting executive function. Here we test the hypothesis that sex differences in impulsivity in youth stem from sex differences in
the controllability of structural brain networks as they rewire over development.
Combining methods from network neuroscience and network control theory, we
characterize the network control properties of structural brain networks estimated from diffusion imaging data acquired in males and females in a sample of
879 youth aged 8-22 years. We summarize the control properties of these networks by estimating average and modal controllability, two statistics that probe
the ease with which brain areas can drive the network towards easy- versus
difficult-to-reach states. We find that females have higher modal controllability in frontal, parietal, and subcortical regions while males have higher average
controllability in frontal and subcortical regions. Furthermore, controllability
profiles in males are negatively related to the false positive rate on a continuous
performance task, a common measure of impulsivity. Finally, we find associations between average controllability and individual differences in activation
during an n-back working memory task. Taken together, our findings support
the notion that sex differences in the controllability of structural brain networks
can partially explain sex differences in executive function. Controllability of
structural brain networks also predicts features of task-relevant activation, suggesting the potential for controllability to represent context-specific constraints
on network state more generally.
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INTRODUCTION
Executive function is necessary for regulation of goal-directed behavior, and encompasses
cognitive processes including working memory, sustained attention, inhibition, task switching, and performance monitoring (Anderson et al. 2001). Deficits in the various subdomains
of executive function can greatly hinder quality of life. For example, deficits in sustained attention can hamper academic and occupational performance (Biederman et al. 2007) while
impulsivity can lead to increased risk taking and associated consequences (Romer et al.
2009; Barkley et al. 2002; Cross et al. 2011; Weafer and de Wit 2014). While many investigations of sex differences are limited by small sample sizes (Hyde 2014), biopsychosocial
confounds (Miller and Halpern 2014), and a focus on sex assigned at birth (Joel 2012),
meta analysis (Hasson and Fine 2012) and large studies (Gur et al. 2012; Riley et al. 2016)
suggest that within the executive function domain, males exhibit selective dysfunction in
impulsivity relative to their female counterparts, as measured by commission error, or false
positives, on the continuous performance task (CPT). Accordingly, these selective executive
deficits may underlie the higher rates of criminality (Cross et al. 2011), violence (Cross et al.
2011), and substance use initiation (Cross et al. 2011; Weafer and de Wit 2014; Romer et al.
2009) among males. Current interventions for disorders of executive function usually do not
consider sex and are relatively limited to psychotherapy and non-specific psychopharmacology (Hosenbocus and Chahal 2012). It remains unknown whether and to what extent the
pathophysiology of executive deficits is sex-specific. Thus, investigating sex differences in
the neurobiology supporting executive function can be a powerful tool for revealing clinically
relevant variation, with potential applications for developing personalized interventions for
neuropsychiatric illness.
A basic understanding of sex-related differences in executive function and their implications for the diagnosis and treatment of executive deficits requires an understanding of
the normative maturation of underlying neural circuitry. Several studies highlight the fact
that such maturation, and sex differences in that maturation, span structure (Gogtay et al.
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2004), anatomical connectivity (Baum et al. 2017), activity (Schmithorst et al. 2015; Nomi
et al. 2017; Keulers et al. 2011), and functional connectivity (Fair et al. 2009). Using structural MRI, a recent study (Gennatas et al. 2017) reported age-related, non-linear increases
in gray matter density with concurrent decreases in cortical thickness. Interestingly, the
maturation of these structural features was markedly different between the sexes, with females showing higher gray matter density globally and higher cortical thickness in frontal
and insular regions (Gennatas et al. 2017). Using diffusion-weighted MRI, another study
found significantly greater within-hemisphere connectivity in males and greater betweenhemisphere connectivity in females (Ingalhalikar et al. 2014). Sex differences have also been
identified in the clustered (or modular) structure in patterns of functional connectivity estimated from resting state fMRI data: males display higher between-module connectivity
while females display higher within-module connectivity (Satterthwaite et al. 2014b). Despite these important descriptive studies, it remains difficult to specify in a mechanistic
sense how executive function might arise from such complex, multimodal patterns of brain
maturation influenced by biological sex.
We posit that such a mechanistic understanding could emerge from recent advances in network control theory, an emerging branch of theoretical physics and systems engineering that
models how network dynamics can be predictably influenced (Liu et al. 2011; Pasqualetti
et al. 2014; Kailath 1980; Kalman et al. 1963) (Fig. 2.1). Prior work has demonstrated
the utility of network control theory in understanding basic brain architecture and function
(Muldoon et al. 2016; Betzel et al. 2016; Gu et al. 2017) across spatial scales (Wiles et al.
2017) and species (Kim et al. 2018), posited its relation to cognition (Gu et al. 2015a; Tang
et al. 2017) and psychiatric illness (Jeganathan et al. 2018), and outlined its developmental
timecourse (Tang et al. 2017). Intuitively, the control of brain dynamics instantiated in
the notion of network controllability could prove relevant for the control of behavior as
instantiated in the notion of impulse control, a key component of executive function (Diamond 2013). In response to environmental demands, white matter connectivity must allow
for transitions to states of brain activity supporting cognition and behavior (Betzel et al.
20

a.

x1

b.

Average controllability: support for nearby transitions

x1

x2

Nearby transition

Diffusion MRI

x2

xo

xo

xo

Tractography

Modal controllability: support for distant transitions
Structural Brain Network

Distant transition

Figure 2.1: Control theory and schematic of data processing. (a) Schematic depicting basic methodological approach. Diffusion tensor imaging (DTI) data was acquired from
879 youth between the age of 8 years and 22 years. Deterministic tractography was used
to identify the number of white matter streamlines, connecting any two regions of interest.
These estimates were used to construct a structural brain network for each subject representing white matter connectivity (edges) between brain regions (nodes). (b) Schematic
(right) of a state space of a two-dimensional dynamical system where the z-value and color
indicate some energetic cost associated with occupying a particular pair of x-y coordinates,
alongside a diagram (left) illustrating brain state transitions from an activated default mode
system (xo ). The blue arrow denotes a distant transition to a deactivated default mode
system and activated frontoparietal/dorsal attention system (x2 ). The red arrow denotes a
nearby transition to a partially deactivated default mode system (x1 ). Regions with high
modal controllability can facilitate transitions to energetically distant states while regions
with high average controllability can facilitate transitions to nearby states while requiring
very little energy.
2016; Gu et al. 2017; Cornblath et al. 2018). Control properties therefore impact a system’s
possible trajectories through different states of activity, as well as the manner in which the
system responds to external stimuli (Gu et al. 2017).
We hypothesize that sex differences in impulse control in youth stem from sex differences
in the controllability of structural brain networks as they rewire over development. Sex
differences in control properties could manifest in a reduced ability of some youths, especially
males, to reach states that support robust impulse control, or they could result in an
increased propensity to occupy states that are unfavorable for impulse control. Thus,
we did not make any directional hypotheses regarding the effects of increasing network
controllability. Accordingly, we focused on identifying control points whose regional input
can be used to drive state transitions in a linear system. Control points are identified
with metrics that assess the ability of specific nodes to alter a system’s state, based on the
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underlying network topology and a specification of network dynamics (Pasqualetti et al.
2014) (Fig. 2.1). The metric of average controllability reflects the average energy input
required at a node to move the system from some initial state to all possible states (Gu
et al. 2015a; Tang et al. 2017; Jeganathan et al. 2018). In contrast, the metric of modal
controllability reflects the ease of transitioning the system from some initial state to a
difficult-to-reach state (Gu et al. 2015a; Pasqualetti et al. 2014; Tang et al. 2017).
Hence, we move forward by describing sex differences in network controllability using the
metrics of average and modal controllability, and measuring impulse control using the false
positive rate on the CPT (Gur et al. 2010). Specifically, we predicted that (i) network
controllability differs by sex, (ii) network controllability changes with age differently in
males and females, (iii) sex differences in network controllability predict false positives
on the CPT (Gur et al. 2010), and (iv) network controllability predicts the activation of
brain regions during a working memory task demanding executive function. To test these
predictions, we constructed structural brain networks from diffusion tensor imaging data
acquired in 879 healthy youth, ages 8–22 years, in the Philadelphia Neurodevelopmental
Cohort (PNC) (Satterthwaite et al. 2014a). Each brain network was comprised of 234
anatomically defined regions (Cammoun et al. 2012) connected by white matter tracts
estimated from diffusion tractography. We show that regional controllability is a significant
mediator of the relationship between sex and impulse control, and that it predicts the
magnitude of fMRI BOLD signal on an n-back task, a brain state associated with high
demands on working memory, a separate domain of executive function. As described in
detail below, our results suggest that sex differences in the controllability of structural
brain networks predict impulse control and that network control properties explain the
activity profiles that support executive function more broadly.
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MATERIALS AND METHODS
Participants
Diffusion tensor imaging (DTI) data were obtained from youth who participated in a large
community-based study of brain development, now known as the Philadelphia Neurodevelopmental Cohort (PNC) (Satterthwaite et al. 2014a). Here we study 879 out of a total
of 1601 subjects between the ages of 8 and 22 years. Due to lack of complete diffusion
scans (n = 227) and incidental findings (n = 20), data from 244 participants was deemed
unusable. The remaining 1354 participants underwent a rigorous manual and automated
quality assurance protocol for DTI datasets (Roalf et al. 2016), eliminating an additional
147 subjects with poor data quality. A subset of 93 of the remaining 1207 participants
were excluded for low quality or incomplete FreeSurfer reconstruction of T1-weighted images (Rosen et al. 2018). Further, 235 of the remaining 1114 participants were excluded
for one or more of the following reasons: gross radiological abnormalities distorting brain
anatomy, medical history that might impact brain function, history of inpatient psychiatric
hospitalization, use of psychotropic medication at the time of imaging, or high levels of
in-scanner head motion during the DTI scan, as defined by a mean relative displacement
between non-weighted volumes of greater than 2 mm. These exclusions left us with a final
sample of n = 879 subjects (Baum et al. 2017; Tang et al. 2017) between the ages of 8 and
22 years (mean age = 15.06, SD = 3.15; 389 males, 490 females).

Age (y)
White
African American
Other Race
d0 (n-back)
CPT False Positives (z)

Males
15 ± 3.2
48.6%
39.3%
12.1%
1.94 ± 0.75
-0.131 ± 0.72

Females
15.1 ± 3.1
37.8%
50.2%
12.0%
1.87 ± 0.73
-0.324 ± 0.71

Table 2.1: Sample characteristics.
Cognitive Phenotyping
Cognition was measured outside of the scanner using the Penn Computerized Neurocognitive
Battery (CNB) (Gur et al. 2010, 2012). Briefly, the 1-hour CNB was administered to all
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participants, and consisted of 14 tests that evaluated a broad range of cognitive functions.
Twelve of the tests measure both accuracy and speed, while two of the tests (motor and
sensorimotor) measure only speed.
In this study, we focus our analysis of executive function on the continuous performance task
(CPT). During the CPT, the participant is presented with 7-segment displays of vertical
and horizontal lines (at a rate of one display per second), and the participant must press
a button when the lines form a number (first 1.5 minutes) or a letter (second 1.5 minutes)
(Gur et al. 2010). This task measures sustained attention via the true positive rate, and it
measures impulsivity via the false positive rate (Gur et al. 2010). A previous study (Gur
et al. 2012) that administered the CPT via the Penn CNB (Gur et al. 2010) found a higher
true positive rate in females, while other measures of executive function such as working
memory did not exhibit sex differences. In our sample, we observed no significant difference
in CPT true positive rate between males and females. However, the CPT false positive rate
on the same task was higher in males 2.2, consistent with a sex difference in impulse control.
Because impulse control intuitively relies on the coordination of spatially distributed brain
networks (Brewer and Potenza 2008), we focus the cognitive portion of the present analysis
on CPT false positives. Of note, 10 subjects in our sample had missing data for the CPT
and thus were excluded from analyses involving CPT data (Fig. 2.6 and 2.7).
Imaging Data Acquisition
MRI data were acquired on a 3 Tesla Siemens Tim Trio whole-body scanner and 32-channel
head coil at the Hospital of the University of Pennsylvania. DTI scans were acquired via
a twice-refocused spin-echo (TRSE) single-shot echo-planar imaging (EPI) sequence (TR
= 8100ms, TE = 82ms, FOV = 240mm2 /240mm2 ; Matrix = RL:128/AP:128/Slices:70,
in-plane resolution (x and y) 1.875 mm2 ; slice thickness = 2mm, gap = 0; flip angle =
90/180/180 degrees, volumes = 71, GRAPPA factor = 3, bandwidth = 2170 Hz/pixel,
PE direction = AP). This sequence utilizes a four-lobed diffusion encoding gradient scheme
combined with a 90-180-180 spin-echo sequence designed to minimize eddy-current artifacts.
The complete sequence consisted of 64 diffusion-weighted directions with b = 1000s/mm2
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and 7 interspersed scans where b = 0s/mm2 . Total scan time was approximately 11 min.
The imaging volume was prescribed in axial orientation covering the entire cerebrum with
the topmost slice being located just superior to the apex of the brain.
In addition to the DTI scan, a B0 map of the main magnetic field was derived from a doubleecho, gradient-recalled echo (GRE) sequence, allowing us to estimate field distortions in each
dataset. Prior to DTI acquisition, a 5-minute magnetization-prepared, rapid acquisition
gradient-echo T1-weighted (MPRAGE) image (TR 1810 ms, TE 3.51 ms, FOV 180 ×240
mm, matrix 256 × 192, effective voxel resolution of 1 × 1 × 1 mm) was acquired. This highresolution structural image was used for tissue segmentation and parcellating gray matter
into anatomically defined regions in native space. Rigorous manual and automated quality
assurance protocols for the T1-weighted structural imaging data were performed for the
879 subjects considered here (Vandekar et al. 2015). Subsequently, all structural images
were processed using FreeSurfer (version 5.3) (Fischl 2012). FreeSurfer reconstructions
underwent rigorous quality assurance protocols (Vandekar et al. 2015; Rosen et al. 2017).
The T1 image was parcellated into 234 regions by FreeSurfer according to the Lausanne
Atlas (Cuadra et al. 2004). We define the subcortex of this 234-region parcellation to be
comprised of the left and right hemispheric counterparts of the thalamus proper, caudate,
putamen, pallidum, nucleus accumbens area, hippocampus, and amygdala, while excluding
the brainstem (14 regions). We define the cortex of this 234-region parcellation to be
comprised of the remaining areas (219 regions).
fMRI BOLD data were acquired as subjects completed a version of the n-back working
memory task using fractal images (Ragland et al. 2002). See the Ref.(Satterthwaite et al.
2013) for details regarding task presentation and structure. Functional images were obtained
using a whole-brain, single-shot, multislice, gradient-echo echoplanar sequence (231 volumes;
TR = 3000 ms; TE = 32 ms; flip angle = 90 degrees; FOV = 192 × 192 mm; matrix =
64 × 64; slices = 46; slice thickness = 3 mm; slice gap = 0 mm; effective voxel resolution =
3.0 × 3.0 × 3.0 mm).
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Imaging Data Preprocessing
All DTI datasets were subject to a rigorous manual quality assessment procedure involving
visual inspection of all 71 volumes (Roalf et al. 2016). Each volume was evaluated for the
presence of artifact, with the total number of volumes impacted summed over the series.
This scoring was based on previous work describing the impact of removing image volumes
when estimating the diffusion tensor (Jones and Basser 2004; Chen et al. 2015). Data was
considered “Poor” if more than 14 (20%) volumes contained artifact, “Good” if between
1 and 14 volumes contained artifact, and “Excellent” if no visible artifacts were detected
in any volumes. All 879 subjects included in the present study had diffusion datasets
identified as “Good” or “Excellent,” and had less than 2mm mean relative displacement
between interspersed b = 0 volumes. As described below, even after this rigorous quality
assurance protocol, motion was included as a covariate in all analyses.
The skull was removed for each subject by registering a binary mask of a standard fractional
anisotropy (FA) map (FMRIB58 FA) to each subject’s DTI image using an affine transformation (Jenkinson et al. 2002). Eddy currents and subject motion were estimated and
corrected using the FSL eddy tool (Andersson and Sotiropoulos 2016). Diffusion gradient
vectors were then rotated to adjust for subject motion estimated by eddy. After the field
map was estimated, distortion correction was applied to DTI data using FSL’s FUGUE
(Jenkinson et al. 2012).
BOLD time series were processed as described in (Satterthwaite et al. 2013; Shanmugan
et al. 2016). Briefly, FSL 5 (Jenkinson et al. 2012) was used to analyze time series data
from three condition blocks (0-back, 1-back and 2-back), with the primary contrast being
2-back > 0-back. BOLD images were co-registered to the T1 image using boundary-based
registration (Greve and Fischl 2009) with integrated distortion correction as implemented in
FSL. Generalized linear model (GLM) beta weights were averaged across all voxels in each
parcel of the 234-node Lausanne atlas. In our assessment of n-back performance-related
activation, we use the difference in GLM beta weights between the 2-back and 0-back
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condition. For all analyses of fMRI data, we excluded 22 subjects with incomplete data or
excessive head motion (mean relative displacement > 0.5 mm or maximum displacement
> 6 mm), leaving n = 837 remaining.
Structural Network Estimation
Structural connectivity was estimated from DTI data in order to generate the adjacency
matrix representing the pattern of white matter tracts between large-scale brain areas. DSI
Studio was used to estimate the diffusion tensor and perform deterministic whole-brain
fiber tracking with a modified FACT algorithm that used exactly 1,000,000 streamlines per
subject after removing all streamlines with length < 10 mm (Gu et al. 2015a). To extend
regions into white matter, parcels defined using the Lausanne atlas were dilated by 4 mm
(Gu et al. 2015a; Tang et al. 2017) and registered to the first non-weighted (b = 0) volume
using an affine transform (Gu et al. 2015a; Tang et al. 2017). The number of streamlines
connecting node i and node j in the 234-region parcellation was used to weight the edge
Aij of the adjacency matrix A.
Network Controllability
We represent the streamline-weighted structural network estimated from diffusion tractography as the graph G = (V, E), where V and E are the vertex and edge sets, respectively.
Let Aij be the weight associated with the edge (i, j) ∈ E, and define the weighted adjacency
matrix of G as A = [Aij ], where Aij = 0 whenever (i, j) ∈
/ E. We associate a real value
with each node to generate a vector describing the network state, and we define the map
x : N≥0 → RN to describe the dynamics of the network state over time.
It is worth noting that this method assumes that the number of streamlines is proportional
to the strength of structural connectivity with regards to propagation of activity between
nodes according to a specified model of dynamics. Here we employ a simplified noise-free
linear discrete-time and time-invariant model of such dynamics:

x(t + 1) = Ax(t) + BK uK (t),
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(2.1)

where x describes the state (i.e. voltage, firing rate, BOLD signal) of brain regions over
time. Thus, the state vector x has length N , where N is the number of brain regions
in the parcellation, and the value of xi describes the activity level of that region. The
matrix A is symmetric, with the diagonal elements satisfying Aii = 0. Prior to calculating
controllability values, we divide A by 1 + ξ0 (A), where ξ0 (A) is the largest eigenvalue of A.
The input matrix BK identifies the control point K in the brain, where K = k1 , ..., km and

BK = [ek1 · · · ekm ],

(2.2)

and ei denotes the i-th canonical vector of dimension N . The input uK : R≥0 → RM denotes
the control strategy.
To study the dynamics by which the activity of one brain region influences structurally
connected regions, we apply the control theoretic notion of controllability to our dynamical
model. Classic results in control theory ensure that controllability of the network, x(t+1) =
Ax(t) + BK uK (t), from the set of network nodes K is equivalent to the controllability
Gramian WK being invertible, where

WK =

∞
X

Aτ BK BTK Aτ .

(2.3)

τ =0

We calculate WK , or rather Wi , with BK set equal to one canonical vector ei and repeat
this process for all N nodes (Tang et al. 2017; Gu et al. 2015a). Although it is well known
that the activity of several brain regions and neuronal ensembles are related via non-linear
dynamics, it has been shown that a linear approximation can explain features of the resting
state fMRI BOLD signal (Honey et al. 2009); this suggests that a linear approximation can
effectively capture the controllability properties of the original non-linear dynamics.
Controllability Metrics
Following Ref.(Tang et al. 2017; Gu et al. 2015a), controllability metrics for structural
brain networks were calculated for two different control strategies which describe the ability
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to change x(t) in a particular fashion (Pasqualetti et al. 2014). Average controllability
describes the ease of transition to energetically similar states, while modal controllability
describes the ease of transition to difficult-to-reach states (Pasqualetti et al. 2014).
Average controllability of a network equals the average input energy applied to a set of
control nodes required to reach all possible target states. It is known that average input en−1
ergy is proportional to Trace(WK
), the trace of the inverse of the controllability Gramian.

Following Ref.(Tang et al. 2017; Gu et al. 2015a), we use Trace(WK ) as an alternative
−1
measure of average controllability because (i) Trace(WK ) and Trace(WK
) are related via
−1
inverse proportionality, and (ii) Trace(WK
) tends to be very ill-conditioned and cannot

be accurately computed even at more coarse connectome parcellations. In addition to its
−1
), Trace(WK ) describes the energy of the network impulse
relationship with Trace(WK

response, or, equivalently, the network H2 norm (Kailath 1980; Kalman et al. 1963). In
summary, to compute the average controllability value for node i in A, we compute the
Trace(WK ) when node i is the only control node (i.e. BK = ei ).
Modal controllability refers to the ability of a node to control the evolutionary modes
of a dynamical network, and is most interpretable when used to identify states that are
poorly controllable given BK . To calculate modal controllability, one must first obtain
the eigenvector matrix V = [vij ] of the adjacency matrix A. If vij is small, then the jth evolutionary mode of the input-independent form of Eq. (1), x(t) = Ax(t), is poorly
controllable from node i. Following prior work (Pasqualetti et al. 2014), we define φi =
PN
2
2
j=1 (1 − ξj (A))vij as a scaled measure of the modal controllability of each of the N modes
ξ0 (A), ..., ξN −1 (A) from node i.
Finally, we calculate the mean of the regional controllability values either across the whole
brain (Fig. S2.1) or within the cortex and subcortex separately (Figs. 2.3, 2.4, 2.5, 2.6). For
each subject, we define the mean modal controllability to be the sum of the values of φi
for each node within A, divided by the number of regions. Similarly, we define the mean
average controllability to be the sum of the values of Trace(WK ) for each node within A,
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divided by the number of regions.
Linear Regressions Involving Network Control Metrics and Cognitive Performance
For all analyses of network control metrics, we examined the effect of sex while controlling
for age, total brain volume (segmented brain volume, as defined by FreeSurfer BrainSegVol
metric), handedness, and motion during the diffusion scan. We used multiple ordinary least
squares (OLS) linear regression with the lm() command in R (R Core Team 2017) to fit
the following general equation:

C = 1 + βa a + βv v + βh h + βmd md + βs s ,

(2.4)

where C is the controllability statistic (either φi for modal controllability or A for average
controllability), a is age, v is total intracranial volume, md is the mean framewise displacement as a summary measure of in-scanner head motion during the diffusion imaging
sequence, h is handedness, and s is sex. We then used the R package visreg (Breheny
and Burchett 2013) to calculate 95% confidence intervals around fitted lines and generate
partial residuals. Multicollinearity between predictors in regression models can confound
estimates of individual predictor weights. Therefore, we computed the variance inflation
factors (VIFs) (O’brien 2007; Fox et al. 2012) for age, brain volume, handedness, head motion, and sex as a predictor set. This analysis demonstrated VIFs ranging from near 1 (the
minimum possible VIF) to 1.5, well below the conservative threshold of 5 (O’brien 2007),
suggesting that collinearity between predictors was low (Fig. S2.7b).
We also used linear regression to test whether regional network control metrics explain
variance in CPT false positives while controlling for age, total brain volume, handedness,
head motion, and sex. We carried this out by fitting the following equation:

F = 1 + βC C + βa a + βv v + βh h + βmd md + βs s ,
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(2.5)

where F is the false positive rate on the CPT and all other variables are the same as above.
For node-level analyses of controllability, we applied a false discovery rate (FDR) correction
(Benjamini and Hochberg 1995) (q < 0.05) over all nodes to control for Type I error due to
multiple testing.
Non-Linear Fits of Network Metrics
Following Ref.(Tang et al. 2017), we used non-linear models to examine the relationships
between synchronizability, average controllability, and modal controllability (Fig. 2.5). Synchronizability measures the tendency of a network to maintain a stable, global activity state
(Tang et al. 2017; Pecora and Carroll 1998), in contrast to network controllability, which
quantifies the capacity for each node to drive transitions to new states (Gu et al. 2015a). By
assaying the contrasting metric of synchronizability, we provide support for the specificity
of sex differences to control dynamics. We generated estimates of parameters for models
of the form y = a + b exp(cx) via non-linear least squares using the nls() function in R
from the . To compare these fits between males and females, we performed an analysis of
variance (ANOVA). For example, when considering sex differences in the nonlinear relation
between modal controllability and average controllability, we examined the expression:

φi = (a + αs) + (b + βs) exp((c + γs)A) ,

(2.6)

where φi is modal controllability, A is average controllability, and s is sex, coded as 0 for
males and 1 for females, so that α, β, and γ each equal zero for males and the equation is
reduced to the base form. The predicted values for males or females obtained from the full
model were used to generate the curves shown in Fig. 2.5.
Linear Regression of BOLD Data on Network Control Metrics
Finally, and in keeping with our linear systems framework, we sought to test whether
controllability would predict brain state (x(t)) as defined by BOLD activation during a
working memory task. In these analyses (Fig. 2.8), we used the residuals from Eq. 2.4 for
controllability. For activation, we used the residuals from the following equation:
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M = 1 + βa a + βh h + βmn mn + βs s ,

(2.7)

where M is 2-back minus 0-back activation (hereafter referred to as “activation”), a is
age, h is handedness, mn is the mean framewise displacement during the n-back working
memory scan, and s is sex. Because we had no prior knowledge about where controllability
might predict activation, we fit linear models between controllability and activation at every
possible pair of nodes; that is, we performed 234×234 regressions of controllability residuals
at each node with activation residuals at each node. The 234 × 234 matrices of p-values
for the slope of controllability on activation were FDR corrected (q < 0.05) separately for
average controllability and for modal controllability. To identify regions where activation
was associated with executive function, we followed previous work (Satterthwaite et al. 2013;
Shanmugan et al. 2016) by examining d0 , a composite measure of n-back task performance
which takes both correct responses and false positives into account to separate performance
from response bias.
When testing for an interaction between controllability and sex as a predictor of n-back
activation, we defined Cr as the residuals from the following equation:

C = 1 + βa a + βv v + βh h + βmd md ,

(2.8)

and we defined Mr as the residuals from the following equation:

M = 1 + βa a + βv v + βh h + βmn mn ,

(2.9)

where all variable names are the same as above. We carried out this procedure so as
to remove biases of other covariates from controllability and activation values while not
removing the effects of sex, in order to fit the following model:
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Mr = 1 + βCr Cr + βs s + βCsint sCr ,

(2.10)

again for every possible pair of 234 × 234 nodes for average and modal controllability, where
βCsint represents the coefficient for the interaction term between controllability residuals and
sex. We applied FDR correction (q < 0.05) separately for average and modal controllability.

RESULTS
Sex differences in executive function
Our analysis of sex differences in the development of executive function and its neurobiological underpinnings began with a sex-stratified comparison of performance on the continuous
performance task (CPT) (Gur et al. 2010), a task designed to measure sustained attention
and impulsivity. In our sample, there was no sex difference in CPT true positive rate, which
reflects sustained attention. Thus, we focused on the false positive rate in order to capture
impulsivity. Sex differences in CPT impulsivity have been replicated in large studies (Riley
et al. 2016; Hasson and Fine 2012), may underlie increased risk taking in males (Cross et al.
2011), and map intuitively to the notion of brain network control. CPT false positives were
significantly higher in males (full model r2 = 0.25, df = 866, p = 3.8 × 10−5 , Cohen’s
2
2
fsex
= 0.02, Cohen’s fage
= 0.31; Fig. 2.2a) with no interaction between age and sex.

Furthermore, CPT false positives decreased with age (p < 10−15 ; Fig. 2.2a). This result
suggests that development of impulse control occurs via a similar course for males and females, but that males exhibit higher impulsivity in this particular task for all ages studied.
After performing this sex-stratified analysis of the developmental course of the impulsivity,
we next turned to a consideration of its potential neurobiological underpinnings (Fig. 2.1a).
Sex differences in regional network controllability
Our general hypothesis was that sex differences in executive function in youth stem from
sex differences in the controllability of structural brain networks as they rewire over development. Notably, this notion bridges the control of behavior (executive function, impulse
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Figure 2.2: Cognitive development and network controllability by sex. (a) False
positive rate on the continuous performance task (Gur et al. 2010), a measure of impulsivity
and inhibition, displayed a linear relationship to age. Red and blue data points and curves
represent females and males, respectively. Each point represents a subject’s partial residual
with respect to sex; solid lines represent the predicted mean for males and females separately, and shaded envelopes denote 95% confidence intervals of the prediction. (b) Rank of
mean average controllability values at each node across 389 male subjects and 490 female
subjects, separately. The Spearman rank correlation between regional average controllability averaged across males and regional average controllability averaged across females was
r = 0.9915.
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control) with the control of brain dynamics (network controllability). To test this hypothesis, we examined the anatomical distribution of control points in the structural brain
networks of males and females separately. We ranked the mean average controllability
value at each region for males and females separately, which revealed that the distribution
of controller strength is virtually identical between males and females (r = 0.99; Fig. 2.2b).
This result suggests that there is no sex difference in the spatial distribution of controllers
when classified by their relative magnitudes. This finding is consistent with meta-analyses
suggesting that if sex differences in neurological and cognitive phenotypes exist, they are
limited to a few specific cognitive domains (Joel 2012; Hyde 2014).
We next investigated whether the actual (rather than ranked) regional controllability estimates differed by sex, and we addressed this question first by considering the cortex and
subcortex separately. We addressed this question first by considering the cortex and subcortex separately, motivated by the notion of top-down (i.e. cortical) versus bottom-up (i.e.
subcortical) control of behavior (Heatherton and Wagner 2011) relevant to impulse control
(Brewer and Potenza 2008). Specifically, we computed mean controllability values for each
subject across 219 cortical regions and 14 subcortical regions. In the cortex, mean average
2
controllability (r2 = 0.083, df = 873, p = 0.018, Cohen’s fsex
= 0.0065; Fig. 2.3a) and
2 = 0.0067; Fig.
mean modal controllability (r2 = 0.13, df = 873, p = 0.016, Cohen’s fsex

2.3a) are higher in females. Mean modal controllability in the subcortex is also higher in
2 = 0.018; Fig. 2.3b), whereas
females (r2 = 0.046, df = 873, p = 7.5 × 10−5 , Cohen’s fsex

mean average controllability in the subcortex is higher in males (r2 = 0.036, df = 873,
2 = 0.0048; Fig. 2.3b). All analyses of sex differences in cortical and
p = 0.041, Cohen’s fsex

subcortical average and modal controllabillity were statistically significant after controlling
the false discovery rate (q < 0.05). Only in the subcortex did males have higher average
controllability than females; this result suggests that the connectivity profile of subcortical
regions may contribute to sex differences in functional brain dynamics.
In a finer-grained analysis, we investigated whether the controllability of single regions dif-
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fered by sex. Modal and average controllability were separately examined at each region,
while accounting for age, total brain volume, handedness, and mean in-scanner head motion
as model covariates. We found that average and modal controllability differed by sex at a
subset of network nodes after FDR correction (q < 0.05) for multiple comparisons. Nodes
with average controllability values that differed by sex were almost all (4/5) higher in males
and located in the frontal lobe or subcortex (Fig. 2.3c-d). Conversely, nodes with modal
controllability values that differed by sex were all (18/18) higher in females and located
in frontoparietal and subcortical systems. Cohen’s f 2 effect sizes for sex as a predictor of
regional controllability ranged from 0.0097 − 0.030, indicating small effects. Average and
modal controllability may be highly negatively correlated depending on the network topology (Wu-Yan et al. 2017), but we show that the covariance between average and modal
controllability depends on both the subject and the brain region (Fig. S2.2a-c), supporting
distinct interpretations of each metric. We also analyzed sex differences in boundary controllability, which quantifies the extent to which a region is poised to coordinate activity
between modules (Gu et al. 2015a). However, we only found a sex difference at one region
(see Supplemental Text for discussion of findings; Fig. S2.8b) and thus we focus the remainder of our analysis on average and modal controllability. These results suggest that
controller strength differs between males and females in a regionally specific and control
strategy specific manner.
Development of network controllability across the sexes
We next turned to an assessment of whether developmental trends of network controllability differed by sex. We found that controllability in the cortex and subcortex tended to
increase with age, with the exception of average controllability in the subcortex. In the
2 = 0.045; Fig. 2.4b) and subcorcortex (r2 = 0.13, df = 873, p = 5.5 × 10−10 , Cohen’s fage
2 = 0.022; Fig. 2.4d), mean modal
tex (r2 = 0.046, df = 873, p = 1.2 × 10−5 , Cohen’s fage

controllability increases with age for males and females. Mean cortical average controlla2 = 0.075;
bility also increases with age (r2 = 0.083, df = 873, p = 1.7 × 10−15 , Cohen’s fage

Fig. 2.4b). Interestingly, there was a weak age-by-sex interaction only with subcortical
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Figure 2.3: Sex differences in regional controllability. (a-b) Controllability estimates
averaged over 219 cortical nodes (a) and 14 subcortical nodes (b), for average controllability and modal controllability. Females have higher cortical average controllability, cortical
modal controllabillity, and subcortical modal controllability, but males have higher subcortical average controllability. In panels a-b, red and blue represent females and males,
respectively. Each point represents a subject’s partial residual with respect to sex; bar
height represents the predicted mean for males and females separately, and shaded grey
envelopes denote 95% confidence intervals of the prediction. (c-d) Heatmaps where color
intensity corresponds to standardized regression coefficients for sex, with warmer colors
indicating higher controllability in females. Average controllability is depicted in (c) and
modal controllability is depicted in (d). Colors reflect values of standardized regression coefficients for controllability at each node as a predictor of executive function while controlling
for covariates (Eq. 2.4). *, p < 0.05, **, p < 0.01, ***, p < 1 × 10−4 .
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average controllability that did not survive FDR correction (q < 0.05), such that the slope
was positive for males and negative for females (r2 = 0.041, df = 872, p = 0.024, Cohen’s
2 = 0.0059; Fig. 2.4c). However, we found that subcortical average controllability refint

mains stable throughout development for both males (βage = 0.51, t = 1.30, p = 0.19,
df = 872) and females ((βage + βage∗sex ) = −0.68, p = 0.06, t = −1.89, df = 872) (Preacher
et al. 2004). Taken together, these results suggest that controllability changes with age
similarly for males and females, but that average controllability in the subcortex is static
during development, unlike modal controllability or cortical average controllability.
With the knowledge that controllability has a sex-independent relationship with age, we
were interested in testing the hypothesis that sex influences the relationship between different types of controllability in the developing brain. Following prior work characterizing the developmental course of network control properties (Tang et al. 2017), we fit
the relationships between average and modal controllability with the exponential function
y = a + b exp(cx) separately for each sex (Eq. 2.6). Our results showed that males and
females did not have a statistically different relationship between average and modal controllability averaged across the whole brain (p = 0.14, df = 3; Fig. 2.5a,e). In the cortex alone,
average and modal controllability followed an increasing exponential form (Fig. 2.5b,f),
similar to that of the whole brain. In contrast, in the subcortex alone average and modal
controllability followed a decreasing exponential form (Fig. 2.5d,h). When sex was included
in the model, fits improved significantly (cortex: p = 1.8 × 10−8 , df = 3, Fig. 2.5b,f; subcortex: p = 7.0 × 10−9 , df = 3, Fig. 2.5c,g), suggesting that these regions may contain
sex-dependent differences in structural connections important for controlling brain network
state via different strategies.
Next, we performed a specificity analysis to determine whether our results could be further
confirmed by sex differences in a contrasting metric – synchronizability – that probed the
susceptibility of the network to be constrained within a narrow (rather than broad) range of
dynamics. We found that synchronizability did not differ between males and females (S2.1b)
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Figure 2.4: Network controllability as a function of age. (a-d) Relationship between
age and controllability estimates, averaged over 219 cortical nodes (a-b) and 14 subcortical
nodes (c-d), for average controllability (a, c) and modal controllability (b, d). Modal
controllability increases with age in the cortex and in the subcortex; average controllability
increases with age in the cortex. In the subcortex, the p-value for the age-by-sex interaction
for average controllability was < 0.05, although it was not significant after correcting for
the false discovery rate (q < 0.05). Moreover, the simple slopes for males (βage ) and
females (βage + βage×sex ) were not significantly different from 0. Age-by-sex interactions
in panels a, b, and d were not significant. Red and blue represent females and males,
respectively. Each point represents a subject’s partial residual with respect to age; lines
represent regression slopes for males and females separately, and shaded envelopes denote
95% confidence intervals of the slopes. The p values for βage are shown in panels (a,b,d)
and for βage×sex are shown in panel (c).
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Figure 2.5: Sex effects on relationships between metrics of network control and
dynamics. Relationships between whole-brain average and modal controllability (a, e),
between synchronizability and whole-brain average controllability (d, h), and between regional average controllability and regional modal controllability (b-c, f-g). Data from male
subjects is depicted in panels ( a-d) and data from female subjects is depicted in panels
(e-h). Non-linear least squares was used on the base model: y = a + b ∗ exp(c ∗ x), and the
full model: y = (a + α∗Sex) + (b + β∗Sex) ∗ exp((c + γ∗Sex) ∗ x). Slopes represent coefficients
from the full model. The p values were obtained from an ANOVA comparing base and full
models. In these cases, a low p-value indicates that allowing for a sex term in the model
significantly increases the explained variance. *, p < 0.05, **, p < 0.01, ***, p < 1 × 10−4 .
and decreased with age in a sex-independent fashion (S2.1d). Moreover, the exponential
relationship between synchronizability and average controllability did not differ by sex (p =
0.33, df = 3; Fig. 2.5d,h), confirming the local (Fig. 2.3c-d) rather than global (Fig 2.2b)
differences in metrics of network control and dynamics.
Sex differences in network controllability predict individual differences in executive function
While sex differences in network controllability are of interest in understanding the structural drivers of brain dynamics, their impact on behavior requires a link to cognition. Here
we examine the relation between impulsivity on the CPT and network controllability across
cortex and subcortex separately, and then at individual brain regions, while controlling
for age, brain volume, handedness, head motion, and sex. When considering mean sub40
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Figure 2.6: Network controllability and cognitive performance. (a-d) Relationship
between age and controllability estimates, averaged over 219 cortical nodes (a-b) and 14
subcortical nodes (c-d), for average controllability (a, c) and modal controllability (b, d).
Cortical modal controllability (b) is positively correlated with CPT false positive rate while
cortical average controllability (a) is not significantly correlated with CPT false positive
rate. Subcortical controllability (c-d) is not significantly related to CPT false positive rate.
In panels (a-d), red and blue represent females and males, respectively. Each data point
represents a subject’s partial residual with respect to controllability; lines represent regression slopes for males and females separately, and shaded envelopes denote 95% confidence
intervals of the slopes. (e) Brain regions with sex-associated average (top) or modal (bottom) controllability and their relation to CPT false positive rate (FDR corrected, q < 0.05).
Colors reflect values of standardized regression coefficients for controllability at each node
as a predictor of CPT false positive rate while controlling for covariates. For panels (a-e),
there were no significant sex-by-controllability interactions on CPT false positive rate.
cortical controllability and CPT false positives we found that neither average (r2 = 0.25,
2
df = 862, p = 0.23, Cohen’s fave
= 0.0017; Fig. 2.6c) nor modal (r2 = 0.25, df = 862,
2
p = 0.48, Cohen’s fmod
= 5.8 × 10−4 ; Fig. 2.6d) controllability in the subcortex was associ-

ated with impulsivity. A different trend was apparent in the cortex: average controllability
was not significantly related to false positives (r2 = 0.25, df = 862, p = 0.37, Cohen’s
2
fmod
= 9.3 × 10−4 ; Fig. 2.6a), while modal controllability was significantly negatively re-

lated to false positives after FDR correction (r2 = 0.25, df = 862, p = 4.3 × 10−3 , Cohen’s
2
fmod
= 0.0095; Fig. 2.6b).
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Figure 2.7: Controllability mediates the relationship between sex and executive
function. (a-b) Sobel mediation testing (Sobel 1982; Baron and Kenny 1986; Wang 2018)
for sex → controllability → CPT false positive rate, using control nodes that are associated
with sex and predict CPT false positive rate. The only regions displaying these relationships
are the right medial orbitofrontal lobe (average controllability; (a)) and the left postcenteral
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2.3c and Fig. 2.3d are shown; cooler colors indicate higher controllability in males. Age,
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Next, we considered the 21 brain areas that we had previously found to display sex differences in controllability values (5 nodes for average controllability and 18 nodes for modal
controllability, with 2 nodes overlapping). Among nodes with sex differences in average
controllability, average controllability at the right medial orbitofrontal cortex was higher in
2 = 0.014, FDR corrected, q < 0.05;
males and positively related to impulsivity (Cohen’s fave

Fig. 2.6e). Among nodes with sex differences in modal controllability, modal controllability
at the left postcentral gyrus was higher in females and negatively related to impulsivity
2
(Cohen’s fmod
= 0.011, FDR corrected, q < 0.05; Fig. 2.6e).

One parsimonious explanation for these results is that controllability mediates the relationship between sex and impulsivity. We explicitly tested for such a mediation and found that,
indeed, average controllability at the right medial orbitofrontal cortex (Fig. 2.7a) and modal
controllability at the left postcentral gyrus (Fig. 2.7b) were statistically significant mediators of the relationship between sex and CPT false positives. Taken together, these results
suggest that increased orbitofrontal average controllability and decreased postcentral modal
controllability may be biomarkers of impulsivity in males. Interestingly, however, we found
that controllability at several regions without sex-associated controllability values was associated with impulsivity (Fig. S2.9a-b), suggesting that structural network controllability
may explain individual differences in impulsivity outside of the context of sex differences.
We also tested for interactions between sex and regional controllability values as predictors
of CPT false positives, which would indicate a sex-dependent relationship between regional
controllability and impulsivity. We found statistically significant interactions between sex
and average controllability at somatomotor regions, but the simple slopes for males and
females did not differ from 0 (see Supplemental Text for discussion of results; Fig S2.9c).
Relationship between sex, n-back task activation magnitudes, and controllability
Describing the relationship between sex, regional controllability, and impulsivity provides us
with a better understanding of the importance of structural brain networks in sex differences
in executive function. The final aspect of our hypothesis pertains to whether network control
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theory can be used to explain how differences in brain network structure produce divergent
patterns of brain activity that underpin other domains of executive function, such as working
memory. We hypothesized that regional controllability values would predict regional n-back
task activation magnitudes, and that associations between controllability and activation
would differ by sex.
To obtain a reference point for activation profiles associated with strong executive function,
we separately regressed activation at each node on d0 (Satterthwaite et al. 2013). This
analysis identified 113 nodes for which activation was associated with successful task performance (Fig. 2.8a, left). Note that in contrast to the use of CPT false positive rate in
the previous analyses, here we considered the d0 measure to summarize performance on
the n-back task only (Snodgrass and Corwin 1988) so that the performance measure is
directly related to the context in which activation values are measured. Consistent with
prior results (Satterthwaite et al. 2013), we found that relative deactivation of default mode
network regions (Raichle 2015) (i.e. posterior cingulate and medial prefrontal cortex) as
working memory load increased was predictive of performance. Interestingly, males exhibited reduced deactivation in the posterior cingulate cortex with increasing working memory
load (FDR corrected, q < 0.05; Figure 2.8a, right).
After identifying regions at which activation was associated with executive function, we
sought to relate these activation values to controllability metrics of structural brain networks. We found that increasing average controllability was only positively related to
activation (Fig. 2.8b). Average controllability at the right transverse temporal gyrus was
associated with activation at 7 different regions, which cluster together in a symmetric
fashion in inferior temporal cortex (Fig. 2.8c). Modal controllability was not significantly
associated with activation.
Next, we tested our hypothesis that the relationship between regional controllability and activation depends on sex. Specifically, we performed the same analysis on males and females,
separately. Consistent with the pooled analysis, the profile of controllability-activation as-
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sociations overlapped significantly between the sexes (Fig. 2.8d, Fig. S2.5a). While there
was no overlap in the precise regions involved in these sex-split analyses, there were gross
anatomical similarities between males and females. In both sexes, controllability at temporal regions was associated with activation at lateral frontal regions. We observed significant
interactions between controllability and sex in predicting activation (Fig. S2.5c), such that
controllability at middle and inferior temporal lobe were more positively related to activation in females (Fig. S2.5a) than in males (Fig. S2.5b). These results support the notion
that both similarities and differences in structure-function relationships exist across the
sexes.

DISCUSSION
Our study demonstrates that network control theory can be used to explain how differences
in brain network structure produce divergent patterns of brain activity that underpin executive function and its differences across males and females. We first showed that the relative
locations of controllers by strength did not differ between males and females, suggesting
that the overall structure of control points is similar across the sexes. Then, we showed
that controllability covaried with age in a sex-independent fashion in both the cortex and
subcortex. While global and developmental sex differences appear minimal, local sex differences in controllability exist and predict false positives on a CPT, a common measure of
impulsivity. Notably, average and modal controllability significantly mediated the associations between sex and CPT false positive rate, such that male controllability profiles are
negatively associated with impulsivity on the CPT. Crucially, consistent with predictions
from network control theory, we also observed associations between nodal average controllability and n-back task BOLD activation magnitudes that differ by sex, suggesting that
network control theory can help predict how differences in brain network structure may
manifest in different activity patterns.
Implications for cognitive and clinical neuroscience
Impulsivity is generally higher in males (Chapple and Johnson 2007; Gur et al. 2012; Hasson
and Fine 2012; Riley et al. 2016), which is reflected in higher rates of criminality (Cross
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Figure 2.8: Regional controllability predicts n-back task activation and cognitive
performance differently for males and females. (a) Brain regions at which the 2back minus 0-back GLM β weights are associated with 2-back d0 , a summary measure of
task performance in n = 837 subjects with quality fMRI data. (b) Heatmap depicting
standardized multiple linear regression β’s for regional average controllability as a predictor
of regional 2-back minus 0-back activation. Only nodes with associations surviving FDR
correction are shown (q < 0.05). (c) Visual representation of the data presented in panel
(b); average controllability at highlighted nodes is associated with activation at nodes of the
same colors. (d) Associations between activation and average controllability for n = 365
males and n = 472 females, separately. Modal controllability was not significantly associated
with activation. For panels (c,d), corresponding colors indicate association between control
node and regional activation.
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et al. 2011) and substance use (Romer et al. 2009; Weafer and de Wit 2014). While it is
known that sex differences exist in the prevalence of disorders of executive function (Cross
et al. 2011) and the putative neural circuitry involved (Castellanos and Tannock 2002;
Pohjalainen et al. 1998), it is unclear whether the pathophysiology of such disorders is sexspecific or sex-independent. Our study significantly extends the boundaries of knowledge
in demonstrating neurophysiological markers of sex differences in CPT false positive rate,
and in couching such markers within a general network control theory of brain function.
The present work also provides important groundwork for clinical therapy. The delivery
of psychiatric care is shifting towards personalized, targeted interventions. This shift can
be supported by the methodology and computational tools of network neuroscience, where
accurate models of brain structure and dynamics can be constructed for single individuals
(Stephan et al. 2017; Izhikevich and Edelman 2008). Such subject-, age-, and sex-specific
models of brain structure and function can directly inform neuromodulatory therapies such
as transcranial magnetic stimulation by offering predictions about how stimulation will affect both the area being stimulated, and other areas connected to it, thereby producing a
complex spatiotemporal influence on brain state. Specifically, assuming a model of brain
dynamics allows us to determine which nodes could most easily drive transitions in the state
of brain activity via some stimulatory input. The network control theory that we use here
to study the internal modulation of brain state (via undertaking a task requiring executive
function) also makes explicit predictions about the external modulation of brain state (via
stimulation or neurofeedback) (Murphy and Bassett 2017). Indeed, average controllability values were associated with sex-dependent, symmetric patterns of brain activity (Fig.
2.8c-d). Our results suggest that average controllability values explains variance in brain
state, beyond what can be predicted from a simple streamline-weighted adjacency matrix.
Notably, however, estimated effect sizes of sex on controllability, and of controllability on
performance, were in ranges considered small, and thus the practical importance of the
observed sex differences are still unclear. Nevertheless, these observations are the first steps
towards a characterization of brain dynamics that would allow clinicians to predict the
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impact of stimulation given a subject-, age-, and sex-specific network architecture, thereby
producing predictable changes in brain state.
An understanding of the relation between network controllability, sex, and executive function could provide important context for the study and diagnosis of neurological disease and
psychiatric disorders whose prevalence may differ by sex and whose presentation includes
alterations in executive function. In our study, the most robust associations between controllability, sex, and impulsivity were found in the right ventromedial prefrontal cortex and
the left superior parietal lobe.
It is widely known that the prefrontal cortex is important for behavioral planning and
working memory (Tanji and Hoshi 2008; Euston et al. 2012; Eriksson et al. 2015), two key
components of executive function. Decreased volume in the right ventromedial prefrontal
cortex (vmPFC) specifically has been previously implicated in impulsive behaviors among
adolescent males (Boes et al. 2008). Injury to vmPFC has been associated with reduced
motor impulse control, aggression, and violence (Brower and Price 2001; Bechara and Van
Der Linden 2005). Activity in right vmPFC has been shown to increase in adults during
response inhibition (Horn et al. 2003), yet is reduced in individuals with alcohol dependence
(Li et al. 2009). Moreover, regional activation in medial prefrontal cortex has been shown to
differ between males and females (Straube et al. 2009; Goldstein et al. 2005). Clearly, both
structure and function of right medial prefrontal cortex play an important role in impulse
control and may differ by sex. Our demonstration that the local control properties of right
vmPFC differ by sex and explain impulsive behaviors helps link these prior findings to a
dynamical systems framework. Specifically, individuals with high average controllability in
vmPFC may exhibit local structural topology that facilitates transitions away from brain
states underlying impulsive behavior.
Activity in the superior parietal cortex is also critical for working memory (Eriksson et al.
2015), especially in rearranging or manipulating information (Koenigs et al. 2009). While
superior parietal cortex is not typically tied to impulse control, gray matter volume in
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the parietal lobe has been found to peak earlier in females than in males (Lenroot et al.
2007; Giedd et al. 1999). In light of these previous findings, our study provides an important account of sex differences in white matter connectivity profiles at medial frontal
and superior parietal cortex from the dynamical perspective of network control theory. For
instance, the relationship between average controllability and working memory task activation might suggest that this task involves transitions to nearby states. Additionally, the
finding that impulsivity was more strongly related to somatomotor average controllability
in males suggests that increasing average controllability can also support transitions that
are unfavorable for certain behaviors. Superior parietal modal controllability was higher in
females and negatively associated with impulsivity, which may indicate that these regions
exhibit greater support in females for transitions to distant states important for impulse
control. Overall, our results suggest that the connectivity profile of frontoparietal structures is related to sex and is important for executive function, supporting the notion that
disorders of executive function arise in part from altered structural connectivity.
Methodological Considerations
Several methodological considerations are pertinent to this work. First, we use a timeinvariant, linear model of brain dynamics because its network control properties have been
well characterized mathematically. However, it is known that the brain is highly non-linear
and explained well by models incorporating noise (Deco et al. 2011; Izhikevich and Edelman
2008). Yet, the associations between controllability and brain activity that we uncover here
suggest that a simple linear model is sufficient to capture some aspect of the underlying
brain dynamics. Our observations beg the question of how and when linear approximations
of nonlinear dynamics can be useful. As is relatively intuitive, linear approximations of
nonlinear dynamics hold true over short time horizons and in the vicinity of the system’s
current operating point (Leith and Leithead 2000). Additional evidence suggests that time
averaged dynamics and slow fluctuations in the blood-oxygen-level-dependent signal can
also be reasonably modeled with assumptions of linearity (Honey et al. 2009; Galan et al.
2008; Gu et al. 2018). Moreover, even when the dynamics of a system are truly nonlinear,
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one can ask whether the predictions of control from the linear model can be used to infer
the response of the nonlinear system, either statistically or formally (Coron 2009; Whalen
et al. 2015). Initial evidence in neural systems suggests that controllability statistics derived
from the linear model of network dynamics can be used to predict transitions into and out
of bursting regimes in neuronal ensembles (Wiles et al. 2017) and changes in activity states
induced by stimulation in Wilson-Cowan oscillator models of cortical columns (Muldoon
et al. 2016). Nevertheless, it remains an important and interesting direction to build on the
emerging approaches for nonlinear control in the physics and engineering literature (Motter
2015) to better understand the control of nonlinear brain dynamics.
Second, axons transmit information in a unidirectional fashion, but diffusion imaging and
associated tractography tools cannot elucidate the directionality of large axonal fiber bundles. Thus, we construct a symmetric adjacency matrix A, assuming bidirectional influence
between network nodes, and all interpretations of regional controllability depend on the
realism of that assumption. The assumption is supported by evidence from tract tracing in
macaques that the majority of connections at this large scale are bidirectional (Bassett and
Bullmore 2017), and by computational studies demonstrating that controllability statistics
are largely conserved across directed and undirected mesoscale connectomes (Kim et al.
2018). Yet, it is nevertheless important to acknowledge that the eigenvalues of a symmetric
matrix can only ever be real and thus the system will not oscillate, as neural systems are
known to do. It will be interesting in future to consider approaches to study the control of
oscillatory activity in the brain, and to validate those approaches with high-resolution data
such as electrocorticography.
Additionally, streamline counts and network density vary between scans (Zhu et al. 2011)
and with different tract reconstruction methods (Maier-Hein et al. 2017), which can complicate interpretation. Head motion can systematically bias estimates of structural connectivity (Baum et al. 2018), and thus we undertook a rigorous protocol to ensure data quality
(see Methods: Imaging Data Preprocessing). However, despite assuring maximum relia-

50

bility of structural connectivity estimates, we must acknowledge that subjects with worse
head motion might comprise an important population to which our results may not generalize. Despite these limitations common to nearly all network analysis of DTI, numerous
DTI-based studies of neuropsychiatric illness have described differences in structural brain
networks consistent with clinical and neuroscientific priors (Kubicki et al. 2007; Pievani et al.
2011), suggesting that quality-controlled DTI is capable of capturing subtle but meaningful
variation in structural connectivity.
It is also important to acknowledge that our analysis of sex differences focuses on sex
assigned at birth, which we refer to as “sex” throughout this paper. Our data does not
include endocrinological measurements relevant to sex, nor does it include any psychosocial
assessment of gender identity. Thus, we were not able to control for or assess gender-based
differences in brain structure. Furthermore, while there exist two distinct classes of human
genitalia, this fact does not imply that brains are also sexually dimorphic (Joel et al. 2015).
Both “male” and “female” features exist in both male and female brains, though some
features are more common in one sex than the other (Joel et al. 2015; Joel and McCarthy
2017). As a result, there may be more meaningful variance in neurologic phenotypes within
each sex than between sexes. The divergent controllability-activation profiles in Fig. 2.8d
may be in part due to this fact. Nevertheless, biological sex is an easily measured variable
and identifying correlates of sex makes it a useful biomarker. In the future, identification of
additional covariates might help uncover a more ubiquitous reason for sex-associated brain
features (Joel and McCarthy 2017).

CONCLUSION
First and foremost, our analysis of sex differences in structural brain networks showed that
males and females are highly similar from the perspective of network controllability. The
organization of relative controller strength was almost identical between males and females,
and sex was not significantly associated with controllability values at most brain regions.
However, the differences in average and modal controllability between males and females
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predicted differences in cognitive performance and effects were most robust in frontal and
parietal regions. Given that BOLD signal is associated with network controllability, an interesting future study might use time-invariant, linear dynamics to predict changes in brain
activity after stimulation of regions with high versus low controllability. Additionally, our
results pave the way for a future study to consider how sex and age may influence the effects
of diffusion imaging-guided brain stimulation. Such an approach may help clinicians tune
parameters for stimulation a priori based on sex and age, aiding the delivery of personalized
psychiatric care.
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SUPPORTING INFORMATION
Calculating network synchronizability
While the metrics of average and modal controllability provide complementary views on the
diverse dynamics that a brain network can display, it is also useful to study contrasting metrics that probe the susceptibility of the network to be constrained within a narrower range
of dynamics. Previous work has demonstrated that a useful contrasting metric to controllability is synchronizability (Tang et al. 2017), which intuitively measures the susceptibility
of a network to remain in a single synchronous state s(t), i.e. x1 = · · · = xn (t + 1) = s(t).
The master stability function (MSF) allows one to analyze the stability of this synchronous
state without fully characterizing the properties of each feature of the system (Pecora and
Carroll 1998). Within this framework, linear stability depends on the positive eigenvalues
P
λi , i = 1, ..., N − 1 of the Laplacian matrix L defined by Lij = δij k Aik − Aij , where δij
is the Kronecker delta function.
The condition for stability depends on the shape of the MSF, i.e. the stability of the
synchronized state to linear perturbations holds when the MSF is negative for all non-zero
eigenvalues of L. This condition is more likely for a smaller range of eigenvalues, hence we
can use the normalized spread of these eigenvalues to quantify network synchronizability as
N −1
1 X
1
d2 (N − 1)
=
λi
,
where
λ̄
:=
P
N −1
2
σ2
N −1
i=1 |λi − λ̄|

(2.11)

i=1

and d :=

1
N

P P
i

j6=i Aij ,

the average coupling strength per node, which normalizes for the

overall network strength. Using this definition, we calculated the synchronizability of A for
each subject.
Weighted degree does not explain controllability trends
Weighted degree has previously been shown to correlate well with controllability metrics
(Gu et al. 2015a). We performed several specificity analyses to determine whether our
results could be trivially explained by sex differences in the weighted degree of nodes in
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the network. We identified 13 nodes where weighted degree was associated with sex (Fig.
S2.4a), and found that only 5/21 unique nodes with sex-associated controllability values
also had a significant association between weighted degree and sex. Conversely, only 5/13
nodes with sex-associated weighted degree also had sex-associated controllability. When
weighted degree was averaged across the anatomical cortex or subcortex, there were no
significant associations between sex and cortical (r2 = 0.091, df = 873, p = 0.63; Fig.
S2.3a) or subcortical (r2 = 0.076, df = 873, p = 0.12; Fig. S2.3c) weighted degree. These
findings suggest that despite the known associations between controllability and weighted
degree (Gu et al. 2015a), weighted degree does not explain the observed sex differences in
controllability.
Next, we tested whether developmental trends of weighted degree paralleled those of controllability metrics. We found that when averaged across the cortex or subcortex, weighted
degree is positively associated with average controllability and negatively associated with
modal controllability. However, mean weighted degree decreased with age in the cortex
(r2 = 0.091, df = 873, p = 0.0024; Fig. S2.3b), but decreased with age in the subcortex
(r2 = 0.076, df = 876, p = 0.0089; Fig. S2.3d). Neither of these two trends (Fig. S2.3b,d)
were simple mirrors of the relationships between age and regional average or modal controllability (Fig. 2.4), suggesting that developmental trends of controllability reflect a more
complex phenomenon than developmental trends of weighted degree. Furthermore, among
nodes with sex-associated weighted degree or sex-associated controllability, weighted degree
was not significantly associated with the false positive rate on the continuous performance
task. These findings suggest that weighted degree does not explain developmental trends
of controllability, nor does it explain the relationship between sex and executive function.
Finally, we assessed whether the associations between controllability and activation could
be simply explained by the weighted degree of nodes in the network. In a pooled analysis,
we found that as the structural weighted degree of precentral and supramarginal gyri increases, so too does working memory task-related activations in nearby regions(Fig. S2.6).
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Notably, weighted degree-activation profiles did not overlap well with average controllabilityactivation profiles. These results suggest that weighted degree does not explain the relation
between controllability and activation.

Sex differences and developmental trends in boundary controllability
Boundary controllability is another metric of controllability that quantifies the extent to
which a region is poised to coordinate activity between structural modules (Gu et al. 2015a).
In addition to average and modal controllability, we assessed whether there were sex differences and age differences in boundary controllability. We found that in the cortex, mean
boundary controllability was slightly higher for females (r2 = 0.078, df = 873, Cohen’s
2 = 0.0049, p = 0.04; Fig. S2.8a). This effect was likely due to the fact that boundary
fsex

controllability at the right superior frontal lobe was higher in females (Fig. S2.8b). We
found that boundary controllability increased with age at many symmetrically distributed
regions, particularly in medial frontal and cingulate regions (Fig. S2.8c). This finding is consistent with the role of these midline frontal regions as structural hubs (Van Den Heuvel and
Sporns 2011), in combination with increasing modularity throughout development (Baum
et al. 2017). Notably, boundary controllability at any region did not predict false positives
on the CPT (all p > 0.05).

Interactions between sex and controllability on impulsivity
In addition to testing for a mediation relationship between sex, controllability, and impulsivity, we also tested for whether the relationship between controllability and impulsivity
might differ by sex. To accomplish this, we fit a linear model of the following form:

F = 1 + βCs Cs + βC C + βs s + βa a + βv v + βh h + βmd md ,
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(2.12)

where C is the controllability statistic (either φi for modal controllability or A for average
controllability), F is CPT false positives, a is age, v is total intracranial volume, md is
the mean framewise displacement as a summary measure of in-scanner head motion during
the diffusion imaging sequence, h is handedness, s is sex, and βCs is the coefficient for the
interaction term between controllability and sex. We found that there were statistically
significant interaction terms at a number of left-sided somatosensory regions and bilateral
insular regions (Fig. S2.9c) after adjusting for FDR (q < 0.05). A positive interaction term
would mean that the relationship between controllability and CPT false positives was more
positive in females; however, meaningful interpretation of these interaction terms requires
knowing the sex-independent coefficient for controllability. Thus, we computed the simple slopes (Preacher et al. 2004) for males and females separately for each region with a
statistically significant interaction term. We found that none of these simple slopes were statistically significant after adjusting for FDR (q < 0.05). However, the results are displayed
in Fig. S2.9d-e for ease of interpretation of the results in Fig. S2.9c. One could interpret
these findings as evidence for opposite effects of increasing structural network controllability
in males and females. Specifically, increasing somatomotor controllability portends worse
impulsivity in males, but portends better impulse control in females. Interestingly, these
effects are present near the putative somatotopic regions corresponding to the right hand,
which was likely in use during the CPT. These results should be interpreted with caution
as the simple slopes did not reach statistical significance.
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Figure S2.1: Whole-brain network controllability and synchronizability by sex. (a,
c) Average (a) and modal (c) controllability, averaged across all brain regions (hereafter
“global”), comparing males and females. Females have higher global average and modal
controllability than males while controlling for covariates. (b) Whole-brain (“global”) synchronizability decreases with age. (d) Global synchronizability by sex. We observed no significant sex differences in synchronizability or age-by-sex interactions on synchronizability.
Red and blue represent females and males, respectively. Each point represents a subject’s
partial residual with respect to sex; bar height represents the predicted mean for males and
females separately, and shaded envelopes denote 95% confidence intervals of the prediction.
*, p < 0.05, **, p < 0.01, ***, p < 1 × 10−4 .
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Figure S2.2: Relationship between average and modal controllability. (a) Variance
explained (R2 ) between regional average and modal controllability across subjects. While
a few regions (i.e. subcortex, superior parietal lobe) have higher R2 values, average controllability and modal controllability share less than 50% of variance at most brain regions.
This analysis suggests that average and modal controllability can capture distinct information about structural brain networks, consistent with their unique interpretations in linear
time-invariant systems.
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Figure S2.3: Trends between regional weighted degree, age, and sex differ from
those with network controllability. (a-d) Weighted degree averaged over 219 cortical
nodes (a-b) and 14 subcortical nodes (c-d). Panels (a, c) show that no significant sex
differences exist in mean cortical (a) or subcortical (c) weighted degree. Panels (b, d)
show that weighted degree decreases with age in the cortex (b) and increases with age
in the subcortex (d). We observed no significant age-by-sex interactions in these models.
Red and blue represent females and males, respectively. Each point represents a subject’s
partial residual with respect to sex; bar height represents the predicted mean for males and
females separately, and shaded envelopes denote 95% confidence intervals of the prediction.
*, p < 0.05, **, p < 0.01, ***, p < 1 × 10−4 .
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Figure S2.4: Relationship between sex and network controllability is not wellexplained by weighted degree. (a) Heatmaps where color intensity corresponds to
standardized regression coefficients for sex, with warmer colors indicating higher weighted
degree in females. Only five out of twenty-one regions with sex-associated controllability
also have sex-associated weighted degree. Conversely, only five out of thirteen regions
with sex-associated weighted degree also have sex-associated controllability. Continuous
performance task false positive rate was not significantly related to weighted degree at any
node.
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Figure S2.5: Relationships between network controllability and activation by sex.
(a-b) Heatmap of standardized multiple linear regression β’s for regional average controllability as a predictor of regional 2-back minus 0-back activation with covariates regressed
out for n = 472 females (a) or n = 365 males (b). Only nodes with associations surviving FDR correction are shown (q < 0.05). (c) Heatmap of standardized β’s for average
controllability × sex interaction, after FDR correction (q < 0.05). Larger values indicate
more positive relationship between activation and controllability in females. Controllability
in the temporal lobe is more positively related to frontal activation during n-back task.
Notably, controllability × sex interactions were significant in the group-level analysis only
at two control regions, suggesting that sex differences in control-activation relationships are
minimal.
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Figure S2.6: Relationship between weighted degree and activation. (a) Left,
heatmap of multiple linear regression β’s for regional weighted degree as a predictor of
regional 2-back minus 0-back activation. Only nodes with associations surviving FDR correction are shown (q < 0.05). There were only significant associations in the sample of
n = 283 males, and not in the pooled sample or in females alone. Right Visualization of associations between weighted degree and activation. Weighted degree at highlighted nodes is
associated with activation at nodes of the same colors; that is, corresponding colors indicate
an association between regional weighted degree and regional activation.
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Figure S2.7: Head motion by sex and estimates of multicollinearity. (a) Mean head
motion during diffusion weighted imaging does not differ between sexes (p = 0.20) even
when controlling for age. Age-regressed mean head motion values are plotted separately
for males (blue) and females (red). (b) Variance inflation factors (VIF) O’brien (2007); Fox
et al. (2012) for age, brain volume, handedness, head motion, and sex as a predictor set.
The minimum possible VIF is 1, and VIFs of 5 or higher indicates multicollinearity. These
predictors had VIFs between 1 and 1.5, suggesting low multicollinearity.
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Figure S2.8: Sex differences and developmental trends in boundary controllability. (a) Estimates of boundary controllability averaged over 219 cortical nodes (left
subpanel) and 14 subcortical nodes (right subpanel) by sex. *, p < 0.05, **, p < 0.01,
***, p < 1 × 10−4 . Females have higher cortical boundary controllability (p = 0.04). In
panel a, red and blue represent females and males, respectively. Each point represents a
subject’s partial residual with respect to sex; bar height represents the predicted mean for
males and females separately, and shaded grey envelopes denote 95% confidence intervals of
the prediction. (b) Heatmaps where color intensity corresponds to standardized regression
coefficients for sex as a predictor of regional boundary controllability while controlling for
covariates (Eq. 2.4), with warmer colors indicating higher controllability in females. (c)
Heatmaps where color intensity corresponds to standardized regression coefficients for age
as a predictor of regional boundary controllability while controlling for covariates (Eq. 2.4),
with warmer colors indicating higher controllability in females.
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Figure S2.9: Controllability, sex, and impulsivity (a-b) Heatmaps where color intensity
corresponds to standardized regression coefficients for average (panel a) or modal (panel b)
controllability as a predictor of CPT false positives while controlling for covariates (Eq. 2.5),
with warmer colors indicating a more positive association between controllability and CPT
false positives. (c) Heatmaps where color intensity corresponds to standardized regression
coefficients for an interaction term between average controllability and sex as a predictor of
CPT false positives while controlling for covariates (Eq. 2.5), with warmer colors indicating
a more positive relationship in females. (d-e) Heatmaps where color intensity corresponds to
standardized regression coefficients for simple slopes of average controllability as a predictor
of CPT false positives for females (panel d) and males (panel e) separately while accounting
for the interaction terms in panel (c). Note that no simple slopes reached significance after
adjusting for FDR (q < 0.05), but results are shown to aid in interpreting panel (c).
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CHAPTER 3: Temporal sequences of brain activity at rest are
constrained by white matter structure and modulated by
cognitive demands
This chapter contains work from Cornblath, E.J., Ashourvan, A., Kim, J.Z., Betzel, R.F.,
Ciric, R., Adebimpe, A., Baum, G.L., He, X., Ruparel, K., Moore, T.M., Gur, R.C.,
Gur, R.E., Shinohara, R.T., Roalf, D.R., Satterthwaite, T.D., and Bassett, D.S. (2020).
“Temporal sequences of brain activity at rest are constrained by white matter structure and
modulated by cognitive demands.” Communications Biology, in press.
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Abstract
A diverse set of white matter connections supports seamless transitions between
cognitive states. However, it remains unclear how these connections guide the temporal
progression of large-scale brain activity patterns in different cognitive states. Here, we
analyze the brain’s trajectories across a set of single time point activity patterns from
functional magnetic resonance imaging data acquired during the resting state and an
n-back working memory task. We find that specific temporal sequences of brain activity
are modulated by cognitive load, associated with age, and related to task performance.
Using diffusion-weighted imaging acquired from the same subjects, we apply tools from
network control theory to show that linear spread of activity along white matter connections constrains the brain’s state space trajectories at rest, while stimulus-driven
visual inputs explain the trajectories taken during the n-back task. Overall, these results elucidate the structural underpinnings of cognitively and developmentally relevant
spatiotemporal brain dynamics.
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INTRODUCTION
An elusive goal of computational neuroscience is to describe the brain as a dynamical system
with a predictable natural temporal evolution and response to input. Such a model would
be invaluable to clinicians as a generalizable tool for identifying optimal brain stimulation
approaches to drive the brain from various states of disease to states of health (Deco et al.
2019). Yet, the endeavor of identifying a real non-linear dynamical system that provides
such insights is exceedingly difficult, in part due to the high dimensionality of brain activity
and the complex nature of the brain’s intrinsic functional interactions. It is known that the
white matter architecture of the brain contributes to the diverse patterns of activity and
functional connectivity that represent information processing underlying cognitive function
(Honey et al. 2009; Cabral et al. 2017; Shine et al. 2019; Betzel et al. 2014). However,
the exact manner in which white matter connectivity constrains the temporal dynamics
of brain activity remains poorly understood. Improving our understanding requires a rich
characterization of time-varying brain activity, as well as a robust model to link brain
structure with brain activity.
Myriad approaches have been applied to resting functional magnetic resonance imaging
(fMRI) to understand intrinsic brain dynamics. The most common approach (“functional
connectivity”) involves analyzing the correlations between the activity time series of pairs
of brain regions. While pairwise correlation-based approaches summarize inter-regional
synchrony over a period of time, cutting-edge signal-processing approaches to fMRI can
provide a richer account of brain dynamics by considering the whole-brain patterns of
activity at single time points (Karahanoğlu and Van De Ville 2015; Chen et al. 2015; Liu
and Duyn 2013; Vidaurre et al. 2017b; Taghia et al. 2018; Chen et al. 2018; Medaglia et al.
2018; Reddy et al. 2018). One can conceive of the brain as progressing through a state
space whose axes correspond to the activity at each region (Shine et al. 2019; Saggar et al.
2018) (Fig. 3.1a). Each point in this space corresponds to an observed pattern of brain
activity, and the sequential trajectories through this space represent how brain activity
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patterns change over time. This approach allows one to utilize the maximum temporal
resolution offered by BOLD fMRI, unlike many dynamic functional connectivity methods,
which are limited by a minimum window size (Preti et al. 2017). Studies analyzing the
brain’s regional activation space have found that frequently visited activity patterns consist
of different combinations of RSN components (Vidaurre et al. 2017b; Karahanoğlu and Van
De Ville 2015; Liu and Duyn 2013; Petridou et al. 2013; Tagliazucchi et al. 2012). Brain
activity patterns are known to represent information content (Naselaris et al. 2011), distinct
modes of information processing (Barch et al. 2013; Vossel et al. 2014), and attention to
stimuli (Vossel et al. 2014; Gandhi et al. 1999). Such activation patterns occur both at rest
and in the presence of tasks or attentional demands, and are often considered to be neural
representations of cognitive state (Karahanoğlu and Van De Ville 2017; Shine et al. 2019;
Saggar et al. 2018).
However, a fundamental understanding of the brain’s trajectories through regional activation space has been limited by the use of thresholding that disrupts the continuity of the
time series (Karahanoğlu and Van De Ville 2015; Chen et al. 2015; Liu and Duyn 2013), a
focus on between- rather than within-scan differences (Saggar et al. 2018), a narrow focus on
only a few brain regions (Taghia et al. 2018), and various modeling assumptions impacting
the nature of the temporal dynamics detected (Vidaurre et al. 2017b). Such limitations have
also hampered progress in understanding how state-space trajectories might be constrained
by or indeed supported by underlying brain structure. One intriguing possibility is that the
white matter architecture of the brain is designed to support coordinated activity within
RSNs and information transfer between RSNs, which might be reflected in the temporal
progression between distinct states of RSN coactivation. For instance, one could imagine that coactivation of visual regions with dorsal attention regions, followed by activation
of frontoparietal executive control regions might reflect reception, integration, and higher
order processing of a visual stimulus. Critically, the normative neurodevelopment of timeresolved brain state dynamics and their cognitive relevance also remain unknown, limiting
our ability to incorporate such neurobiological features into our understanding of neuropsy78

chiatric disorders with developmental origins (Jernigan et al. 2016; Di Martino et al. 2014;
Satterthwaite et al. 2016; Bassett et al. 2018). Specific neuropsychiatric symptoms, such
as hallucinations or negative rumination, may be represented in coactivation patterns and
their temporal dynamics, which could be disrupted with brain stimulation (Stiso et al. 2018;
Silvanto and Pascual-Leone 2008; Rachid 2018; Chen et al. 2013).
To address these fundamental gaps in knowledge, we consider a large, community-based
sample (n = 879) of healthy youth from the Philadelphia Neurodevelopmental Cohort (Satterthwaite et al. 2014, 2016), all of whom underwent diffusion- and T1-weighted structural
imaging, passive fixation resting state fMRI, and n-back working memory task fMRI (Ciric
et al. 2017; Roalf et al. 2016; Rosen et al. 2018). We begin by using k-means clustering
to extract a set of discrete brain states from the fMRI data (Chen et al. 2015; Liu and
Duyn 2013; Chen et al. 2018; Gutierrez-Barragan et al. 2019), and to assign each functional volume from both rest and task scans to one of those states. We hypothesize that
the brain’s temporal progression between different states is influenced by cognitive demands
and stimuli, which we test by quantifying the time that subjects dwell within states, and the
propensity to transition between states. Next, we hypothesize that structural connectivity
constrains the temporal progression of brain states and explains why these particular brain
states exist. We test these hypotheses using emerging tools from network control theory
(Gu et al. 2015b, 2017; Betzel et al. 2016; Tang et al. 2017; Stiso et al. 2018), along with
comparison to stringent null models (Alexander-Bloch et al. 2018; Betzel and Bassett 2017)
to ensure the specificity of our findings. Finally, we hypothesize that brain state dynamics
change throughout development to optimize cognitive performance.
By rigorously testing these hypotheses, we find increased temporal persistence of a state
associated with high activity in frontoparietal cortex during task. On the other hand, states
associated with coherent activity in default mode areas have similar temporal persistence
between rest and task with an increased rate of appearance during rest. Interestingly,
two divergent trajectories towards frontoparietal and default mode states following from a
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Figure 3.1: Schematic of methods for functional image analysis. (a) Regional BOLD
time series from resting-state and n-back task scans are concatenated across subjects. Each
row in this concatenated data matrix represents a point in a high-dimensional space whose
axes correspond to regional activity. A schematic of a low-dimensional version of this space
is shown as an example on the right. Our goal is to identify frequently visited locations
in this space and study the temporal progression between these locations during rest and
task. (b) We then apply a k-means clustering algorithm to generate a series of cluster labels
that can be mapped back to individual subjects, producing subject-specific brain state time
series.
sensory-driven state are positively and negatively related to task performance, respectively.
Using tools from linear network control theory, we show that state transitions with small
energy requirements given the brain’s white matter architecture occur more frequently in
the observed data than state transitions with large energy requirements. Additionally,
accounting for visual input explains the differences in state-space trajectories between rest
and task. Finally, we show that brain state dynamics and predicted energies of state
transitions are associated with age and explain individual differences in working memory
performance. Overall, we demonstrate the utility of state-space models in understanding
the structural basis for developmentally and cognitively relevant context-dependent brain
dynamics.
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RESULTS
Brain states capture instantaneous coactivation between resting state functional networks
The spatiotemporal dynamics of brain activity are exceedingly complex and not fully understood. Analyzing pairwise correlations between regions over time (“functional connectivity”
or FC) is a common approach used to quantify interactions between brain regions. However,
static FC does not necessarily account for spontaneous or stimulus-evoked coactivation observed at single time frames (Supplementary Fig. S3.1), which is the maximum temporal
resolution offered by BOLD fMRI for a given repetition time (TR) (Liu and Duyn 2013; Liu
et al. 2013). Here, we used k-means clustering (Liu and Duyn 2013; Gutierrez-Barragan
et al. 2019; Cabral et al. 2017) to assign each time point from resting and n-back task
fMRI scans into clusters of statistically similar and temporally recurrent whole-brain spatial coactivation patterns, hereafter referred to as “brain states” (Fig. 3.1a). We found that
little additional variance in BOLD signal was explained by increasing k beyond 5, and the
clustering solution at k = 5 demonstrated high reliability in split-half resampling (Supplementary Fig. S3.2). Importantly, we found that these BOLD data exhibited clustering in
regional activation space beyond what would be expected from signals with the same autocorrelation profiles (Supplementary Fig. S3.3a). Additionally, states were highly similar
between rest and n-back task scans (Supplementary Fig. S3.4b), in a second parcellation
(Supplementary Fig. S3.5a), in an independent sample with older subjects (Supplementary
Fig. S3.6a-c), and after removal of high-motion frames (Supplementary Fig. S3.7a-b).
We found that “resting-state functional networks” (RSNs) (Yeo et al. 2011; Schaefer et al.
2017), groups of regions with stronger static FC with each other than with other regions,
exhibited coherent high or low amplitude activity within each cluster centroid. This finding
is consistent with strong within-network FC. Due to their similarity to RSNs, we named
each of the five states that we observed after the previous RSN whose isolated high or
low amplitude activity best explained each state. This choice did not influence any anal-
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Figure 3.2: Brain states represent coactivation within and between resting state
functional networks. (a) Brain states defined as the centroids of clusters identified using
an unsupervised machine learning algorithm applied to rest and n-back task fMRI data.
Brain states are labeled based on cosine similarity with a priori resting state functional
networks (RSNs) (Yeo et al. 2011). The top label corresponds to the RSN with the most
overall similarity, and the bottom two labels separated by a forward slash reflect the RSNs
with the most similarity to the positive and negative components of each state, respectively.
(b) Cosine similarity between positive (black) and negative (red) components of each state
with binary state vectors corresponding to a priori definitions of RSNs (Yeo et al. 2011).
Larger radial values correspond to higher cosine similarity. DAT, dorsal attention network,
DMN, default mode network, FPN, frontoparietal network, LIM, limbic network, SOM
somatomotor network, VAT, ventral attention network, and VIS, visual network.
yses and is solely for convenient interpretation. We refer to them as the DMN+, DMN-,
FPN+, VIS+, and VIS-, representing activity above (+) or below (-) regional means in
default mode (DMN), frontoparietal (FPN), and visual networks (VIS), respectively (Fig.
3.2a). We also asked which additional RSNs exhibited coherent activity in each state by
quantifying the alignment of the high and low amplitude components of each brain state activity pattern separately with each RSN, indicating the presence of coherent activity within
SOM (somatomotor network), DAT (dorsal attention network), and VAT (ventral attention
network) (Fig. 3.2b).
Interestingly, in addition to coherent activity within each RSN, we found that centroids
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contained multiple RSNs simultaneously exhibiting coherent high or low amplitude activity.
For example, the DMN exhibited high amplitude while the DAT simultaneously exhibited
low amplitude in the DMN+ state. This spatial organization likely reflects known patterns
of between-network FC between task-positive and task-negative systems (Fox et al. 2005)
(Supplementary Fig. S3.8a, mean r = −0.10, one-sample t-test, df = 878, t = −80.45,
p < 10−15 ). However, the DMN-, VIS+, and VIS- states evidence unexpected, transient
patterns of coactivation between VIS and SOM systems. Specifically, in the DMN- state,
SOM and VIS regions were both at high amplitude (Fig. 3.2b). In the VIS+ state, SOM
regions were at low amplitude and VIS regions were at high amplitude (Fig. 3.2b). In the
VIS- state, SOM regions were at high amplitude and VIS regions were at low amplitude
(Fig. 3.2b). Despite the presence of three unique coactivation patterns between these two
RSNs, the mean FC between regions in VIS and SOM did not significantly differ from 0
(Supplementary Fig. S3.8a, mean r = −0.0012, one-sample t-test, df = 878, t = −0.085,
p = 0.40). These patterns of simultaneous activation and deactivation provide a snapshot of
instantaneous interactions between RSNs that could not be obtained through the analysis
of FC.
Temporal patterns of brain state occurrence and occupancy
After identifying large-scale brain states representing instantaneous coactivation between
RSNs, we were interested in comparing the dynamics of brain state occupancy and dwelling
between rest and n-back scans (Fig. 3.3a). To provide a rich characterization of the dynamics of brain state occupancy, we defined and studied three related metrics for each state: (1)
fractional occupancy, the percentage of frames assigned to a state for a given scan or condition, (2) dwell time, the mean duration in seconds of temporally continuous runs of state
occupancy, and (3) appearance rate, the number of times a run of any length appeared per
minute. Using paired t-tests, we assessed whether the population means of subject-specific
differences between n-back and rest (µnback−rest ) for each of these metrics were different
from 0. Here, we focus on the FPN and DMN, whose activation and suppression, respectively, are classically seen during cognitively demanding tasks (Anticevic et al. 2012; Fox
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et al. 2005; Scolari et al. 2015).
During the n-back task, we observed lower fractional occupancies in the two default mode
states (paired t-tests, df = 878, t = −31.38, DMN+: µnback−rest = −7.10, pcorr < 10−15 ,
DMN-: µnback−rest = −6.15, df = 878, t = −30.57, pcorr < 10−15 ). However, higher
fractional occupancy in DMN states at rest was best explained by increased appearance
probability of DMN states at rest (paired t-tests, DMN+: µnback−rest = −0.77, df = 878,
t = −40.03, pcorr < 10−15 , DMN-: µnback−rest = −0.68, df = 878, t = −40.74, pcorr <
10−15 ), while dwell time in DMN states did not differ between rest and task (paired t-tests,
DMN+: µnback−rest = −0.01, df = 878, t = −0.17, pcorr = 1, DMN-: µnback−rest = 0.06,
df = 878, t = 1.45, pcorr = 0.73). Lower DMN+ state fractional occupancies during
the n-back task is consistent with DMN suppression observed during attention-demanding
tasks (Anticevic et al. 2012). However, the high DMN- fractional occupancy suggests that
coherent DMN suppression is not specific to task conditions, and may occur in the context of
a unique, transient interaction with primary sensory areas (Fig. 3.3a). Interestingly, FPN+
state fractional occupancy was similar between rest and task, despite higher dwell time with
a lower appearance rate in the n-back task (paired t-tests, FPN+ dwell time: µnback−rest =
0.95, df = 878, t = 23.69, pcorr < 10−15 , FPN+ appearance rate: µnback−rest = −0.26,
df = 878, t = −14.74, pcorr < 10−15 ). These findings suggest that the FPN is activated
more frequently albeit transiently at rest, while sustained activation of the FPN is found
during the n-back working memory task.
Next, we decided to examine the dynamics of DMN suppression and FPN activation as a
function of cognitive load within the n-back task and as a predictor of task performance. We
hypothesized that as cognitive load increased, DMN+ fractional occupancy would decrease
and FPN+ fractional occupancy would increase. As expected, the FPN state fractional
occupancy increased from the 0-back to the 2-back block (Fig. 3.3d). Interestingly, spatially
anticorrelated DMN states both decreased with increasing cognitive load (Fig. 3.3d). This
finding suggests that working memory involves reduced representation of brain states with
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coherent activity in the DMN, whether high or low amplitude, and increased representation
of the high amplitude FPN state, clarifying the roles of task-positive and task-negative
networks (Anticevic et al. 2012; Fox et al. 2005; Scolari et al. 2015). Next, when we examined
associations between fractional occupancy and block-specific working memory performance
(Fig. 3.2c-d), we found that increasing FPN+ fractional occupancy (Fig. 3.3e; multiple
linear regression, standardized βF O = 0.12, df = 872, t = 3.85, pcorr = 1.9 × 10−3 ) and
decreasing DMN+ fractional occupancy (Fig. 3.3e; multiple linear regression, standardized
βF O = −0.15, df = 872, t = −4.71, pcorr = 4.4×10−5 ) were associated with working memory
performance during the 2-back block. However, for 0-back blocks, these trends were reversed
(Fig. 3.3e, multiple linear regression; 0-back FPN+, standardized βF O = −0.11, df = 872,
t = −3.49, pcorr = 7.7 × 10−3 ; 0-back DMN+, standardized βF O = 0.10, df = 872, t = 2.96,
pcorr = 0.047). This pattern of results might reflect the engagement of alternative systems
for low difficulty tasks by strong performers, thus introducing a layer of complexity to the
notion of DMN and FPN as primary task-negative and task-positive systems (Fox et al.
2005).
Transitions between brain states
After demonstrating that cognitive demands influence dwell times in large-scale brain states,
we were interested in how cognitive demands would affect transitions between large-scale
brain states. We conceptualized brain state transitions as directional trajectories between
different locations in a high-dimensional space whose axes correspond to the level of activity
in each brain region. Neuroimaging studies suggest that the brain progresses along a lowdimensional manifold in regional activation space (Shine et al. 2019; Saggar et al. 2018),
but it remains unknown the extent to which specific trajectories in this space are influenced
by cognitive demands and may represent cognitive processes.
Here, in order to study the relationship between cognition and progression through regional
activation space, we computed transition matrices for each subject’s resting state scan, nback task scan, and each condition of the n-back task scan. Because we were interested in
state changes, we constructed transition matrices that ignore the potentially independent
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Figure 3.4: Brain state transitions are influenced by task demands and related
to behavior. (a-b) Group average state transition probability matrices for resting state
scans and the 2-back condition. Matrix elements reflect the probability of a state transition
after removing the effects of state autocorrelation. (c) Non-parametric permutation testing
demonstrating differences between the rest and n-back group average transition probability
matrices. *, pcorr < 0.05, after Bonferroni correction over 20 transition probabilities. (d)
Standardized linear regression β weights for the transition probability during the 2-back
condition of the n-back task as a predictor of task performance during the 2-back condition. Transitions from the VIS- state into the DMN+ and FPN+ states are negatively and
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at 0.25. (g) Graphical representation of results shown in panel d.
effects of state persistence, or autocorrelation, and only capture the probabilities of moving
to new states; that is, the ij th element of the transition matrix represents the transition
probability between state i and state j given that a transition out of state i is occurring
(Fig. 3.4a, see Methods). As an initial step, we used two null models to confirm previous
findings (Vidaurre et al. 2017a) that brain state transitions are non-random, in that the
observed transition probabilities would be unlikely in uniformly random sequences of states
and state transitions (Supplementary Fig. S3.9).
Next, we explored how cognitive load impacts brain state transitions using a non-parametric
permutation test to assay for differences between transition matrices computed from resting
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state scans and from the 2-back condition of the n-back task. We hypothesized that we
would see more transitions from states driven by sensory cortex activation into states driven
by activation in executive control and attention areas, reflecting reception, integration, and
task-relevant processing of stimuli. Indeed, we found that transitions from VIS+ and VISstates into the FPN+ state were increased during the 2-back condition compared to rest
scans (Fig. 3.4b). Transitions from DMN+, DMN-, and FPN+ states into VIS+ states
were also increased in the 2-back condition, likely reflecting the interruption of ongoing
transmodal processing by sensory input. Finally, we tested for associations between 2back transition probabilities and performance during the 2-back condition. In support of
our hypothesis, we found that transitions from the VIS- state to the DMN+ state were
negatively associated with performance (Fig. 3.4d, multiple linear regression, standardized
βT P = −0.14, df = 873, t = −4.42, pcorr = 2.24 × 10−4 ), while transitions from the VISstate to the FPN+ state were positively associated with performance (Fig. 3.4d, multiple
linear regression, standardized βT P = 0.14, df = 873, t = 4.37, pcorr = 2.84 × 10−4 ).
These results are consistent with prior work positing roles for the FPN and DMN as taskpositive and task-negative systems (Fox et al. 2005), but suggest that interactions with
motor, visual, and salience networks found in the VIS- state may also contribute to working
memory. Overall, these findings suggest that specific trajectories in brain activation space
are favored during increased cognitive load and may represent task-relevant processing.
Control properties of white matter networks explain brain state transitions
In the previous section, we described how the presence of cognitive demands and sensory
inputs leads the brain towards certain trajectories in state space. However, it is not well
understood how the static white matter connectome contributes to these divergent dynamics. Here, we modeled the influence of structure on brain activity as the time-evolving state
of a linear dynamical system defined by white matter connectivity. By applying tools from
network control theory (Fig. 3.5a; see Methods, subsection “Network Control Theory”
and Supplementary Information, subsection “Calculating transition energy using control
theory”), we calculated the transition energy as the minimum input energy needed to tran-
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sition between every pair of the empirically observed brain states. In all calculations, we
allowed the inputs to come from all brain regions, weighted either uniformly or towards a
particular cognitive system (Yeo et al. 2011). Using this framework, we tested a series of
hypotheses unified under the notion that the brain prefers trajectories through state space
requiring minimal input energy given structural constraints.
First, we hypothesized that the brain is optimized to support the observed brain states
and state transitions with relatively little energy. We measured brain state stability as
persistence energy, or the energy needed to maintain each state. In a single representative
human structural brain network (Betzel et al. 2017; Roberts et al. 2017) (see Methods for
details), we compared the transition and persistence energies for real structural connectivity
(Fig. 3.5b) and for two null models based on the group average human structural brain
network: (1) a null model that preserves only degree sequence in the networks (Rubinov and
Sporns 2010) (Deg. Pres., DP), and (2) a null model that preserves degree sequence, edge
length distribution, edge weight distribution, and edge weight-length relationship (Betzel
and Bassett 2017) (Strength-Length Preserving, SLP). Compared to the DP null model,
transition and persistence energy were always lower in the group average SC (Fig. 3.5b,
all pcorr < 0.001). Compared to the SLP null model, every single persistence energy value
and all but two transition energy values were lower in the group average SC (Fig. 3.5b,
pcorr < 0.001). Finally, we found that the energy required to maintain the DMN+ state was
lower than a set of null states with similar spatial covariance (Alexander-Bloch et al. 2018)
(Supplementary Fig. S3.10). Collectively, these findings suggest that unique geometric
and topological features of white matter networks allow for low energy transitions and
maintenance of the empirically observed functional states.
Next, we hypothesized that the brain prefers trajectories through state space that require
little input energy to achieve in a dynamical system defined by white matter connectivity.
To test this hypothesis, we computed the Spearman correlation between transition energy
values and transition probabilities observed during resting state scans and during the 2-back
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condition of n-back task scans (Fig. 3.5c-d). When inputs are evenly weighted throughout
the whole brain (Fig. 3.5c), transition energy values are strongly anticorrelated with resting
state transition probabilities and weakly correlated with 2-back transition probabilities.
Importantly, the energy estimates from real structural connectivity were more strongly
anticorrelated with resting state transition probabilities than energy estimates from null
models or transition distance in state space alone (Spearman’s r = −0.86, pSLP < 0.001,
pDP < 0.001, Supplementary Fig. S3.11b). When inputs are biased towards the visual
system (Yeo et al. 2011) (Fig. 3.5d), transition energy values are strongly anticorrelated
with 2-back transition probabilities (Spearman’s r = −0.81) and weakly correlated with
resting state transition probabilities (Spearman’s r = −0.03). However, this result was
primarily explained by transition distance in state space, rather than the effects of structure
(pSLP = 1, pDP = 1). Overall, these findings suggest that linear diffusion of brain activity
along white matter tracts constrains brain state transitions at rest, and that the distribution
of inputs to the brain is an important factor in the brain’s progression through state space.
Brain state dynamics and control energies are associated with age
Developmental changes in white matter, grey matter, functional networks, and task-related
activations accompany changes in behavior and cognition (Richards and Xie 2015; Power
et al. 2010; Satterthwaite et al. 2013b; Betzel et al. 2014; Hutchison and Morton 2015).
However, it is unclear how state space trajectories and their supporting structural features
contribute to these cognitive and behavioral changes. Given that the spatiotemporal brain
dynamics identified by our approach have clear structural underpinnings, we hypothesized
that these dynamics change throughout normative neurodevelopment in support of emerging
cognitive abilities (Tang et al. 2017; Cui et al. 2018).
We used multiple linear regression to ask whether age was associated with state dwell times
and fractional occupancies while controlling for brain volume, handedness, head motion, and
sex as potential confounders. Interestingly, we found that fractional occupancies in FPN+
and DMN+ states exhibited context-dependent associations with age (Fig. 3.6a). FPN+
fractional occupancy increased with age for all blocks of the n-back task (Fig. 3.6a; multiple
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Figure 3.5: Linear dynamics along white matter explain brain state transition
probabilities. (a) Schematic demonstrating calculation of minimum control energy needed
to move a linear dynamical system defined by white matter connectivity from some initial
state xo to some final state xfi over a time horizon T . (b) Schematic of network null models
(left) preserving different spatial and topologic features of networks defined by white matter
connectivity. The energies (Emin ) required to maintain or transition between each state
are lower in real brain networks compared to these null models (right). (c-d) Spearman
correlation between structure-based transition energy prediction (x-axis) and empirically
derived transition probability (y-axis) for resting state (left) and the 2-back condition of
the n-back task (right), using inputs weighted evenly throughout the whole brain (c) or
weighted positively towards the visual system (d). Linear fit of rank values are shown due
to the monotonic, non-linear relationships in the data.
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task. *, pcorr < 0.05 after Bonferroni correction over 20 state transitions. (c) Standardized
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linear regression, 2-back standardized βage = 0.12, df = 873, t = 3.40, pcorr = 0.014) and
not rest, while DMN+ fractional occupancy increased with age for rest only (Fig. 3.6a;
multiple linear regression, standardized βage = 0.12, df = 873, t = 3.59, pcorr = 0.015).
The relationships between dwell time and age followed similar but weaker trends to those
observed with fractional occupancy, with the exception of resting state DMN+ state dwell
time which increased with age. We also found that the minimum control energy required to
undergo all transitions that terminated in the DMN+ state decreased with age (Fig. 3.6c; all
pcorr < 0.05). This finding suggests that age-associated structural changes allow individuals
to coherently activate the default mode network with greater ease, and is consistent with
the observation that DMN+ dwell time and fractional occupancy increase with age at rest.
We also assessed whether transition probabilities were associated with age. Using multiple
linear regression, we tested for relationships between transition probabilities or transition
energy values and age, while controlling for brain volume, handedness, head motion, and
sex. Similar to the context-dependent associations with age that we observed with fractional
occupancy, we found that transition probabilities were differentially associated with age
across the conditions of the n-back task (Fig. 3.6e-h). The probability of transitions from
both DMN- (Fig. 3.6f; multiple linear regression, standardized βage = 0.15, df = 873,
t = 4.33, pcorr = 1.7 × 10−3 ) and DMN+ (Fig. 3.6f; standardized βage = 0.13, df = 873,
t = 3.68, pcorr = 0.025) into FPN+ during the n-back task increased with age. This
observation is particularly interesting in light of previous work implicating the DMN and
FPN in increasing working memory performance across development (Satterthwaite et al.
2013b). Specifically, this result provides evidence for the importance of direct switching
between DMN and FPN states, as opposed to deactivation and activation without any
temporal constraints. Overall, these findings suggest that task-oriented and spontaneous
brain dynamics involving the DMN and FPN may mature through independent processes.
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DISCUSSION
In the present study, we examined the temporal sequence of whole-brain activity patterns
in individuals during rest and task, and demonstrate a structural basis for large-scale brain
activity patterns and their dynamic temporal evolution. Using a diverse array of techniques
from network neuroscience, dynamical systems, and network control theory, we generated
new insights into the complex relationship between brain structure, spatiotemporal patterns
of brain activity, neurodevelopment, and behavior.
Cognitive functions are often represented as brain activity patterns (Barch et al. 2013), but
substantially less is known about how sequences of activity patterns may represent links
between cognitive functions. In this paper, we considered each fMRI image acquisition to
be a point in a high-dimensional state space whose axes correspond to regional activity.
Next, we identified brain states as frequently visited locations in this space comprised of
combinations of active and inactive brain networks (Yeo et al. 2011). Finally, we described
the directional trajectories between these states in time as state transitions. Our work adds
to a body of literature suggesting that coactivation of brain networks at relatively short
temporal scales evidences rich functional interactions supporting behavior (Vidaurre et al.
2017b; Karahanoğlu and Van De Ville 2015; Chen et al. 2018). For instance, we found that
the brain state transition probabilities observed at rest were strongly modulated by cognitive
demand. During resting state scans, in which external stimuli are constant over time,
transitions likely occur spontaneously, while during n-back task scans, transitions are likely
caused by a combination of spontaneous fluctuations, stimulus-evoked activity in primary
sensory areas, and task-related activity changes in higher order association areas. In the
n-back task, we found more frequent transitions into states driven by coactivation of sensory
systems from states involving coactivation of higher order association areas when compared
to the resting-state. This finding was present in two independent samples (PNC and HCP)
with different task structure and is consistent with increased top-down modulation (Vossel
et al. 2014) of sensory input during task performance.
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We also found that certain trajectories in state space were related to task performance. The
VIS- state occurred more frequently during the n-back task and is composed of visual cortex
suppression alongside mixed dorsal and ventral attention network activation, consistent
with top-down suppression of sensory cortex (Vossel et al. 2014). While its occupancy
alone was not related to task performance, transitions from VIS- to FPN+ or DMN+ were
positively and negatively associated with performance, respectively. These findings suggest
that early stimulus processing followed by manipulation (D’Esposito et al. 1999) of taskrelevant information facilitates accurate performance, while stimulus processing followed by
internally directed cognition (Anticevic et al. 2012) is detrimental to performance. More
broadly, this result suggests that the paths through which activation patterns are reached
are important, in addition to the activation patterns themselves.
Our major contribution to cognitive neuroscience and applied network science lies in describing how linear diffusion of activity along a static white matter architecture constrains
trajectories through brain activation space at rest. We hypothesized that the state space of
brain activity could be explained by two components: linear diffusion of activity along white
matter tracts (Abdelnour et al. 2014) and some nonlinear inputs, which include but are not
limited to neuronal membrane dynamics, metabolic factors, and external stimuli. Under
this model, we solved for the magnitude of these nonlinear inputs required to maintain and
transition between brain states, given the constant constraint of linear diffusion of activity
along white matter tracts.
Using this approach, we found that the brain empirically prefers trajectories in state space
requiring the least energy needed to overcome structural constraints for a given set of inputs. Specifically, when we modeled uniformly weighted inputs or input weighted towards
the DMN, the resulting transition energy values best explained resting state transition probabilities, possibly reflecting a regime with heterogeneous drivers centered around the DMN
(Anticevic et al. 2012). As expected, these transition energies did not explain transition
probabilities during the 2-back condition, likely due to task-derived inputs which were not
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explicitly modeled. Indeed, when we weighted system input towards the visual system to
account for the frequent delivery of visual stimuli, we were better able to explain 2-back
transition probabilities. While this finding represents constraints of distance alone and not
white matter topology, it quantitatively explains how that stimulus-derived input alters
the state-space trajectories of the brain. Future investigations may resolve the effects of
structure on task dynamics using data-driven approaches that attempt to recover the full
set of task-related inputs (Ashourvan et al. 2019; Becker et al. 2018).
Unlike previous time point level fMRI analyses (Vidaurre et al. 2017b; Karahanoğlu and
Van De Ville 2015; Chen et al. 2018), our method unambiguously labels every time point
in every subject for rest and n-back as belonging to a discrete, common state. We intentionally designed our method in this way to make comparisons across contexts and across
subjects throughout different developmental stages (Stiles and Jernigan 2010; Casey et al.
2008). Indeed, these comparisons revealed context-specific associations between age and
brain state dynamics, suggesting that as brain structure develops, multiple trajectories
through state space are supported. Our study offered insights into previously unexplored
time-resolved brain dynamics in normative neurodevelopment. Neuropsychiatric illnesses
such as schizophrenia, autism, epilepsy, and ADHD are increasingly considered developmental disorders, and therefore it is critical to understand the maturation of brain dynamics
in healthy youth. Previous studies have shown that structural and functional changes in
the DMN and FPN accompany normal cognitive development (Supekar et al. 2010; Luna
et al. 2010; Casey et al. 2000). Here we contribute to our understanding of these networks
by demonstrating context-dependent associations between age and DMN and FPN state
dynamics (Fig. 3.6a,d-e). Interestingly, both fractional occupancies and state transition
probabilities exhibit context-dependent associations with age, with DMN+ fractional occupancies increasing with age at rest only (Fig. 3.6a), FPN+ fractional occupancies increasing
with age in n-back only (Fig. 3.6a), and DMN to FPN+ transitions increasing with age
during task only (Fig. 3.6e). However, like other cross-sectional studies of the relationship
between brain function and age (Satterthwaite et al. 2013c; Sato et al. 2014; Satterthwaite
96

et al. 2013b), we found relatively small effects of age on individual measures. Consistent
with the finding of DMN+ fractional occupancy increasing with age, we also found that
the predicted energy of transitioning into the DMN+ state from all other states decreased
with age. However, we did not find a significant relationship between DMN+ transition energy values and DMN+ fractional occupancy across subjects. Future work should explore
how the relative architecture of control energies within subjects may explain a bias towards
certain trajectories over others.
Methodological limitations
We acknowledge that a limitation of this study was a focus on discrete brain states with
common spatial activity patterns across subjects rather than a combination of continuously
fluctuating spatial modes of brain activity (Shine et al. 2019; Karahanoğlu and Van De Ville
2015). While BOLD fMRI fluctuations are generally thought to be continuous in nature,
several studies have found evidence for temporally “bursty” whole-brain activity patterns
(Betzel et al. 2019; Thompson and Fransson 2016; Tagliazucchi et al. 2012), consistent
with discrete, event-like dynamics. Additionally, a discrete model is consistent with the
notion of that specific patterns of neural activity and connectivity represent information
(Ritchie et al. 2017; Churchland and Sejnowski 1990). k-means clustering and principal
component analysis (PCA) are two related techniques (Ding and He 2004) providing discrete
and continuous solutions, respectively. We observed that our cluster centroids separately
corresponded to the positive and negative versions of the spatial principal components
of our data, suggesting that these two approaches would likely reveal convergent findings.
However, our discrete approach approach constituted a major strength of the study, because
it allowed us to study sequences of brain activity using approaches from stochastic process
theory (Cox and Miller 1977), including calculating transition probabilities. The discrete
model also allowed us to use network control theory to relate structural connectivity to brain
activity patterns at each image acquisition, while PCA models each image acquisition as a
mixture of lower dimensional components. Assuming that our clusters are comparable to
positive and negative loadings on principal components (PCs), then the clustering approach
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employed here essentially provides a data-driven thresholding to identify time points when
the brain moves from a loading on one spatial mode to another, while providing information
about the direction (positive or negative) of loading on those components involved in those
transitions. An arbitrary threshold would be required to identify these time points relative
to PC time courses. Discretization also allows us to easily identify, for example, that
a negative loading on PC i tends to be followed in time by a negative loading on PC
j, whereas the analagous continuous approach of computing a lagged correlation value
between PC time courses would not by itself discern between positive following positive
and negative following negative. Importantly, our approach also inherently accounts for the
temporal autocorrelation within the BOLD signal (Woolrich et al. 2001) by measuring state
transitions while excluding state persistence.
We also demonstrated that k = 5 yields stable cluster partitions robust to outliers (Supplementary Fig. S3.2), and our results were consistent for multiple values of k (Supplementary
Fig. S3.12). These findings suggest that k = 5 is not a “magic number” of states visited
by the brain, but rather one scale at which the brain can be studied. One can always identify k clusters from a dataset; however, in our case, we showed that the observed cluster
centroids depended on the covariance structure of the BOLD data that was not explained
by autocorrelation (Supplementary Fig. S3.3), suggesting that the studied states reflect
non-trivial coactivations between brain regions. Nevertheless, discretizing a system that
exhibits continuous behavior will remove information, some of which may be important for
understanding brain-behavior relationships.
The relatively low sampling rate (TR = 3s) likely limited our ability to resolve fast changes
in brain activity. Nevertheless, we were able to resolve the effects of specific brain state
transitions on behavior (Fig. 3.4d, g). Additionally, there likely exist meaningful differences
in individual brain state topographies (Kong et al. 2018; Gratton et al. 2018) that certainly
warrant further investigation, but could not be studied convincingly here due to the relatively small number of time frames acquired for each subject. To partially address these
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limitations, we reproduced key findings in a second parcellation (Supplementary Fig. S3.5)
and an independent sample with a higher sampling rate and no global signal regression
(Supplementary Fig. S3.6).
Future directions
The novel approaches in this study pave the way for many future studies to continue to
elucidate how a static structural connectome can give rise to complex, time-evolving activity
patterns important for cognition. An intuitive and important application of our approach
lies in the field of neurostimulation, where clinicians aim to implement targeted changes in
the temporal evolution of brain activity patterns (Stiso et al. 2018; Muldoon et al. 2016;
Chen et al. 2013) to alleviate symptoms of neuropsychiatric illness. In particular, network
control theory and data-driven estimation of brain states are a powerful combination for this
purpose. However, before this application can be realized, the robustness of these models
at the level of individual subjects must be confirmed. One could similarly ask whether
individual differences in structural connectivity explain variance in brain state dynamics,
and thus response to neural stimulation. Application of these methods to electrophysiologic
data could help to validate our findings and elucidate more complex neural dynamics that
are not reflected in the slow fluctuations of hemoglobin oxygenation captured by BOLD
fMRI (Mateo et al. 2017; Pan et al. 2013).
Targeted, model-informed brain stimulation (Deco et al. 2019; Muldoon et al. 2016; Stiso
et al. 2018) will likely need to account for interactions between exogenous input and endogenous dynamics (Ashourvan et al. 2019; Becker et al. 2018). Recent evidence (Shine et al.
2019) implicates ascending neuromodulatory inputs in the brain’s progression through state
space. Release of neuromodulators can be driven by external stimuli or spontaneous neural
activity (Avery and Krichmar 2017), and therefore may serve as both an important mediator
of external inputs and a critical aspect of endogenous dynamics. Ultimately, a model that
integrates the dynamic and static interactions between brain structure, neuromodulators,
fast ionotropic neurotransmission, and exogenous inputs might allow clinicians to solve for
inputs that effect beneficial changes in brain activity and connectivity. Nonlinear neural
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mass models of brain activity hold substantial promise for this purpose (Deco et al. 2018;
Muldoon et al. 2016) and in the future could be used to more deeply probe the structural
constraints on brain dynamics identified here.

METHODS
Participants
Resting state functional magnetic resonance imaging (fMRI), n-back task fMRI, and diffusion tensor imaging (DTI) data were obtained from n = 1601 youth who participated in a
large community-based study of brain development, known as the Philadelphia Neurodevelopmental Cohort (PNC) (Satterthwaite et al. 2014). The institutional review boards of the
University of Pennsylvania and the Children’s Hospital of Philadelphia approved all study
procedures. Participants had been previously enrolled in a study at the Center for Applied
Genomics, and participants and/or their parents provided informed consent (assent) to be
re-contacted for participation in additional studies, including the PNC. Here we study a
sample of n = 879 participants between the ages of 8 and 22 years (mean = 15.9, s.d.
= 3.3, 386 males, 493 females) with high quality diffusion imaging, rest BOLD fMRI, and
n-back task BOLD fMRI data. Our sample only contained subjects with low estimated
head motion and without any radiological abnormalities or medical problems that might
impact brain function (see Supplementary Information for detailed exclusion criteria). Details about imaging parameters, task design, and image preprocessing can be found in the
Supplementary Information.
Unsupervised clustering of BOLD volumes
BOLD fMRI activity patterns are known to represent information content (Naselaris et al.
2011), information processing (Barch et al. 2013; Vossel et al. 2014), and attention to stimuli
(Vossel et al. 2014). Here, we use a discrete model as a simplification of brain dynamics
(Vidaurre et al. 2017a), in which we view repeatedly visited locations in regional activation
space to be neural representations of cognitive states, or “brain states” for simplicity. In
order to ultimately characterize the progression of these brain states from one time point to
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the next, and by extension the progression of the brain through regional activation space,
we began by concatenating all functional volumes into one large data matrix (Shine et al.
2019). Specifically, we took all brain-wide patterns of BOLD activity from the resting-state
scan and from the n-back task scan from all subjects, and we placed them into a matrix
X with N observations (rows) and P features (columns). Here, P is the number of brain
regions in the parcellation (462), and N is the number of subjects (879) × (120 resting state
volumes + 225 n-back task volumes), summing up to N = 303255.
To determine the brain states present in these data, we performed 20 repetitions of kmeans clustering for k = 2 to k = 11 using Pearson correlation as the algorithm’s measure
of distance (Liu and Duyn 2013; Chen et al. 2015; Gutierrez-Barragan et al. 2019). Because
we aimed to study the temporal progression between coactivation patterns using a k × k
transition probability matrix, and our resting state scans contained 120 frames, k 2 must be
less than 120 in order to theoretically observe each transition at least once. Therefore, we
chose k = 11 (k 2 = 121) as our maximum possible value of k. After selecting k = 5, we
chose to consider the partition with the lowest error out of all 20 repetitions for subsequent
analyses. To identify the optimal number of clusters k, we assessed the variance explained
by the lowest error solution of the clustering algorithm at each value of k from 2 to 11,
and the gain in variance explained for a unit increase in k. The variance explained by the
clustering algorithm is defined by the ratio of between-cluster variance to total variance in
the data (within-cluster variance plus between-cluster variance) (Gutierrez-Barragan et al.
2019; Goutte et al. 1999). We also intended to make cross-subject comparisons of state
dynamics as continuous measures, so it was important to use partitions that identified
brain states that were common across all subjects, rather than identifying many different
states that were each only represented in a few subjects.
We observed that the variance explained by the clustering algorithm began to taper off
after k = 5 (Supplementary Fig. S3.2a), and the additional variance explained for each unit
increase in k after 5 was < 1% (Supplementary Fig. S3.2b). Additionally, k values greater
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than 5 produced states that were not all represented in every subject (Supplementary Fig.
S3.2c). To avoid using an unnecessarily large number of states while maintaining intersubject correspondence in state presence, we chose k = 5. To further validate the choice
of k = 5, we evaluated the split reliability of the partition at this resolution (Supplementary Fig. S3.2d-f). This analysis showed that cluster centroids and transition probability
matrices were highly similar between independently clustered subject samples (see Supplementary Methods for details). Another recent paper (Gutierrez-Barragan et al. 2019) found
a similar drop off in additional variance explained at k = 6 instead of k = 5. Key findings
are reproduced at k = 6 in the supplement and at k = 5 for a second parcellation.
Analysis of spatiotemporal brain dynamics
After using k-means clustering to define discrete brain states, we generated names for each
state using the maximum cosine similarity to binary vectors reflecting activation of communities in an a priori defined 7-network partition (Yeo et al. 2011); names were generated
separately for maximum cosine similarity of positive and negative state entries. These names
only serve as a convenient way of referring to clusters instead of their index (i.e., 1-k), and
have no impact on any analyses. Next, we computed subject-level state fractional occupancy as the percentage of volumes in each scan that were classified as a particular state.
Additionally, we computed subject-level state dwell time as the mean length of consecutive
runs of each state. We defined the transition probability between state i and state j to be
the probability that j is the next new state occupied after state i. This can also be equivalently framed as the probability of a specific state transition occurring given that some
state transition is occurring. We chose this metric in order to understand state transitions
without bias from potentially independent effects of state dwell time or autocorrelation.
Operationally, this computation was performed by reducing the empirically obtained state
sequences to a new sequence (e.g. [1 1 1 2 2 3 2 2] becomes [1 2 3 2]) in which the dwell
time of every state is equal, and then computing the probability of state j following state
i. In the supplement, we also compute the transition probability between two states as the
probability of transitioning from state i at time t to state j at time point t + tr given that
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the current state is i, where tr is the TR of the BOLD scanning sequence (3 seconds for
PNC and 0.72 seconds for HCP) for the purposes of demonstrating the non-random nature
of brain state dynamics.
Finally, in order to assess the context-dependent nature of brain state dynamics, we performed a non-parametric permutation test to compare group-average transition probabilities
between the n-back task and the resting state. First, we randomly selected two halves of
the full sample. Next, we generated two group-average transition matrices by averaging
together resting state transition matrices from one half and n-back transition matrices from
the other half, and vice versa. This procedure was repeated 10000 times, and we retained
the difference between the two halves at every element of the transition matrix. We generated a p-value for each element of the transition matrix by dividing the number of times the
observed difference between n-back and rest at that element exceeded the null distribution
of differences.
Network control theory
To better understand the structural basis for the observed brain states themselves, as well
as their persistence dynamics, we employed tools from network control theory (Gu et al.
2015a; Tang et al. 2017). We represent the fractional anisotropy-weighted structural network
estimated from diffusion tractography as an N ×N matrix A, where N is the number of brain
regions in the parcellation and the elements Aij contain the estimated strength of structural
connectivity between region i and j, where i and j can range from 1 to N . Because diffusion
tractography cannot estimate within-region structural connectivity, Aij = 0 whenever i = j.
We allow each node to carry a real value, contained in the map x : R≥0 → RN , to describe
the activity at each region in continuous time. Next, we employ a linear, time-invariant
model of network dynamics:

ẋ(t) = Ax(t) + Bu(t) ,

(3.1)

where x describes the activity (i.e. BOLD signal) in each brain region over time, and the
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value of the ith element of x describes the activity level of region i.
After stipulating this dynamical model, we computed the k × k transition energy matrix Te
as the minimum energy required to transition between all possible pairs of the k clustered
brain states, given the white matter connections represented in A. See Supplementary
Methods for details on computation of minimum control energy and selection of a control
horizon. For the purposes of control theoretic simulations, we were interested in exploring
the fundamental role of white matter architecture in supporting brain state transitions.
Thus, we constructed a single group-representative A generated through distance-dependent
consistency thresholding (Betzel et al. 2017) of all subjects’ structural connectivity matrices,
a process which has been described in detail elsewhere (Roberts et al. 2017).
Developmental and cognitive trends of brain dynamics
After identifying non-random brain dynamics at the level of individual frames, we hypothesized that features of these dynamics would change throughout normative neurodevelopment, and moreover that they would map to cognitive performance. To assess potential
developmental trends of spatiotemporal brain dynamics, we fit the following model using
linear regression:

D = β0 + βa a + βv v + βh h + βmd md + βs s +  ,

(3.2)

where a is age, v is total intracranial volume, md is the mean framewise displacement during
rest or n-back scans, h is handedness, s is sex,  is an error term, and D is a measure of
brain dynamics such as fractional occupancy, transition probability, or asymmetry. To assess
potential relations between cognitive performance and spatiotemporal brain dynamics, we
fit the following model using linear regression:

C = β0 + βD D + βa a + βv v + βh h + βmd md + βs s +  ,
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(3.3)

where C is the overall or n-back block-specific d0 score, which we use as our measure of
working memory performance, and all other variables are the same as described above.
For all analyses, we applied a Bonferroni correction for multiple comparisons, accounting
for tests performed over all states or state transitions within each scan. We chose the
Bonferroni-level correction because it is a conservative approach given that each state’s
fractional occupancies and transitions are not fully independent of one another.

Statistics and Reproducibility
In general, we computed statistics comparing metrics of brain dynamics between resting
state and n-back task conditions, based on clustering fMRI data obtained during these
conditions. These comparisons were Bonferroni-corrected over the number of metrics tested.
In order to test the extent to which the clustering solution was reproducible, we repeated the
clustering procedure in 500 split-half subsamples of our data and found strong agreement
between the two independent split halves. Additionally, custom code for all data analysis
is available publicly (see section Code availability) to facilitate reproducibility. This code
uses MATLAB, R, and python.

DATA AVAILABILITY
All structural and functional neuroimaging data are available at https://www.ncbi.nlm.
nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000607.v3.p2. Source data
for main text figures can be found at 10.6084/m9.figshare.11911101.v1 (Cornblath
2020).

CODE AVAILABILITY
All analysis code is available at https://github.com/ejcorn/brain_states.
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citation practices such that papers from women and other minorities are under-cited relative to the number of such papers in the field. Here we sought to proactively consider
choosing references that reflect the diversity of the field in thought, form of contribution,
gender, and other factors. We used automatic classification of gender based on the first
names of the first and last authors (Dworkin et al. 2020; Zhou et al. 2020), with possible
combinations including male/male, male/female, female/male, and female/female. Excluding self-citations to the first and last authors of our current paper, the references contain
56.94% male/male, 11.11% male/female, 19.44% female/male, and 8.33% female/female.
Relative to the expected proportions in the field of neuroscience, we over- or under-cited
these categories by the following ratios: -2.49% male/male, 18.20% male/female, -23.75%
female/male, and 24.38% female/female. We look forward to future work that could help
us to better understand how to support equitable practices in science.
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Figure S3.1 (previous page): Instantaneous coactivation can deviate from temporal
correlation patterns. (a) Sinusoidal signal X1 with additive Gaussian noise is plotted in
blue. Signal X2, generated by subtracting X1 from a slower sine wave, plus Gaussian noise,
is plotted in red. k-means clustering extracts three visually obvious coactivation states
(partition shown in light red, green, and blue). (b) Plot of X1 amplitude (x-axis) vs. X2
amplitude (y-axis), yielding a Pearson’s r = −0.70. (c) X1 and X2 concatenated into a
data matrix, Xa . We concatenated Xa with two channels of Gaussian noise to generate a
4-column data matrix Xn in order to use the correlation distance metric. (d) Centroids,
or “states,” obtained through k-means clustering of Xn . Three states emerge; the first
state consists of low- and high-amplitude activity in X1 and X2, respectively. The second
state consists of low amplitude activity in X2 with near 0 activity in X1. The third state
consists of high amplitude activity in X1 with low amplitude activity in X2. (e) The first 3
principal component (PC) loadings of Xa . PC1 captures States 1 and 2, but no single PC
captures State 3. (f ) The cross-correlation structure of Xa , which does not reveal the states
in panel (d). (g) Signal X1, generated by Gaussian noise plus random positive sinusoidal
activations is plotted in blue. Signal X2, generated by Gaussian noise plus synchronized
coactivation or coinactivation with X1, is plotted in red. k-means clustering extracts three
visually obvious coactivation states (partition shown in light red, green, and blue). (h) Plot
of X1 amplitude (x-axis) vs. X2 amplitude (y-axis), yielding a Pearson’s r =0.018. (i)
X1 and X2 concatenated into a data matrix Xb . We concatenated Xb with two channels
of Gaussian noise to generate a 4-column data matrix Xm in order to use the correlation
distance metric. (j) Centroids, or “states,” obtained through k-means clustering of Xm .
Three states emerge; the first consists of high-amplitude activity in X1 with low-amplitude
activity in X2. The second consists of near 0 activity in X1 and X2. The third consists
of high-amplitude activity in both X1 and X2. (k) The first 3 principal component (PC)
loadings of Xb . PC1 does not exist within the data; PC2 mirrors State 1; and both States
2 and 3 are not reflected in any PCs. (l) Cross-correlation structure of Xb , which does not
trivially reveal the cluster centroids in panel (d).
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k is increased from k − 1 to k. Less than 1% of additional variance explained is added for
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each pair of split cluster partitions are predominantly r > 0.99, thus showing a high degree
of robustness to sample composition in estimating brain states and their dynamics.
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Figure S3.6: Brain states and dynamics in an independent sample with higher
sampling rate and no global signal regression. (a) Cluster centroids for clustering of
rest and n-back task BOLD data from the Human Connectome Project (HCP) with volumes
acquired 4 times as frequently as the PNC and no global signal regression. (b) Spatial
correlation between centroids for HCP and PNC data sets, is high along the diagonal,
allowing for unambiguous matching of brain states between the two samples. (c) Spatial
correlation between HCP centroids. DMN+ and DMN-, along with VIS+ and VIS-, exhibit
strong anticorrelation. (d-e) HCP group average state transition probability matrices for
rest (d) and n-back (e) scans. Off-diagonal elements of HCP rest and n-back transition
matrices exhibit Pearson correlations of r = 0.83 and r = 0.76 with the PNC, respectively.
HCP persistence probabilities are correlated with PNC persistence probabilities at r = 0.85
and r = 0.85 for rest and n-back, respectively. (f ) Non-parametric permutation testing
demonstrating differences between the rest and n-back group average transition probabilities
and persistence probabilities. Extremes of the color axis indicate statistical significance,
with larger values indicating higher transition probabilities in n-back relative to rest. *,
Bonferroni-adjusted p < 0.05 or p > 0.95.
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Figure S3.8 (previous page): Functional connectivity does not fully explain spontaneous coactivation. (a) Group average, mean functional connectivity within and between
cognitive systems defined a priori (Yeo et al. 2011). We first computed average functional
connectivity matrices by averaging functional connectivity matrices over rest and n-back
scans for each subject. Next, we computed the average edge strength within and between
regions in each a priori defined system to yield mean within- and between-system functional
connectivity. Finally, we computed the group average mean within- and between-system
functional connectivity across the n = 879 subjects from the main text, the values of which
are displayed in black text overlaying each heatmap element. *, p < 0.05 for a one-sample
t-test comparing the mean of the distribution of correlations across subjects to 0. (b)
Mean temporal correlation values within regions belonging to the default mode network
(DMN), visual system (VIS), and somatomotor system (SOM) show positive correlations
within systems on average. (c) Mean temporal correlations between DMN, VIS, and SOM
regions show weakly negative (DMN-VIS, DMN-SOM) or near 0 (VIS-SOM) correlations
on average. (d) Histogram of TRs (individual BOLD frames) exhibiting activity patterns
with low activity in the DMN and high activity in the SOM and VIS systems, as measured
by correlation with a binary indicator vector. Despite low temporal correlations, we still
find activity patterns with spatial anticorrelation between these systems. (e-g) BOLD data
in regional activation space. Scatter plots where points are individual BOLD TRs in the
DMN- cluster and axes reflect the mean activity across regions in the DMN, VIS, or SOM
for each TR, shown in 2 dimensions for ease of visualization. These plots show that TRs in
the DMN- cluster (Fig. 2a) have simultaneous high activity in VIS and SOM (panel d ) in
addition to low activity in the DMN (panel e-f ).

SUPPLEMENTARY NOTES, DISCUSSION, AND METHODS
Sample exclusion criteria
We excluded 722 of the initial 1601 subjects for the following reasons: medical problems
that may impact brain function, incidental radiologic abnormalities in brain structure, poor
or incomplete FreeSurfer reconstruction of T1 images (Rosen et al. 2018), high motion in
rest or n-back fMRI scans, high signal-to-noise ratio or poor coverage in task-free or nback task BOLD images, and failure to meet a rigorous manual and automated quality
assurance protocol for DTI (Roalf et al. 2016). Notably, our goal in constructing a sample
was to compare structure-function relationships between contexts across all subjects in our
sample. This analysis required highly stringent inclusion criteria that only included subjects
with high quality data for rest BOLD, n-back task BOLD, and DTI.
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We compare the minimum control energy required to maintain the brain in each state (persistence energy) relative to spatially permuted states. (b) We computed persistence energy
for each state and its permuted variants in group average SC (orange) and found that the
DMN+ state required less energy to persist than its permuted variants. We performed the
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preserving both topology and spatial constraints (light blue). Orange *, pcorr < 0.05 after Bonferroni correction over each of the 5 states, separately for each null model. (Deg.
Pres.), degree distribution-preserving null model (Rubinov and Sporns 2010). Space Pres.,
degree sequence, edge weight and length distribution and relationship preserving null model
(Betzel and Bassett 2017).
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Figure S3.11: Selection of control horizon T and weighted control. (a-d) Relationship between control horizon T (x-axis) and Spearman rank correlation (y-axis) between
structurally predicted transition energies and empirically observed transition probabilities
for resting state data (panel a-b) and 2-back task data (panel c-d ). (a, c) Transition
energies are computed for uniformly weighted inputs. Dashed line represents correlation
between transition probabilities and ||xT − xo ||. Teal trace represents Spearman correlation
using transition energies obtained from a distribution of null networks with preserved degree sequence (DP Null). Shaded region represents the full range of this distribution. (b, d)
Transition energies are computed by weighting inputs towards different cognitive systems
(Yeo et al. 2011). Dashed line represents correlation between transition probabilities and
weighted state-space transition distance, computed as (xT − xo )| (BK B|K )−1 (xT − xo ). Teal
trace represents Spearman correlation using transition energies computed with uniformly
weighted inputs, the exact same as the blue and orange traces in panel a and panel c,
respectively. TP, transition probability. E, minimum control energy Em .
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Functional Scan Types
During the resting-state scan, a fixation cross was displayed as images were acquired. Subjects were instructed to stay awake, keep their eyes open, fixate on the displayed crosshair,
and remain still. Total resting state scan duration was 6.2 minutes. As previously described
(Satterthwaite et al. 2012), we used the fractal n-back task (Ragland et al. 2002) to measure
working memory function. The task was chosen because it is a reliable probe of the executive system and is not contaminated by lexical processing abilities that also evolve during
adolescence (Schlaggar et al. 2002; Brown et al. 2005). The task involved the presentation
of complex geometric figures (fractals) for 500 ms, followed by a fixed interstimulus interval of 2500 ms. This occurred under the following three conditions: 0-back, 1-back, and
2-back, inducing different levels of working memory load. In the 0-back condition, participants responded with a button press to a specified target fractal. For the 1-back condition,
participants responded if the current fractal was identical to the previous one; in the 2-back
condition, participants responded if the current fractal was identical to the item presented
two trials previously. Each condition consisted of a 20-trial block (60 s); each level was
repeated over three blocks. The target/foil ratio was 1:3 in all blocks, with 45 targets and
135 foils overall. Visual instructions (9 s) preceded each block, informing the participant of
the upcoming condition. The task included a total of 72 s of rest, while a fixation crosshair
was displayed, which was distributed equally in three blocks of 24 s at the beginning, middle, and end of the task. Total task duration was 693 s. To assess performance on the task,
we used d0 , a composite measure that takes into account both correct responses and false
positives to separate performance from response bias (Snodgrass and Corwin 1988).
Imaging data acquisition and preprocessing
MRI data were acquired on a 3 Tesla Siemens Tim Trio whole-body scanner and 32-channel
head coil at the Hospital of the University of Pennsylvania. High-resolution T1-weighted
images were acquired for each subject. For diffusion tensor imaging (DTI), 64 independent
diffusion-weighted directions with a total of 7 b = 0 s/mm2 acquisitions were obtained over
two scanning sessions to enhance reliability in structural connectivity estimates (Satterth122

waite et al. 2014). All subjects underwent functional imaging (TR = 3000 ms; TE = 32
ms; flip angle = 90 degrees; FOV = 192 × 192 mm; matrix = 64 × 64; slices = 46; slice
thickness = 3 mm; slice gap = 0 mm; effective voxel resolution = 3.0 × 3.0 × 3.0 mm) during
the resting-state sequence and the n-back task sequence (Satterthwaite et al. 2014, 2013b).
During resting-state and n-back task imaging sequences, subjects’ heads were stabilized in
the head coil using one foam pad over each ear and a third pad over the top of the head in
order to minimize motion. Prior to any image acquisition, subjects were acclimated to the
MRI environment via a mock scanning session in a decommissioned scanner. Mock scanning
was accompanied by acoustic recordings of gradient coil noise produced by each scanning
pulse sequence. During these sessions, feedback regarding head motion was provided using
the MoTrack motion tracking system (Psychology Software Tools, Inc., Sharpsburg, PA).
Raw resting-state and n-back task fMRI BOLD data were preprocessed following the most
stringent of current standards (Satterthwaite et al. 2013a; Ciric et al. 2017) using XCP engine (Ciric et al. 2018): (1) distortion correction using FSL’s FUGUE utility, (2) removal of
the first 4 volumes of each acquisition, (3) template registration using MCFLIRT (Jenkinson et al. 2002), (4) de-spiking using AFNI’s 3DDESPIKE utility, (5) demeaning to remove
linear or quadratic trends, (6) boundary-based registration to the individual high-resolution
structural image, (7) 36-parameter global confound regression including framewise motion
estimates and signal from white matter and cerebrospinal fluid, and (8) first-order Butterworth filtering to retain signal in the 0.01 to 0.08 Hz range. Following these preprocessing
steps, we parcellated the voxel-level data using the 463-node Lausanne atlas (Cammoun
et al. 2012). We excluded the brainstem, leaving 462 parcels. Our choice of parcellation
scale was motivated by prior work showing that parcellations of this scale replicate voxelwise clustering results more than coarser scales with fewer parcels (Chen et al. 2015). We
excluded any subject with mean relative framewise displacement > 0.5 mm or maximum
displacement > 6 mm during the n-back scan, and mean relative framewise displacement
> 0.2 mm for the resting state scan.
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All DTI datasets were subject to a rigorous manual quality assessment protocol that has
been previously described (Roalf et al. 2016). The skull was removed by applying a mask
registered to a standard fractional anisotropy map (FMRIB58) to each subject’s DTI image
using an affine transformation. The FSL EDDY tool was used to correct for eddy currents
and subject motion and rotate diffusion gradient vectors accordingly. Distortion correction
was applied using FSL’s FUGUE utility. DSI studio was then used to estimate the diffusion tensor and perform deterministic whole-brain fiber tracking with a modified FACT
algorithm that used exactly 1,000,000 streamlines per subject excluding streamlines with
length < 10 mm (Baum et al. 2017b; Gu et al. 2015b). Lausanne 463-node atlas parcels
were extended into white matter with a 4 mm dilation (Baum et al. 2017b; Gu et al. 2015b)
and then registered to the first b = 0 volume using an affine transform (Roalf et al. 2016;
Baum et al. 2017b). For all analyses, edge weights in the structural network were defined
by the average fractional anisotropy value for streamlines connecting each pair of parcels
(Baum et al. 2017a).
Split-halves validation of clustering
To ensure that our final clustering solution for k = 5 was not influenced by outliers or
adversely impacted by model overfitting, we split our sample into two equal partitions 500
times and performed k-means clustering separately on each half of the dataset. We then
matched clusters by computing the cross-correlation between both sets of centroids, and
then by reordering the clusters based on the maximum correlation value for each cluster.
We plotted those maximum correlation values and found that most were > 0.99, suggesting
a high degree of robustness and stability in brain states (Supplementary Fig. S3.2d). We
also computed the state transition probabilities and state persistence probabilities for each
half separately for rest and n-back, and then computed the correlation between the transition or persistence probabilities between the two data set partitions. Similarly, we found
very high correlation values (> 0.99) for state transition probabilities and state persistence
probabilities for both rest and n-back (Fig S3.2e-f). These observations suggest that our
estimates of brain dynamics are robust to outliers and consistent across different subsamples
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of our data.
Functional connectivity does not fully explain instantaneous coactivation
We posit that the alignment between a priori resting state functional networks (Yeo et al.
2011) (RSNs) and our coactivation patterns cannot be fully explained by analyzing interregional correlations in BOLD signal across time, which is often called “functional connectivity.” Here, we provide evidence that suggests that our coactivation patterns are consistent
with but not trivially explained by functional connectivity. We also provide examples that
explain why temporal correlation does not necessarily explain instantaneous coactivation in
general, and demonstrate that k-means clustering is a useful tool for extracting coactivation
patterns.
In general, time series data can contain (1) unexpected coactivation patterns in the presence
of temporal correlation and (2) unexpected coactivation patterns in the absence of temporal correlation. Here, we provide two examples that illustrate how k-means clustering can
resolve dissociation between temporal correlation and instantaneous coactivation in multidimensional time series data. First, we show two stationary signals that are anticorrelated
across time (Supplementary Fig. S3.1b, r = −0.70), but exhibit three unexpected coactivation patterns (rather than two simple “on-off” and “off-on” patterns) due to fluctuation
between variable amplitudes (Supplementary Fig. S3.1a-b). In this example, one sinusoidal
signal fluctuates between three distinct amplitudes and the other sinusoidal signal simply
fluctuates between a peak and a trough (Supplementary Fig. S3.1a). The combination of
these signals yields 3 distinct coactivation patterns, rather than the 2 patterns that would
be expected from a pair of temporally anticorrelated signals (Supplementary Fig. S3.1c-e).
Next, we show two signals that are uncorrelated across time, but still have multiple spontaneous coactivation patterns (Supplementary Fig. S3.1a). Because these two signals sometimes activate together and at other times exhibit opposing activity, their temporal correlation is near 0 (r = 0.018), yet there are 3 unique coactivation patterns in the time series
that k-means faithfully extracts. Positive temporal correlations could occur either through
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simultaneous activation or simultaneous inactivation, while temporal anticorrelation can
result from opposing activity patterns. One could envision how adding in additional signals
(i.e. dimensions or brain regions) could provide additional degrees of freedom to construct
a range of coactivation patterns for a given temporal correlation structure. The sensitivity
of the k-means approach to coactivation patterns in these two contexts supports its use
in fMRI data for identifying previously unknown spontaneous interactions between neural
networks, as well as the temporal organization of those networks.
When we apply k-means clustering to high-dimensional BOLD data from resting state and
n-back scans (Fig. 3.2a), we identify activity patterns with both expected and unexpected
features based on functional connectivity. In general, we saw that RSNs show coherent
high or low amplitude activity in each state (Supplementary Fig. S3.8c). This finding
reflects the strong positive correlations within RSNs (Supplementary Fig. S3.8a). We also
see coactivation patterns consistent with patterns of functional connectivity between RSNs.
For instance, the DMN+ state (Fig. 3.2a) shows spatial anticorrelation between the temporally anticorrelated dorsal attention network and default mode network (Fox et al. 2005)
(Supplementary Fig. S3.8a, mean r = −0.10, one-sample t-test, df = 878, t = −80.45,
p < 10−15 ). However, we also identify coactivation patterns that do not trivially reflect
functional connectivity. The DMN- state centroid (Fig. 3.2a) consists of low amplitude activity throughout the default mode network (DMN) with high amplitude activity throughout
somatomotor and visual systems (Fig. 3.2c). When clustering on functional connectivity
(Yeo et al. 2011), these three systems emerge as separate. Mean correlations within these
systems are positive (Supplementary Fig. S3.8a-b), but correlations between them are near
zero (SOM and VIS) or weakly negative (DMN with SOM and VIS) (Supplementary Fig.
S3.8c). Based solely on functional connectivity, one would not expect these three systems
to strongly coactivate or oppose one another at the level of individual BOLD frames (TRs),
yet our analysis suggests that there are many TRs with low DMN activity, high VIS activity, and high SOM activity (Supplementary Fig. S3.8d-g). Moreover, VIS and SOM
have two additional configurations of coactivation represented in the VIS+ and VIS- states
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(Fig. 3.2a-c). In the VIS- state, we see high amplitude SOM activity with low amplitude
VIS activity, suggesting that at times VIS and SOM systems coactivate and at other times
they oppose one another. In the VIS+ state we see low amplitude SOM activity with high
amplitude VIS activity. Purely based on functional connectivity, one might inappropriately
draw the conclusion that these two RSNs are independent given their mean correlation
of zero, when in reality they have 3 distinct configurations at the level of individual time
points. The behavior of VIS and SOM is most consistent with the scenario presented in
Supplementary Fig. S3.1. Overall, these findings suggest that our analysis identifies recurrent activity patterns whose spatial organization reflects strong temporal correlations
within RSNs, but also with coactivation between RSNs that cannot be trivially explained
by temporal correlations between RSNs.
Silhouette analysis of clustering
In order to support the use of a discrete model of brain dynamics, we asked whether individual BOLD time points from rest and n-back scans exhibited clustering in a 462-region
activation space. We used the silhouette scores of BOLD time points as a measure of clustering in this space. Silhouette scores range from -1 to 1 and are computed for each data
point, with 1 indicating that a data point is closer to members of its assigned cluster than to
members of the next closest cluster, 0 indicating equidistance between the assigned cluster
and the closest cluster, and -1 indicating that the data point is closer to another cluster. We
compared the silhouette scores for real BOLD data points from the PNC, data points from
462 independent random Gaussian distributions, and data points from independent phase
randomized null time series (Liégeois et al. 2017) based on subject-specific BOLD data. This
independent phase randomized null model (IPR) preserves the autocorrelation within each
region, but destroys covariance between regions. When we compared the silhouette scores
for clustering of real BOLD data to independent random Gaussian and autocorrelationpreserving null data, we found that the real data had higher mean silhouette scores than
that of the autocorrelation-preserving null data (Supplementary Fig. S3.3a, difference in
mean silhouette score actual minus null = 0.047, two sample t-test, df = 27598, t = 115.03,
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p < 10−15 ). Additionally, the centroids generated by clustering this null data had little
obvious structure (Supplementary Fig. S3.3e) and showed little similarity to the original
centroids (Supplementary Fig. S3.3f). These findings suggest that BOLD data exhibit
non-trivial clustering in regional activation space.
Impact of scan composition on brain states and dynamics
To ensure that our results were not biased by the fact that there were a larger number
of n-back volumes (225 per scan) than rest volumes (120 per scan), we used the partition
generated by clustering both entire scans together to compute separate centroids for volumes
in rest or n-back scans. This analysis revealed a mean spatial Pearson correlation of 0.96
between corresponding centroids (Supplementary Fig. S3.4b). Next, we generated a new
sample by concatenating the first 6 minutes of the n-back task data for each subject and
the entire 6 minutes of the rest data for each subject. We ran this sample through the
clustering algorithm at k = 5 and found that the cluster centroids (Supplementary Fig.
S3.4c) were highly similar to those computed from the full sample (mean Pearson r =
0.99; Supplementary Fig. S3.4d). We also computed transition probabilities using this
cluster partition and identified highly similar group average transition matrix structure
(rest, Pearson r = 0.997, n-back, Pearson r = 0.989, Supplementary Fig. S3.4e), suggesting
that the temporal order of state labels was largely unaffected by the scan composition of
the sample. Moreover, these results suggest that n-back state transitions are internally
consistent.
Finally, we show that the differences between rest and n-back in the proportion of subjects
with any absent states (Supplementary Fig. S3.4f) is attenuated relative to the full sample
(Supplementary Fig. S3.2e). This finding suggests that in the full sample, the n-back task
data has better state representation due to better sampling, rather than poor classification
of rest volumes. However, even with equal samples, the rest dataset still has more subjects
with missing states, suggesting that there may be more variability in brain dynamics during
rest. Importantly, there were still no subjects with absent states for rest or n-back at k < 5
(Supplementary Fig. S3.4f), and there was at least 1 subject with a missing state in rest
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or n-back at k > 5 (though bars are very small in Supplementary Fig. S3.4f). Collectively,
these results support the simultaneous generation of partitions for rest and n-back volumes
and the choice of k = 5 for analysis in the main text.
Impact of sampling rate, global signal regression, and head motion on brain
states and dynamics
The BOLD data from the PNC was acquired at a sampling rate of one volume every 3
seconds (Satterthwaite et al. 2014), which is relatively slow compared with other large data
sets, including the Human Connectome Project (Van Essen et al. 2013), which samples every
0.72 seconds. The standard preprocessing pipeline for this data set involves regression of
head motion parameters, white matter confounds, cerebrospinal fluid confounds, and global
signal from each voxel’s time series (Ciric et al. 2018; Xia et al. 2018). It is controversial
whether this procedure, known as “global signal regression,” induces anticorrelation (Chai
et al. 2012; Murphy and Fox 2017).
Thus, we selected 100 unrelated subjects from the minimally preprocessed version of the
Human Connectome Project (HCP) data set (Glasser et al. 2013) and performed the following preprocessing steps on resting state and n-back working memory task scans: (1) head
motion regression, (2) linear and quadratic detrending, (3) bandpass filtering to retain the
0.01 to 0.08 Hz range, and (4) parcellation according to the 462 region Lausanne atlas. We
concatenated all 405 volumes from the working memory task with the first 405 volumes
from the resting state over all 100 subjects. We chose to make the number of volumes from
each scan equal so that the clustering algorithm would not be biased towards one scan or
the other.
Next, we performed k-means clustering on this matrix and computed the centroids (Supplementary Fig. S3.6a). Every HCP centroid was maximally correlated with only one PNC
centroid, and vice versa, allowing for unambiguous matching between the two sets of brain
states (Supplementary Fig. S3.6b). The DMN+ and DMN- states were the most similar
to PNC states, while VIS+ and VIS- exhibited slightly lower correlations (Supplementary
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Fig. S3.6b). DMN+ and DMN- states, as well as VIS+ and VIS- states, exhibited strong
anticorrelation with each other (Supplementary Fig. S3.6c). Nevertheless, the HCP offdiagonal elements of the transition probability matrices (i.e. transitions not persistence) for
rest and 2-back block of the n-back task were correlated with PNC transition probabilities
at r = 0.74 and r = 0.57, respectively (Supplementary Fig. S3.6d-e). This finding suggests
that while there were differences in the spatial activity patterns of brain states, their dynamic progression through time was relatively similar. The unexplained variance between
the two samples could be due to differences in age, with the PNC comprised of developing
youths and the HCP comprised of healthy adults. Notably, task dynamics were less similar
between the two groups, possibly reflecting stronger age-related changes in task dynamics
relative to resting state. Moreover, the differences in transition probabilities between 2-back
and rest were highly similar in HCP and in PNC (Supplementary Fig. S3.6e), with increased
transitions from DMN and FPN states into VIS states. Overall, these findings suggest that
while global signal regression and sampling rate may impact the spatial activity patterns
comprising brain states to some degree, it does not impact estimation of their dynamics or
the presence of spatial anticorrelation in their activity patterns.
Finally, we tested whether the identification of recurrent coactivation patterns with k-means
clustering was biased by the inclusion of single frames with sub-millimeter framewise displacement. We removed 76,339 frames associated with > 0.1 mm framewise displacement,
and repeated the clustering on the remaining 226,916 frames using correlation distance and
k = 5. The resulting centroids (Supplementary Fig. S3.7a) were nearly identical to the
centroids found in Figure 3.2a (Supplementary Fig. S3.7b, all r > 0.99 for corresponding
centroids). These findings suggest that high motion frames minimally impact the clustering
process. Therefore, we included these frames so that we could have the largest continuous
sample of sequential frames from which to compute transition probabilities and dwell times.
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Assessing randomness, asymmetry, autocorrelation, and distance dependence
of brain state sequences
In addition to assessing the relationship between brain state transitions, cognitive demands,
and behavior, we were also interested to assess important basic properties of the state transition probability matrix. First, we were interested to validate previous findings which
suggest that the brain does not undergo every possible transition with equal probability
(Vidaurre et al. 2017b). For these analyses, we begin with a transition matrix (Supplementary Fig. S3.9a-b) whose ij th element indicates the probability that state i occurs at
time t and state j occurs at time t + tr , where tr is the repetition time (TR) of the scan
(here, 3 seconds). The state transition probability matrix houses several pieces of important
information. We refer to the diagonal entries in the transition probability matrix as the
persistence probabilities, because they indicate the probability of remaining in a given state,
and we refer to the off-diagonal entries in the transition probability matrix as the transition
probabilities, because they indicate the probability of transitioning between two distinct
states. Given this structure, we were interested to determine whether the brain dynamics
that we observed could occur in a uniformly random distribution of states and state transitions. To test the randomness of persistence probabilities, we generated subject-level null
state time series that preserved fractional occupancy but shuffled the temporal sequence of
states; for example, if the state time series was given by the vector [1 1 2 2 3 3], then we
would permute the order of the entries in that vector uniformly at random, yielding a distribution of vectors with the same proportion of each state, i.e. [1 2 1 3 3 2]. By comparing
the observed persistence probabilities to the persistence probabilities in this null model, we
can test whether the observed persistence probabilities would be expected based solely on
fractional occupancy. We averaged together all subjects to generate a distribution of group
average null persistence probabilities and compared them to the empirically observed group
average persistence probabilities.
To test the randomness of transition probabilities, we generated null state time series that
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preserved only the states involved in transitions and reduced sequences of repeating states
to a single state. We removed repeating states to control for the potentially independent
effects of state persistence, which is equivalent to temporal autocorrelation, in estimating
transition probabilities. For example, if the state time series was given by the vector V =
[112233], then we would reduce that original vector to the new vector Vt = [123], and
subsequently permute the new vector uniformly at random. Specifically, for subject i =
1, .., ..N , we reduce the state sequence vector Vi to a transition sequence vector Vti by
eliminating repeating states, compute a transition matrix Ti , and average across all subjects
P
to generate a group average transition matrix T = N1 N
i=1 Ti that excludes state persistence
(i.e. diagonal entries of Ti are equal to 0). Next, we shuffle Vti uniformly at random to
generate Vni , compute a transition matrix Tni , and average across all subjects to generate a
P
group average null transition matrix Tn = N1 N
i=1 Tni that excludes state persistence. We
generate a distribution of Tn by independently shuffling Vti for each subject many times and
averaging them across subjects. Finally, we compare each element of T to the corresponding
element in a distribution of Tn to compute a two-tailed, non-parametric p-value for each
transition. These analyses demonstrated that almost all of the observed persistence and
transition probabilities in both resting state and the n-back task were unexpected under
these uniformly random null models (all pcorr < 0.05 except for DMN- to DMN+ during
n-back, Supplementary Fig. S3.9a-b).
Next, we assessed the properties of these transition matrices, such as the matrix symmetry,
which reflects whether transitions from state 1 → 2 occur as frequently as transitions from
state 2 → 1, and so forth for every state pair. Specifically, we quantified the asymmetry ψ
of a k-by-k transition matrix A as:
k
P

ψ = 0.5 ×

k
P

i=1 j=1,j6=i
k
P

|Aij − A|ij |

k
P

i=1 j=1,j6=i
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.
|Aij |

In calculating this asymmetry score, we exclude the elements along the diagonal of A so
as to only capture directional bias in transitions between pairs of states, without including
the probability of persisting in each state. The values of this score range from 0 to 1, where
0 represents a matrix that is symmetric about the diagonal and 1 represents a matrix in
which the upper triangle is −1× the lower triangle.
We were also interested in how much information about future states was contained within
the current state. Drawing from information theoretic approaches to analysis of discrete
signals, we computed the normalized auto mutual information (NMI) between lagged state
time series to answer this question. Here, we asked whether the current state contains
information about the subsequent state by computing NMI between the original state time
series and a state time series lagged by one element. First, we created two copies of the state
time series. Then, we removed the first element from one, X, and the last element from the
other, Y, to generate two vectors of equal length such that Xi = Yi+1 . We computed the
NMI between X and Y as:
H(X) − H(X|Y)
,
H(X)
where H(X) is the entropy of X and H(X|Y) is the conditional entropy of X given Y.
Where k is the number of brain states,

H(X) =

k
X

P (X = i) × log(P (X = i)) ,

i=1

and
H(X|Y) =

k X
k
X

P (X = i ∧ Y = j) × log(P (X = i ∧ Y = j)) .

i=1 j=1

In normalizing by H(X), we ensure that the NMI ranges from 0 to 1, with 0 representing
two completely independent signals and 1 representing two identical signals.
We anticipated that stimulus driven activity in the n-back task that occurs independently
of the current brain state would result in a reduction of directional, asymmetric state
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transitions relative to resting state and a reduction in the dependency of state transitions on
the current state. Indeed, using the normalized measure of matrix skewness described above,
we found that transition probabilities at rest were more asymmetric than during the n-back
task (Supplementary Fig. S3.9d; paired t-test, µnback−rest = −0.062, df = 878, t = −24.96,
p < 10−15 )s. Additionally, using the normalized auto-mutual information metric described
above, we found that the current brain state carried less information about the subsequent
state during the n-back task relative to rest, even when controlling for autocorrelation
(Supplementary Fig. S3.9f: normalized auto mutual information, µnback−rest = −0.028,
df = 878, t = −20.88, pcorr < 10−15 ). Consistent with our hypothesis, we also found that
the Euclidean distance between states was anticorrelated with the transition probabilities
between states (Supplementary Fig. S3.9e). Interestingly, however, the effect was stronger
for n-back than for rest (Supplementary Fig. S3.9e; paired t-test, µnback−rest = −0.17,
df = 878, t = −22.74, p < 10−15 ), suggesting that the brain is more prone to transition
between distant states while at rest.
Transition probabilities within task blocks
In addition to computing transition probabilities across the entire n-back task scan, we
also computed transition probabilities within each task block. Because the instances of a
specific task block (i.e. 0-back, 1-back, 2-back) are not continuous, we counted the number
of each transition found within all instances of a given task block, and then we divided
the counts by the total number of possible transitions within all instances of that task
block (Supplementary Fig. S3.13a-c). Similar to the analysis of transition probabilities in
the entire n-back scan, we found that in the 2-back block, transitions from the DMN+ and
DMN- states into the VIS+ state were increased relative to the 0-back block (Supplementary
Fig. S3.13d). Interestingly, we saw that transitions from DMN+ and DMN- states in to
FPN+ states increased from 0-back to 2-back (Supplementary Fig. S3.13d), although in
the resting state these transitions were more frequent relative to the entire n-back scan
(Fig. 3.4c). However, transitions from VIS+ to FPN+ did not differ between the two
conditions, while transitions into DMN+ and DMN- states decreased (Supplementary Fig.
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S3.13d). These findings suggest that increasing cognitive load biases the traversal of some
trajectories in state space without affecting others.
Spatially embedded null models
To assay the specificity of brain state activity patterns themselves, we compared Pe for
actual brain states to Pe for a distribution of null brain states. We generated null states
using a recent method developed to find overlap between activation maps while accounting
for spatial clustering of activity (Alexander-Bloch et al. 2018). Following this method
(Alexander-Bloch et al. 2018), we projected node-level data to a cortical surface, inflated
the surface to a sphere using FreeSurfer tools, applied a rotation to the sphere, collapsed it
back to a cortical surface, and extracted node-level data by averaging over vertices belonging
to each region. This process preserves the spatial grouping and relative locations of regions
with similar activity while still changing their absolute locations. Importantly, reflected
versions of the same rotation are applied for each hemisphere, thus also preserving the
symmetry of the original activity pattern.
To assay the specificity of our findings to higher order topological features found in real
structural brain networks, we compared Pe estimates to a recently developed network null
model (Betzel and Bassett 2017), which preserves several important spatial and topological
features. This model exactly preserves the degree sequence and edge weight distribution,
while approximately preserving the edge length distribution and edge length-weight relationship. We also compared our findings to a more commonly used topological null model
(Rubinov and Sporns 2010) which preserves only the degree distribution, but not the degree
sequence, of the network.
Comparing transition energies and transition probabilities using control theory
A main goal of the present work was to provide a mechanistic description for how the brain’s
large-scale white matter architecture constrains its progression through activation space.
To accomplish this goal, we began with a simple model of linear, time-invariant dynamics
along the white matter structural connectome estimated from diffusion tractography. We
represent the volume-normalized, fractional anisotropy-weighted structural network as the
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graph G = (V, E), where V and E are the vertex and edge sets, respectively. Let Aij be the
weight associated with the edge (i, j) ∈ E, and define the weighted adjacency matrix of G
as A = [Aij ], where Aij = 0 whenever (i, j) ∈
/ E. We associate a real value with each of
the N brain regions to generate a vector describing the activity in each node at time t, and
we define the map x : R≥0 → RN to describe the dynamics of activity in network nodes
over time. Here we employ a simplified noise-free linear continuous-time and time-invariant
model of such dynamics:

ẋ(t) = Ax(t) + Bu(t) ,

(3.4)

where x describes the activity (i.e. voltage, firing rate, BOLD signal) of brain regions over
time. Thus, the vector x has length N , where N is the number of brain regions in the
parcellation, and the value of xi describes the activity level of that region. The matrix A
is symmetric, with the diagonal elements satisfying Aii = 0. Prior to calculating control
energy, we divide A by ξ0 (A) and subtract 1 from the diagonal elements of A, where ξ0 (A)
is the largest eigenvalue of A. This step makes the system marginally stable by ensuring
that the maximum eigenvalue of the system is equal to 0. The input matrix B identifies
the control input weights, which we set to the N × N identity matrix by default. For
certain analyses (Fig. 3.5d, Supplementary Fig. S3.11b and d, Supplementary Fig. S3.5d,
Supplementary Fig. S3.12d), a set of brain regions K ⊂ V that belong to a particular
cognitive system (Yeo et al. 2011) was given increased weight, such that

Bii =




c

if i ∈ K



1

otherwise

,

(3.5)

and c is a positive, real scalar value, which we set equal to 2 here. The input u : R≥0 → RM
denotes the control strategy.
To compute the minimum control energy required to drive the system from an initial activity
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pattern xo to a final activity pattern xf over some time T , we compute an invertible
controllability Gramian W for controlling the network A from the set of network nodes K
(in our case, every node in the network), where:
Z
W=

T

| (T −τ )

eA(T −τ ) BB| eA

dτ,

(3.6)

0

where T is the time horizon, which specifies the time over which input to the system
is allowed. After computing the controllability Gramian, we can solve for the minimum
control energy Em by computing the quadratic product between the inverted controllability
Gramian and the difference between xo and xT :
Em = (eAT xo − xT )| W−1 (eAT xo − xT ) .

(3.7)

In Fig. 3.5b, we computed the k × k transition energy matrix Te as the minimum energy
required to transition between all possible pairs of the k clustered brain states, given the
white matter connections represented in A. We refer to the on-diagonal elements of Te
as persistence energies, because they quantify the energy required to maintain xo in the
special case where xo = xT . We refer to the off-diagonal elements of Te as transition
energies, because they quantify the energy required to move between all pairs of xo and xT
where xo 6= xT .
First, we sought to determine whether the brain states that we observed (Fig. 3.2a) were
easier to maintain (1) compared to null states and (2) in real brain networks compared to
null brain networks. Thus, we compared the persistence energy for the actual states to
that of null brain states (Alexander-Bloch et al. 2018) with preserved symmetry and spatial
clustering (Supplementary Fig. S3.10a). We found that the persistence energy of the DMN+
state was significantly lower than that of its respective null states (Supplementary Fig.
S3.10b: one-tailed non-parametric test, DMN+, pcorr = 0.045, 1000 sphere-permuted null
states). The DMN- state also required lower persistence energy than many of its respective
null states, although this result was not significant after Bonferroni correction over all states
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(Fig. 3.5b, one-tailed non-parametric test, pcorr = 0.05, 1000 sphere-permuted null states).
Crucially, the DP and SLP null models did not exhibit selectively increased stability in
DMN states, suggesting that DMN-driven states may arise in part due to complex features
of white matter topology that allow for their stability.
Next, we hypothesized that the off-diagonal elements of the empirically observed state
transition matrix at rest (Fig. 3.4a) would be anticorrelated with the off-diagonal elements
of Te . This hypothesis was based on the notion that the brain would empirically prefer
trajectories in state space requiring smaller magnitude control inputs to achieve. Note that
we ignored the diagonal of Te , which captures whether persistence energies explain observed
state dwell times, a question that we were not sufficiently powered to ask with only k = 5
states but that should be revisited in future studies.
The choice of the control horizon T is critical for the calculation of Te . When control
inputs are uniformly distributed across the brain such that BK is the identity matrix, then
as T approaches 0, the minimum control energy Em becomes proportional to the squared
Euclidean norm of xT − xo . ||xT − xo ||2 is the state space distance between the initial and
final state in the transition. At longer time horizons, both ||xT − xo ||2 and the topology
of A determine Em . When BK is not the identity matrix, Em becomes proportional to
(xT − xo )| (BK B|K )−1 (xT − xo ) as T approaches 0.
However, because the units of the edge weights of A, obtained from deterministic tractography performed on diffusion-weighted imaging data, are not measured in activity per unit
time, the value of T is arbitrary relative to A and the real time in which neural activity was
measured through BOLD fMRI. Therefore, we chose T in a data-driven fashion by computing transition energies for a range of T values using a group representative structural A
matrix, and computing the Spearman rank correlation between transition energies and the
group average transition probability matrix from resting state fMRI data (Supplementary
Fig. S3.11a). We used the Spearman rank correlation rather than the Pearson correlation
in order to reduce the effect of outliers on estimating the relationship between transition
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probability and transition energy. We found that the strongest negative correlation value
was obtained for T = 5, but similarly strong negative correlations were found for the range
T = [5, 10] (Supplementary Fig. S3.11a). Accordingly, we used T = 5 for the analyses presented in Fig. 3.5b-c, Fig. 3.6c, and Supplementary Fig. S3.10b. We also carried out the
same analysis using a distribution of null networks with preserved degree sequence (see Fig.
3.5b), which revealed that there was no T value yielding a correlation between transition
energies and observed resting state transition probabilities as strongly negative as when we
used the real structural connectivity matrix (Supplementary Fig. S3.11a).
In addition to controlling the brain with uniformly weighted inputs, we also asked whether
transition energies obtained using a non-uniform distribution of inputs might better explain the observed transition probabilities. Specifically, we hypothesized that accounting
for external visual input during the fractal n-back task might provide a more accurate estimation of the input energy needed to achieve each transition. We weighted the inputs
towards one cognitive system (Yeo et al. 2011) at a time while still allowing input into every
brain region, and then recomputed the Spearman correlation between transition energies
and transition probabilities for the resting state (Supplementary Fig. S3.11b) and the 2back condition of the n-back task (Supplementary Fig. S3.11d). This analysis revealed
that accounting for visual input in computing transition energies improved our ability to
explain the observed brain state transition probabilities during the 2-back condition (Supplementary Fig. S3.11d VIS-weighted subpanel, orange trace is lower than teal trace), and
abolished our ability to explain resting state transition probabilities (Supplementary Fig.
S3.11b VIS-weighted subpanel, blue trace is greater than 0 and dashed line is near 0). However, we did not find a clear role for brain structure in this relationship, as evidenced by
the fact that transition energy did not explain transition probability any better than the
weighted distance between states (Supplementary Fig. S3.11d, orange trace does not dip
below dashed line). Thus, we present results in Fig. 3.5d for T = 0.001, where Em is proportional to (xT − xo )| (BK B|K )−1 (xT − xo ). Nevertheless, this finding suggests a specificity
of the constraints of state-space transition distance on the brain’s empirically observed
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progression through state space. Resting state transition probabilities can be explained
by unweighted state-space distance (Supplementary Fig. S3.11a, dashed line, Spearman’s
r = −0.32) but not by visual system-weighted state-space distance (Supplementary Fig.
S3.11b, VIS-weighted dashed line, Spearman’s r = −0.06); 2-back transition probabilities
can be explained by unweighted state-space distance (Supplementary Fig. S3.11c, dashed
line, Spearman’s r = −0.61), but are explained best by visual system-weighted state-space
distance (Supplementary Fig. S3.11b, VIS-weighted dashed line, Spearman’s r = −0.80).
This result suggests that visual input allows the brain to deviate from the constraints of
state-space distance found at rest, while an equal consideration of visual inputs alongside
other inputs is key to explaining resting state transitions. Resolving the effect of structure
on brain dynamics during a task may require full knowledge of all input sources, which
could potentially be uncovered through a data-driven approach (Ashourvan et al. 2019).
Impact of parcellation and cluster number
The choice of parcellation scale may impact analyses involving tractography, where relative
region sizes may bias estimates of connectivity. We chose a relatively fine-grained parcellation with 462 nodes because previous coactivation pattern analyses (Chen et al. 2015) at
this scale produced cluster assignments similar to those obtained by clustering at the voxel
level. However, we were interested to know whether we would obtain the same results using
a coarser parcellation scale. Therefore, we repeated the clustering procedure and subsequent control theoretic analyses using the Lausanne 234 node parcellation (Cammoun et al.
2012).
First, this analysis revealed brain states whose spatial maps were virtually identical to those
generated using the 462 node parcellation (Supplementary Fig. S3.5a). The fractional occupancy of these states also changed with cognitive load in a similar fashion (Supplementary
Fig. S3.5a) compared to the results in Fig. 3.3d. Similar to the results presented in the
main text, we found a negative relationship between transition energies and empirically
observed brain state transition probabilities at rest (Supplementary Fig. S3.5c, Spearman’s
r = −0.62, pSLP < 0.001, pDP < 0.001) with a weak positive relationship between tran140

sition energies and transition probabilities from the 2-back condition (Supplementary Fig.
S3.5c, Spearman’s r = 0.21, pSLP = 1, pDP = 0.85). We also found that discounting the
weight of the visual system in calculating state-space transition distance allowed us to better
explain 2-back transition probabilities (Supplementary Fig. S3.5d, Spearman’s r = −0.78,
pSLP = 1, pDP = 1), and reduced our ability to explain resting state transition probabilities
(Supplementary Fig. S3.5d, Spearman’s r = −0.31, pSLP < 0.001, pDP < 0.001). These
results suggest that one can quantify the constraints of white matter architecture on brain
state transitions at rest at multiple scales of region definition, supporting the generalizability
of our findings.
A limitation of k-means clustering is the need to specify an absolute number of clusters.
While the data suggests that k = 5 is the optimal solution, one could certainly choose to
analyze this data at multiple scales. Because of a recent study (Gutierrez-Barragan et al.
2019) in which k = 6 was identified as the optimal solution by the same heuristic, we
reproduce our results at k = 6 in the interest of facilitating comparison between the two
studies.
At k = 6, cluster centroid brain states interestingly become grouped into 3 anticorrelated
pairs (DMN+ and DMN-, VIS+ and VIS-, FPN+ and SOM+), similar to Ref. (GutierrezBarragan et al. 2019). The states were also highly similar to those at k = 5, with the
DMN- state from k = 5 essentially “split” into the SOM+ and DMN- state at k = 6. The
DMN- state at k = 6 state houses concurrent high amplitude activity in the dorsal attention network and visual system with low amplitude activity in the default mode network
(Supplementary Fig. S3.12a). This appearance of “split” brain states is consistent with
hierarchical state organization (Vidaurre et al. 2017b; Chen et al. 2018), which becomes
apparent at different clustering scales. As WM load increased from 0-back to 2-back, we
saw a decrease in DMN+ fractional occupancies with a concurrent increase in FPN+ and
VIS state fractional occupancies (Supplementary Fig. S3.12b). Direct transitions between
anticorrelated states were infrequent (Supplementary Fig. S3.12c-d), with a drastic shift
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in transition probabilities towards VIS states and away from DMN states during 2-back
relative to rest (Supplementary Fig. S3.12e). Similar to k = 5, at k = 6 we found that
2-back task performance was related to 2-back state transitions from the VIS- state into
states with coherent frontoparietal and default mode activity (Supplementary Fig. S3.12e).
Specifically, we found that transitions from VIS- into DMN- and FPN+ were positively
associated with performance, consistent with the high amplitude dorsal attention network
activity and low amplitude DMN activity found in the DMN- state (Supplementary Fig.
S3.12a). Additionally, transitions from the VIS- state to the SOM+ state were negatively
associated with performance, consistent with the frontoparietal deactivation found in the
SOM+ state (Supplementary Fig. S3.12a). We again found a strong negative correlation
between transition energies and resting state transition probabilities (Supplementary Fig.
S3.12f, Spearman’s r = −0.87, pSLP < 0.001, pDP < 0.001) that was specific to the topology
of white matter, supporting the notion that the constraints of white matter on state-space
progression generalizes across multiple scales of states. Similar to our results at k = 5,
we found that discounting the weight of the visual system in calculating the state-space
distance of transitions allowed us to better explain the state transitions observed during
the 2-back task, during which visual stimuli are frequently delivered (Supplementary Fig.
S3.12g, Spearman’s r = −0.75, pSLP = 0.4, pDP = 0.7). Overall, this analysis suggests that
our main findings hold true at near optimal values of k, and that much can be learned from
studying the states of the brain at different scales.
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fMRI Time Series. NeuroImage, 9(3):298–310.
Gratton, C., Laumann, T. O., Nielsen, A. N., Greene, D. J., Gordon, E. M., Gilmore, A. W.,
Nelson, S. M., Coalson, R. S., Snyder, A. Z., Schlaggar, B. L., Dosenbach, N. U., and
Petersen, S. E. (2018). Functional Brain Networks Are Dominated by Stable Group and
Individual Factors, Not Cognitive or Daily Variation. Neuron, 98(2):439–452.e5.
Gu, S., Betzel, R. F., Mattar, M. G., Cieslak, M., Delio, P. R., Grafton, S. T., Pasqualetti,
F., and Bassett, D. S. (2017). Optimal trajectories of brain state transitions. NeuroImage,
148:305–317.

146

Gu, S., Pasqualetti, F., Cieslak, M., Telesford, Q. K., Alfred, B. Y., Kahn, A. E., Medaglia,
J. D., Vettel, J. M., Miller, M. B., Grafton, S. T., and Others (2015a). Controllability of
structural brain networks. Nature communications, 6.
Gu, S., Pasqualetti, F., Cieslak, M., Telesford, Q. K., Yu, A. B., Kahn, A. E., Medaglia,
J. D., Vettel, J. M., Miller, M. B., Grafton, S. T., and Bassett, D. S. (2015b). Controllability of structural brain networks. Nature Communications, 6:1–10.
Gutierrez-Barragan, D., Basson, M. A., Panzeri, S., and Gozzi, A. (2019). Infraslow
State Fluctuations Govern Spontaneous fMRI Network Dynamics. Current Biology,
29(14):2295–2306.e5.
Honey, C. J., Sporns, O., Cammoun, L., Gigandet, X., Thiran, J. P., Meuli, R., and Hagmann, P. (2009). Predicting human resting-state functional connectivity from structural
connectivity. Proceedings of the National Academy of Sciences, 106(6):2035–2040.
Hutchison, R. M. and Morton, J. B. (2015). Tracking the Brain’s Functional Coupling
Dynamics over Development. Journal of Neuroscience, 35(17):6849–6859.
Jenkinson, M., Bannister, P., Brady, M., and Smith, S. (2002). Improved optimization
for the robust and accurate linear registration and motion correction of brain images.
NeuroImage, 17(2):825–41.
Jernigan, T. L., Brown, T. T., Hagler, D. J., Akshoomoff, N., Bartsch, H., Newman, E.,
Thompson, W. K., Bloss, C. S., Murray, S. S., Schork, N., Kennedy, D. N., Kuperman,
J. M., McCabe, C., Chung, Y., Libiger, O., Maddox, M., Casey, B. J., Chang, L., Ernst,
T. M., Frazier, J. A., Gruen, J. R., Sowell, E. R., Kenet, T., Kaufmann, W. E., Mostofsky,
S., Amaral, D. G., and Dale, A. M. (2016). The Pediatric Imaging, Neurocognition, and
Genetics (PING) Data Repository. NeuroImage, 124(0 0):1149–1154.
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CHAPTER 4: Spread of α-synuclein pathology through the brain
connectome is modulated by selective vulnerability and
predicted by network analysis
This chapter contains work from Henderson, M.X., Cornblath, E.J., Darwich, A., Zhang,
B., Brown, H., Gathagan, R.J., Sandler, R.M., Bassett, D.S., Trojanowski, J.Q., and Lee,
V.M.Y. (2019). “Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis.” Nature Neuroscience, 22,
1248-1257.
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Abstract
Studies of patients afflicted by neurodegenerative diseases suggest that misfolded
proteins spread through the brain along anatomically-connected networks, prompting
progressive decline. Recently, mouse models have recapitulated the cell-to-cell transmission of pathogenic proteins and neuron death observed in patients. However, factors
regulating spread of pathogenic proteins remain a matter of debate due to an incomplete understanding of how vulnerability functions in the context of spread. Here, we
use quantitative pathology mapping in the mouse brain combined with network modeling to understand the spatiotemporal pattern of spread. α-synuclein pathology patterns
are well-described by a network model based on two factors: anatomical connectivity
and endogenous α-synuclein expression. The map and model allow assessment of selective vulnerability to α-synuclein pathology development and neuron death. Finally, we
use quantitative pathology to understand how the G2019S LRRK2 genetic risk factor
impacts the spread and toxicity of α-synuclein pathology.
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INTRODUCTION
The synaptic protein α-synuclein misfolds in Parkinson’s disease (PD) (Spillantini et al.
1998a,b; Baba et al. 1998) and related diseases and aggregates into large intraneuronal inclusions known as Lewy bodies (LBs) (Rodrigues e Silva et al. 2010). Recent evidence suggests that α-synuclein not only accumulates in LBs, but can itself act as an agent of disease,
templating the aggregation of α-synuclein in anatomically connected neurons throughout
the brain (Luna and Luk 2015). While the cell-to-cell transmission of α-synuclein explains
much of the pathology and symptom progression seen in PD and related synucleinopathies,
certain neuron populations are clearly more vulnerable than others (Surmeier et al. 2017),
resulting in specific degeneration of certain neurons while sparing others nearby (Elstner
et al. 2011). Therefore, the extent to which intrinsic cell vulnerability or cell-to-cell spread
of α-synuclein pathology drive of PD pathogenesis is still a matter of debate.
Exogenous misfolded α-synuclein injected into wildtype mice induces misfolding of endogenous α-synuclein into phosphorylated, aggregated inclusions resembling human LBs (Luk
et al. 2012; Henderson et al. 2017). These inclusions are found in many brain regions directly
or indirectly connected to the injection site, and the inclusions induce a time-dependent degeneration of the inclusion-bearing neurons (Luk et al. 2012; Osterberg et al. 2015; Rey et al.
2017). Previous work has demonstrated that pathogenic α-synuclein is transmitted extracellularly since spread can be blocked by an anti-α-synuclein antibody (Tran et al. 2014), or
by blocking a receptor for misfolded α-synuclein (Mao et al. 2016). Thus, injection of misfolded α-synuclein into mice is an ideal model to understand the spatiotemporal pattern of
pathogenic protein spread and how network connectivity and neuronal vulnerability affect
spreading dynamics.
In this study, we used quantitative assessment of α-synuclein pathology in non-transgenic
(NTG) mice injected with α-synuclein pre-formed fibrils (PFFs) to generate a spatiotemporal map of pathology spread and neuron death. A network diffusion model based on
anatomical connectivity explains much of the variation in pathological burden. Further,

155

α-synuclein gene (Snca) expression correlates well with the differential vulnerability observed between regions, suggesting that anatomical connectivity and α-synuclein protein
expression are major contributors to pathogenic protein spread. Finally, we sought to determine how genetic risk factors affect network dynamics of pathological α-synuclein spread.
We performed quantitative pathology mapping in transgenic mice carrying the Gly2019Ser
(G2019S) leucine-rich repeat kinase (LRRK2) risk factor for PD (Li et al. 2010) and assessed how transgene expression affects network properties of α-synuclein spread, neuron
vulnerability and neuron toxicity. The quantitative pathology maps and network model presented here represent an important framework for understanding and treating progressive
neurodegenerative diseases.

RESULTS
Brain-wide quantification of α-synuclein pathology
A model for PD pathogenesis has recently been described in which α-synuclein pathology
can be induced in non-transgenic mice following a single injection of α-synuclein pre-formed
fibrils (PFFs) (Luk et al. 2012) but pathology is not induced by injection of either monomeric
α-synuclein or PBS (Luk et al. 2012). While the α-synuclein pathology in these mice has
been described qualitatively, we sought to understand the spatiotemporal spread of αsynuclein pathology quantitatively and to use this data to develop a network model of
spread. To accomplish these aims, we injected 3-month-old NTG (C57BL/6J) mice in the
dorsal striatum with 5 µg α-synuclein PFFs and allowed them to age 1, 3 or 6 months
post-injection (MPI, Fig. 4.1a). Brains embedded in paraffin were sectioned and stained
using traditional immunohistochemical techniques for pathological misfolded (Syn506) and
phosphorylated (pS129) α-synuclein. These sections were then scanned into a digitized
format, allowing for automated quantitation of α-synuclein pathology burden. An expert in
mouse neuroanatomy, but blinded to treatment, manually annotated 172 regions in 5 coronal
slices for each mouse (Fig. 4.1b, Fig. S4.1). These anatomical regions were selected to
encompass all major regions in which α-synuclein pathology appears. Regions with little α-
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synuclein pathology but a large number of nuclei, such as the thalamus and mesencephalon,
were grouped so as to minimize error in annotation and to maximize efficiency.
A simple quantitative algorithm identified the percentage of each region occupied with
α-synuclein pathology above a threshold 0.157 optical density (Fig. 4.1b). To minimize
sampling bias, a completely separate set of sections flanking the original sections was immunostained, annotated and analyzed in a similar manner. The mean of the two sets is
reported in Supplementary Table 1 and is used in all subsequent analysis (n, 1 MPI=4, 3
MPI=6, 6 MPI=6).
Dynamic spread patterns in non-transgenic mice
Regional pathological burden values differed by greater than 1000-fold and revealed dynamic
patterns of regional α-synuclein pathology spread over time. Several distinct patterns of
spread were observed that are consistent with pathological progression and neuron death
(Fig. 4.2a): (1) Slow initiation of pathology, but constant progression after initiation as seen
in the ipsilateral caudoputamen (iCPu) and hippocampus (iHipp-b). (2) Delayed initiation,
constant progression as seen in the contralateral caudoputamen (cCPu), likely due to the
trans-synaptic nature of pathology spread. 3) Rapid initiation, slow progression as seen in
the directly-connected ipsilateral secondary motor cortex (iM2) cortex. (4) Rapid initiation,
rapid decrease as seen in the vulnerable ipsilateral substantia nigra (iSN) (Luk et al. 2012;
Henderson et al. 2019) which has robust cell death by 6 MPI, causing a commensurate
reduction in pathology. (5) Constant initiation, slow progression as seen in the ipsilateral
primary somatosensory cortex (iS1). The pathological burden of each region at all three
timepoints can be displayed as a heat map overlaid onto the brain anatomy (Fig. 4.2b) or
in a region by time graph (Fig. S4.2). Whole-brain quantitation of α-synuclein pathology
facilitates macroscopic observation of network patterns, including the overall increase in
pathology over time and most substantial spread to highly connected ipsilateral regions.
While pathological α-synuclein load in informative, we also sought to develop a brain-wide
measure of neuron death.
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Figure 4.1: Quantitation of α-synuclein pathology allows for brain-wide analysis
of pathology spread. (a) Experiment schematic: mice were injected in the dorsal striatum
with α-synuclein at 3 months of age. The mice were then aged 1, 3 or 6 months post-injection
and assessed for motor behaviors during that time period. The brains of mice were used
for quantitative pathology analysis. (b) Representative images of brain sections (similar
for 16 wildtype mice) with manual annotation of 172 regions displayed (scale bar= 1mm).
The ipsilateral SN of this brain is shown below with and without an analysis mask overlaid
(scale bar= 100 µm).

158

Figure 4.2: α-synuclein spreads in a dynamic spatiotemporal pattern throughout
the mouse brain. (a) Representative quantitative pS129 α-synuclein pathology plots and
images are shown for 1-, 3- and 6-month timepoints (scale bar= 50µm). Plots display
mean ± standard error. (b) Heat map of regions affected with α-synuclein pathology. The
names of the associated areas are plotted onto identical maps in the supplementary material.
The color scale represents log-transformed mean percentage area occupied with α-synuclein
pathology. n (number of mice), 1 MPI=4, 3 MPI=6, 6 MPI=6.
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Estimating neuron death
α-Synuclein pathology can take multiple morphological forms. Soon after injection, the
majority of pathology is neuritic (Fig. 4.3a). By 3 MPI, much of the pathology has consolidated into large LB-like cell body inclusions. By 6 MPI, some regions have diminished
pathology possibly due to consolidation of neuritic pathology into cell body inclusions and
neuron death. Previous work has demonstrated that in the substantia nigra (SN) (Luk et al.
2012), cortex (Osterberg et al. 2015) and accessory olfactory nucleus (Rey et al. 2017) loss
of cell body pathology is indicative of the death of the inclusion-bearing neurons. Therefore, we proposed to obtain estimates of neuron loss in each region by measuring cell body
inclusions throughout the brain and using the difference between timepoints as an estimate
of neuron loss (Fig. 4.3a).
To exclude neuritic pathology, we developed a second algorithm to measure only cell body
inclusions based on size (40 − 400 µm2 ), shape (round) and texture (thick) (Fig. 4.3b).
After optimizing the ability of the algorithm to identify exclusively cell body pathology
throughout the brain, the algorithm was applied to all annotated sections. The difference
between the number of cell body inclusions at sequential timepoints was used to give an
estimate of neuron loss (Fig. 4.3c). The highest observed neuron loss was in the SN between
3 and 6 MPI, consistent with the SN’s high vulnerability in PD.
To validate the neuron loss measure, sections from 3 MPI mice between the two sections
used for pathology quantitation were stained for tyrosine hydroxylase (TH) and the number
of neurons in the SN were counted (Fig. 4.3d). The mean estimated neuron loss for this
region from 3 to 6 MPI was then subtracted from the TH cell counts to give an estimated
35% neuron loss on the side ipsilateral to the injection side compared to the contralateral
side (Fig. 4.3e). To test the accuracy of this estimate, every 10th section through the
midbrain of 6 MPI mice was stained for TH, and the number of TH cells was counted (Fig.
4.3f, 4.3g). The actual TH cell loss in the ipsilateral SN of 6 MPI mice was 34% compared
to the contralateral side. The concordance of the estimated and actual neuron loss suggests
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Figure 4.3: Select quantification of cell body pathology allows for assessment of
neuron loss. (a) Theoretical framework for assessing neuron loss. Pathology appears at
1 month as primarily neuritic pathology, which consolidates over time into large LB-like
inclusions. If these large inclusions can be measured as sequential timepoints, it would
allow an approximation of the number of neurons that are lost during that time period. (b)
An example of a region that has both high neuritic and cell body pathology burden. The
total pathology mask identifies both forms of pathology, while the cell body pathology mask
excludes neuritic pathology and identifies only cell body pathology (scale bar= 100µm). (c)
Heat map of the estimated number of neurons lost in each anatomical region. The color
scale represents log-transformed mean number of neurons lost between 1 and 3 (1-3 MPI)
and between 3 and 6 (3-6 MPI) months post-injection. (d) One section in between the two
sections used for pathology quantitation was stained with an anti-TH antibody and used for
quantification of substantia nigra neurons in each 3 month post-injection mouse (two-tailed
paired t-test, p = 0.0026). (e) The mean estimated neuron loss between 3 and 6 months
from the SN was subtracted from the TH cell counts in 3 MPI mice (two-tailed paired t-test,
p = 0.0075). (f ) Every 10th section through the SN was stained with an anti-TH antibody
and SN neurons were counted to estimate the total number of neurons present in NTG mice
6 months after injection (two-tailed paired t-test, p = 0.0003). (g) Representative images of
the contralateral and ipsilateral substantia nigra from NTG mice 6 months post-injection
(scale bar = 500µm). Plots display mean ± standard error with individual values plotted.
n (number of mice), 1 MPI= 4, 3 MPI= 6, 6 MPI= 6.

161

that loss of cell body inclusions is a valid proxy for neuron loss.
Network model of pathological α-synuclein spread
Observationally, many of the regions to which α-synuclein spreads have high direct anatomical connectivity to the injected CPu (Oh et al. 2014) (Fig. S4.3). However, this connectivity
hypothesis has not been tested using quantitative pathology data. Here, we experimentally
validated a network diffusion model based on anatomical connectivity (Fig. S4.4, see Methods for details). Using this model, we estimated pathology as a function of time given
the introduction of misfolded protein into the iCPu. The model specified that pathological α-synuclein would propagate retrogradely along synapses at a rate proportional to the
density of axonal projections, and explained much of the overall variability in the mean
regional pathology across all mice at 1, 3 and 6 MPI (Fig. 4.4a). These results suggest
that linear dynamics imposed on a network of synaptic connections can explain pathological
α-synuclein spread over time.
To further test the ability of anatomical connectivity to predict the spread of pathology,
each of the other brain regions was used as the seed region, and the model was propagated
forward to generate predictions of pathological spread at 1, 3 and 6 MPI. The fit of the
predicted pathology to the actual pathology displayed a range of accuracies, but an iCPu
seed produced either the best or second-best fit at all time points (Fig. 4.4b). The other
seed regions that showed a high fit to the empirical data had high in-projection similarity
to the CPu (Fig. S4.5), suggesting that seed regions exhibiting high degrees of topological
similarity yield similar predictions.
To explore the directionality of spread, retrograde and anterograde connectivity values were
inserted into the model separately. While retrograde connectivity had r = 0.56 − 0.69 (Fig.
4.4a), anterograde alone gave r = 0.32 − 0.43 (Fig. S4.6), suggesting that α-synuclein
spreads primarily in a retrograde manner or that retrograde spread to cell bodies is more
easily detected than anterograde spread to nerve terminals.
We further tested the specificity of the network diffusion model by evaluating the ability of
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Figure 4.4: Network diffusion model based on anatomical connectivity explains
pathological α-synuclein spread. (a) Scatterplots and Pearson correlation coefficients
(r) of log predicted pathology based on anatomical connectivity versus actual pathology
values for each region are shown for 1 (df = 95, pcorr = 9.85 × 10−9 ), 3 (df = 111, pcorr =
1.66 × 10−16 ) and 6 (df = 111, pcorr = 2.64 × 10−14 ) MPI (two-tailed t-tests). p-values were
Bonferroni-corrected over the 3 time points. The green line represents the line of best fit, and
the shaded ribbon represents the 95% prediction interval. (b) Each different brain region was
seeded and pathology propagation was modeled from each site. The fit of each of these sites
is plotted for 1, 3, and 6 MPI (purple dots). The CPu seed (black diamond) produced either
the best fit (3 and 6 MPI, 100th percentile of fits) or second best fit (1 MPI, 99th percentile
of fits). (c) Heat map of the residuals between the log(predicted) and log(pathology) are
plotted on an anatomical mouse brain as a measure of the relative vulnerability of regions.
(d) Heat map of the Snca mean expression energy values from the Allen Brain Atlas in
situ hybridization data for each of the designated regions. (e) Scatterplots and Pearson
correlation coefficients (r) of Snca expression energy and vulnerability estimates for each
region. The two values show a positive Pearson correlation of r = 0.53 (two-tailed ttest, df = 114, p = 1.08 × 10−9 ). The purple line represents the line of best fit, and
the shaded ribbon represents the 95% prediction interval. (f ) Scatterplots and Pearson
correlation coefficients (r) of log predicted pathology based on anatomical connectivity and
Snca expression vs. log actual pathology values for each region are shown for 1 (df = 95,
pcorr = 1.85×10−9 ), 3 (df = 111, pcorr = 5.84×10−19 ) and 6 (df = 111, pcorr = 1.34×10−20 )
MPI (two-tailed t-tests). p-values were Bonferroni-corrected over the 3 time points. The
green line represents the line of best fit, and the shaded ribbon represents the 95% prediction
interval. n (number of mice): 1 MPI=4, 3 MPI=6, 6 MPI=6).
163

proximity to the injection site and higher-order topological features to explain the observed
α-synuclein pathology. A network defined by the Euclidean distance between regions poorly
explains the observed pathology (Pearson’s r = −0.066 − 0.1, Fig. S4.7a), and disruption
of higher-order topological features also abrogates the predictive capabilities of the model
(Pearson’s r = 0.14 − 0.18, Fig. S4.7b).
Notably, the model requires only a single parameter to be fit, which is a time constant that
simply scales the location of the observed time points along the trajectory of the model.
We selected the time constant that produced the best mean fit across all time points with
the empirical data. To ensure that the time constant we selected was externally valid,
we performed split reliability tests. Specifically, we fit the time constant on a random
sample composed of half of the mice, and tested its ability to explain the mean regional αsynuclein pathology values in the remaining half of the mice. This procedure was repeated
100 times, and the fits observed when using every mouse (Fig. 4.4a) did not lie outside of
the distribution of out-of-sample fits (Fig. S4.8). These results suggest a high reliability of
the estimated time constants, and low variability between mice in the time course of the
spread of pathological α-synuclein.
Differential vulnerability of regions is correlated with α-synuclein expression
Intrinsic vulnerability is postulated to be a critical factor that impacts the development of
pathology at any given time (Surmeier et al. 2017), and the network model provides a framework to understand which regions are more or less vulnerable than expected if anatomical
connectivity were the sole driver of pathological spread (Fig. S4.9). We therefore define the
difference, or residual, between the connectivity-based prediction and observed pathology to
be a measure of relative vulnerability. Regions wherein the α-synuclein pathology is exactly
predicted by the model have a vulnerability value of 0. Regions that have more pathology
than predicted have vulnerability values greater than 0; regions that have less pathology
than predicted have vulnerability values less than 0 (Fig. S4.10a).
In order to account for noise in the estimation of intrinsic neuron vulnerability, we computed
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a summary measure of vulnerability based on two principles that can be enforced on the
residuals between the model and the empirical data: (1) Intrinsic vulnerability should not
change over time and (2) intrinsic vulnerability should not be different on the ipsilateral
and contralateral sides. Accordingly, we averaged the residuals for each region across all
timepoints (Fig. S4.10b) and both hemispheres (Fig. 4.4c). We posit that these two
assumptions bring us closer to an estimation of the true regional vulnerability to pathological
α-synuclein spread. It is interesting to note that the basolateral amygdala, rostral cortical
regions and piriform cortex are the most vulnerable, while thalamic and mesencephalic
nuclei are largely resilient to α-synuclein pathology (Fig. S4.11a, S4.11b).
While incorporating relative vulnerability values into the network model would improve the
predictive ability of the model for a CPu injection, we sought to identify a factor which
would explain the regional vulnerability without any reliance on the empirical data set.
We hypothesized that one factor which should influence the development of α-synuclein
pathology is α-synuclein expression. We used α-synuclein gene (Snca) expression energy
values (Lein et al. 2007) from the Allen Brain Atlas (Fig. 4.4d, Fig. S4.11a, S4.11c,
brain-map.org) to examine the relationship of Snca expression to regional vulnerability. In
support of our hypothesis, Snca expression is highly correlated with vulnerability values
(Fig. 4.4e, Fig. S4.11a, S4.11d).
While Snca expression explained variance in vulnerability (Fig. S4.12), we also sought
to explicitly incorporate Snca expression levels into our network diffusion model. We accomplished this aim by weighting the outgoing connections of every node by its respective
Snca expression value, based on the notion that retrograde propagation of misfolded αsynuclein will lead to greater pathological accumulation in regions with greater endogenous
Snca expression. Indeed, incorporation of Snca expression into the model in this fashion
improved the ability of the model to accurately predict the burden of α-synuclein pathology
(Fig. 4.4f). Together, these data suggest that Snca expression is an important factor in
determining the vulnerability of regions to developing α-synuclein pathology. Importantly,
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our network diffusion model is based only on factors intrinsic to the brain, i.e. anatomical
connectivity and Snca expression, and can therefore be used as a powerful tool to model
spread from other sites and investigate the role of network topology in pathological protein
spread.
Model Applications
To demonstrate the generalizability of our model, we placed seeds in alternate sites and
propagated the model forward in time to observe pathological α-synuclein spread in silico.
One of the most comprehensive assessments of α-synuclein pathology spread to date used
injections of α-synuclein PFFs into the olfactory bulb of wildtype mice followed by semiquantitative pathology grading through the mouse brain at 1, 3, 6 and 12 months postinjection(Rey et al. 2016). To replicate this injection in silico, we seeded pathology in the
piriform cortex and propagated the model 1, 3 and 6 MPI (Fig. 4.5a). The model shows
a remarkable visual correspondence to the scoring previously reported (Rey et al. 2016),
suggesting our model is generalizable to different injection sites.
LB staging from human PD and preclinical patients has led to a hypothesized neuroanatomical pathway by which pathology spreads from the brainstem or olfactory bulb up through
the midbrain and limbic structures to cortical regions (Braak et al. 2002, 2003; Beach et al.
2009). Portions of this hypothesis can be tested by placing a seed in midbrain regions,
including the SN (Fig. 4.5b). The seeding of α-synuclein pathology in the SN results in
slow propagation through the CPu to cortical regions, analogous to what has been observed
in the staging of human cases. Seeding other regions including the hippocampus and secondary motor cortex (M2) (Fig. S4.13) shows very distinct patterns of spread. Intriguingly,
injections into M2 result in rapid decreases in pathology in frontal cortical structures in
conjunction with progressive increases in pathology in subcortical structures (Fig. S4.13b).
In silico injection into the caudoputamen demonstrates the ability of the network model to
recapitulate the empirical spread pattern, but also highlights regions in which spread is not
fully recapitulated by the model (Fig. S4.13c). Future in vivo injections at other sites will
be important to quantitatively validate this model and determine other factors influencing
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Figure 4.5: In silico seeding of alternate regions in mouse brain. Heat map of regions
affected with α-synuclein pathology with in silico propagation of α-synuclein pathology
after seeding in either (a) the piriform cortex or (b) the substantia nigra. The color scale
represents log-transformed mean percentage area occupied with α-synuclein pathology.
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pathological protein spread.
Understanding changes in network parameters due to G2019S LRRK2 expression
While theoretical manipulations of the network model can provide a powerful means of
hypothesis testing, we sought to directly assay how a genetic risk factor for PD alters the
spread of pathogenic α-synuclein and to use network modeling to understand properties
underlying these alterations. While most cases of PD are idiopathic, autosomal dominant
mutations in LRRK2 are responsible for 1-2% of all PD cases (Healy et al. 2008). PD
patients with LRRK2 mutations have a similar onset and somewhat slower progression of
disease than idiopathic patients (Saunders-Pullman et al. 2018) and a similar incidence
of pathological α-synuclein inclusions (Healy et al. 2008). The most common mutation
Gly2019Ser (G2019S) leads to elevated kinase activity (West et al. 2005; Greggio et al.
2006; Sheng and Wu 2012), and a recent report has suggested that LRRK2 kinase activity
is elevated even in idiopathic PD patients (Di Maio et al. 2018). Despite the strong evidence
implicating LRRK2 in PD pathogenesis, only 25-42.5% of G2019S carriers will get disease
(Lee et al. 2017), suggesting that mutations in LRRK2 modulate pathogenesis of PD. We
therefore hypothesized that while G2019S LRRK2 expression may not initiate α-synuclein
pathogenesis in mice, it may alter the vulnerability of neurons, alter the toxicity of αsynuclein pathology and/or change the rate of pathology progression. Using the approach
described thus far for NTG mice, we quantitatively measured and modeled α-synuclein
pathology spread in the brains of G2019S LRRK2 mice to understand the contribution of
this genetic risk factor to disease.
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Figure 4.6 (previous page): Quantitative α-synuclein pathology mapping allows a
direct comparison between NTG and G2019S LRRK2 mice. (a) Representative
quantitative pS129 α-synuclein pathology plots and images are shown for 1-, 3- and 6-month
timepoints for both NTG and G2019S mice (scale bar = 100µm). Plots display mean ±
standard error. (b) Heat map of regions affected with α-synuclein pathology. The names
of the associated areas are plotted onto identical maps in the supplementary material.
The color scale represents log-transformed mean percentage area occupied with α-synuclein
pathology. n (number of mice), 1 MPI-NTG=4, 1 MPI-G2019S=6, 3 MPI-NTG=6, 3
MPI-G2019S=6, 6 MPI-NTG=6, 6 MPI-G2019S=7.

The BAC transgenic G2019S LRRK2 mice used for this study have similar expression of
α-synuclein as wildtype (NTG) mice (Fig. S4.14a, S4.14b) and show no accumulation of
pathogenic α-synuclein without α-synuclein PFF injection up to at least 12 months of age
(Fig. S4.14c, S4.14d). Interestingly, G2019S mice weigh less than NTG (Fig. S4.14e) but
show similar grip strength (Fig. S4.14f) and enhanced motor performance on rotarod at
early ages (Fig. S4.14g), consistent with previous reports (Volta et al. 2017).
G2019S LRRK2 mice were injected with the same α-synuclein PFFs in the dorsal striatum
at the same time as C57BL/6J mice, so the two groups of mice could be directly compared.
α-Synuclein PFF injection causes reduced grip strength in both NTG and G2019S mice
compared to uninjected controls, but no difference between the genotypes (Fig. S4.14f).
α-Synuclein PFF injection did not cause a change in the latency to fall in the rotarod assay
for NTG mice, but abrogated the enhanced performance seen in G2019S mice (Fig. S4.14g).
The overall pattern of pathological spread in NTG and G2019S is similar (Fig. 4.6, N,
1 MPI-NTG=4, 1 MPI-G2019S=6, 3 MPI-NTG=6, 3 MPI-G2019S=6, 6 MPI-NTG=6,
6 MPI-G2019S=7). In fact, the spread pattern in many regions is nearly identical (Fig.
4.6a, iCPu, cCPu, iM2) validating the replicability of this quantitative pathology method.
However, there are large regional differences in the degree and rate of α-synuclein pathology
accumulation (iHipp-b, iSN, iS1). These regional differences lead to an overall alteration
in the dynamics of pathological α-synuclein spread (Fig. 4.6b) which is best understood at
the network level.
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Figure 4.7 (previous page): α-Synuclein pathology shows enhanced spread and toxicity in resilient regions in G2019S LRRK2 mice. (a) Scatterplots and Pearson
correlation coefficients (r) of log predicted pathology based on anatomical connectivity and
Snca expression versus actual pathology values for each region are shown for 1 (df = 104,
pcorr = 2.00×10−9 ), 3 (df = 112, pcorr = 2.39×10−10 ) and 6 (df = 113, pcorr = 9.07×10−19 )
MPI (two-tailed t-tests). p-values were Bonferroni-corrected over the 3 time points. The
green line represents the line of best fit, and the shaded ribbon represents the 95% prediction interval. (b) Heat map of regional ratios of pathology in G2019S/NTG mice. Warm
colors represent areas with more pathology in G2019S mice, while cooler colors represent
regions with less pathology in G2019S mice. (c) Heat map of the estimated number of
neurons lost in each anatomical region in NTG and G2019S mice. The color scale represents log-transformed mean number of neurons lost between 3 and 6 (3-6 MPI) months
post-injection. (d) Scatterplots and Pearson correlation coefficients (r) of timepoint-specific
NTG regional vulnerability measures versus log G2019S/NTG pathology, showing a negative correlation between the two variables at 1 (df = 89, pcorr = 2.88 × 10−6 ), 3 (df = 109,
pcorr = 0.0027) and 6 (df = 110, pcorr = 0.00035) MPI (two-tailed t-tests). p-values were
Bonferroni-corrected over the 3 time points. The purple line represents the line of best
fit, and the shaded ribbon represents the 95% prediction interval. n (number of mice), 1
MPI=6, 3 MPI=6, 6 MPI=7.

We first fit the G2019S pathology data with the same network model as we had done
previously for NTG mice. Specifically, we used a network based on anatomical connectivity
weighted by Snca expression and fit a time constant to the G2019S pathology data. The
model showed similar predictive power for the G2019S mice as we have already established
for the NTG mice (Fig. 4.7a), suggesting that anatomical connectivity and Snca expression
are powerful predictors of pathological spread. The model including Snca expression also
had similarly elevated fit over a model only incorporating anatomical connectivity (Fig.
S4.15). However, the mean of the bootstrapped time constants was lower for G2019S
than for NTG mice. This finding suggests that the rate of connectivity-based spread of
α-synuclein pathology is globally reduced in G2019S mice.
To test the hypothesis that the G2019S mutation would systematically affect vulnerability
to connectivity-based spread, we visually compared the difference in α-synuclein pathology between the NTG and G2019S plotted out on anatomical coordinates (Fig. 4.7b) to
vulnerability values in NTG mice (Fig. 4.4c). It appeared that many of the regions with
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elevated pathology in G2019S are those that were resilient in NTG mice. Further, many of
these regions also undergo enhanced neuron loss in the G2019S mice (Fig. 4.7c), including
the ipsilateral SN, a phenomenon which was confirmed by TH cell counts (Fig. S4.16). To
further explore the relationship between the vulnerability of regions to α-synuclein pathology as established in NTG mice and the pathology observed in G2019S mice, we plotted
vulnerability values against the difference in log(pathology), i.e. log(G2019S/NTG pathology) (Fig. 4.7d) for each timepoint. There was a negative correlation at all timepoints,
suggesting that G2019S expression selectively enhances α-synuclein pathology in otherwise
resilient populations of neurons.

DISCUSSION
With limited neuropathology data, there appear to be islands of vulnerable neurons that are
susceptible to developing pathogenic protein inclusions. However, meticulous neuropathological examination throughout the brain at different stages of disease has revealed patterns
that suggest pathology spreads between anatomically-connected regions over time (Braak
et al. 2002, 2003; Beach et al. 2009). Mouse models have further indicated that exogenous
misfolded proteins can be taken up by neurons and induce the misfolding of endogenous
protein, eventually leading to neuron death. Here, we employed absolute quantification
paired with network diffusion modeling to explore the factors that dictate the rate and
severity of pathogenic α-synuclein spread.
The current study takes advantage of several features of pathological protein spread in mice.
First, the disease factor (pathological α-synuclein) can be directly imaged in tissue. Second,
the origin and timing of the disease factor is known since α-synuclein PFFs were injected in
the dorsal striatum at 3 months of age and allowed to age a further 1, 3, or 6 months. Third,
anatomical connectivity of the mouse brain has been extensively characterized at a similar
scale (Oh et al. 2014), providing accurate antero- and retrograde connectivity measures
for the model. Comparison of the network diffusion model developed in this study to the
empirical data set found that anatomical connectivity is a major pathway of pathogenic
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protein spread. Studies using human imaging datasets have demonstrated the utility of
similar network diffusion models to explain the degree of atrophy seen in human patients
and even to extrapolate an initiation site for the observed atrophy (Pandya et al. 2017;
Raj et al. 2012; Dagher and Zeighami 2018). Future development of ligands which bind
misfolded proteins in the human brain will allow longitudinal in vivo imaging of pathogenic
protein and direct comparison between mouse and human neuropathology.
We were particularly interested in regions that showed higher or lower pathology than
would be expected given the anatomical connectivity-based prediction, which may represent vulnerable and resilient populations of neurons, respectively. We found that Snca gene
expression showed a remarkably similar pattern to inferred vulnerability, suggesting that
resilient regions are those with very low α-synuclein expression and vulnerable regions have
relatively higher α-synuclein expression. This finding is consistent with work from human
brains showing that regions with low α-synuclein expression are resilient to LB pathology
(Erskine et al. 2018). While other factors such as neurotransmitter type, spike rate, reactive oxygen species production and hyperbranching axons may shape the susceptibility of
neurons to cell death (Surmeier et al. 2017), much of the variance in α-synuclein spread
was explained purely by anatomical connectivity and α-synuclein expression. It should
be noted that Snca mRNA expression was utilized due to the public availability of this
data and the correspondence of in situ hybridization data to neuronal cell bodies. Future
studies should confirm whether other pathogenic proteins, such as tau, may spread based
on anatomical connectivity and endogenous protein expression and whether incorporating
other factors such as neuron type into the network model can explain even more of the
variance in pathological protein spread.
The current study also found a high correspondence between clearing of LB-like inclusions
and neuron death in the substantia nigra, confirming previous studies which found that neurons bearing LB-like inclusions eventually die (Luk et al. 2012; Osterberg et al. 2015). This
observation allows us to use LB-like inclusion loss as a proxy for neuron loss. Measurement
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of LB-like inclusion number through the brain of mice at different timepoints indicates that
neuron loss mostly occurs after long time periods and is related to the pathological burden
in that region.
Though the data presented here are based on a single injection site, the factors dictating
the network diffusion model are independent of the pathology data set. As intrinsic components of the network, these factors can be applied similarly to any injection site. Future
empirical data is necessary to fully assess the generalizability of the model. In the interim,
we believe that modulation of the factors controlling pathogenic protein spread will allow
the assessment of the likely efficacy of therapeutic treatments and will aid understanding
of the impact of genetic risk factors. This method can be merged with tools from network
control theory (Tang and Bassett 2018; Lynn and Bassett 2019) to analytically identify
the optimal approach to effect a targeted change in the progression of pathology, either by
modifying network nodes (Tang and Bassett 2018) (therapies targeted to regions) or edges
(Pang et al. 2017) (therapies targeted to connections).
The current study found that G2019S mice exhibit higher pathology in some regions, yet
lower pathology at other regions relative to NTG mice, perhaps explaining some of the
conflicting data suggesting that either increases (Chen et al. 2019; Ramonet et al. 2011;
Xiong et al. 2018) or decreases (Tong et al. 2010; Giaime et al. 2017) in LRRK2 activity
can lead to α-synuclein aggregation and dopaminergic neuron death. The increase in αsynuclein pathology in the SN at 3 MPI and increased neuron death at 6 MPI in G2019S
mice are consistent with what has been observed in G2019S BAC mice injected with PFFs
(Volpicelli-Daley et al. 2014b) or G2019S knock-in mice overexpressing A53T α-synuclein
via AAV (Novello et al. 2018). However, our work reveals that broader network dynamics
of pathogenic protein spread are changed. The global rate of pathogenic α-synuclein spread
is reduced in G2019S mice, and resilient populations of neurons show enhanced α-synuclein
pathology and toxicity. It will be interesting to integrate these novel findings relating
G2019S LRRK2 to pathological α-synuclein network spread with the known involvement of
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LRRK2 in vesicle trafficking and network physiology (Benson et al. 2018).
One limitation of the data and model presented here is the mesoscale of analysis, which was
chosen to allow comparison to anatomical connectivity data. Pathology in cortical regions
shows a clear laminar distribution and the closer investigation of the layer and neuron
types affected in the future will provide additional information about pathology spread.
Another limitation is the sparseness of the regions sampled. Given current technological
limitations, it was not possible to map quantitative pathology in the whole brain. However,
the sparse data provides sufficient constraints of the network model to allow remarkably
accurate reconstruction of pathological α-synuclein spread. The further ability of in silico
injection in an independent brain region to capture the spread pattern suggest that the
data captured is sufficient to develop highly informative predictions. Possible differences
in anatomical connectivity between strains of mice is also an important caveat to keep in
mind in future modeling studies. Future work will also focus on improving performance of
the model by incorporating factors such as regional protein turnover rate, neuron type and
functional connectivity.
The network model presented here is informed by quantitative empirical data, but it is
simple and uses only intrinsic network properties including anatomical connectivity and
gene expression for its predictions. Therefore, the model is also easily manipulated by
seeding in different regions, predicting the effects of known genetic risk factors and modeling
therapeutic intervention by changing parameters of the model (e.g. reducing diffusivity to
mimic α-synuclein immunotherapy).

METHODS
Animals
All housing, breeding, and procedures were performed according to the NIH Guide for the
Care and Use of Experimental Animals and approved by the University of Pennsylvania
Institutional Animal Care and Use Committee. C57BL/6J (NTG, JAX 000664, RRID:
IMSR JAX:000664) and B6.Cg-Tg(Lrrk2*G2019S)2Yue/J (G2019S, JAX 012467, RRID:
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IMSR JAX:012467) mice have been previously described (Li et al. 2010). The current
G2019S BAC line was backcrossed to C57BL/6J mice for > 10 generations and bred to
homozygosity at loci as determined by quantitative PCR and outbreeding. The expression
level of G2019S LRRK2 was thereby stabilized in this line of mice. All experiments shown
use homozygous G2019S mice. Both male and female mice were used for this study.
Behavior
Mouse all-limb grip strength was measured using the animal grip strength test (IITC 2200).
For this test a grid mesh is attached to a digital force transducer. Mice are moved to a
quiet behavioral testing suite and allowed to acclimate for 1 hour. Each mouse was held by
the base of the tail and allowed to grasp the grid mesh. Once the mouse clasps the grid,
the mouse is slowly moved backwards, in line with the force transducer until the mouse
released the grid. The maximum grip force was recorded. The mouse was allowed to rest
for several seconds, and then was placed on the grid again. The maximum grip strength of
5 tests was recorded. No fatigue was observed during the test period, so the average of all
5 measures is reported.
An accelerating rotarod (MED-Associates) was used to assess motor coordination. Mice
received two training sessions and two tests sessions. During the training sessions, mice
were placed on a still rod. The rod then began to accelerate from 4 rotations per minute
(rpm) to 40 rpm over 5 minutes. Mice were allowed to rest at least one hour between
training and testing sessions. During the testing sessions, mice were treated as before, and
the latency to fall was recorded. Time was also stopped if a mouse gripped the rod and
rotated with it instead of walking. Mice were allowed a maximum of 10 minutes on the rod.
α-Synuclein PFF Stereotaxic Injections
Purification of recombinant α-synuclein and generation of α-synuclein pre-formed fibrils
(PFFs) was conducted as described elsewhere (Volpicelli-Daley et al. 2014a; Luk et al. 2009;
Volpicelli-Daley et al. 2011). All of the surgery or experiments were performed in accordance
with protocols approved by the Institutional Animal Care and Use Committee (IACUC)
of the University of Pennsylvania. Mouse α-synuclein PFFs, which were generated at a
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concentration of 5 mg/mL were vortexed and diluted with Dulbecco’s phosphate-buffered
saline (DPBS) to 2 mg/mL. They were then sonicated on high for 10 cycles of 30 seconds
on, 30 seconds off (Diagenode Biorupter UCD-300 bath sonicator).
Mice were injected when 3-4 months old. Mice were evenly assigned to one of two surgeons
at random. Even groups of NTG and G2019S mice were injected concurrently to minimize
any differences due to surgery date or α-synuclein PFF preparation. Mice were injected
unilaterally by insertion of a single needle into the right forebrain (coordinates: +0.2 mm
relative to Bregma, +2.0 mm from midline) targeting the dorsal striatum (2.6 mm beneath
the dura) with 5 µg α-synuclein PFFs (2.5 µL). Injections were performed using a 10 µL
syringe (Hamilton, NV) at a rate of 0.4 µL/minute. After 1, 3 or 6 months, mice were
perfused transcardially with PBS, brains were removed and underwent overnight fixation
in 70% ethanol in 150 mM NaCl, pH 7.4.
Immunohistochemistry
After perfusion and fixation, brains were embedded in paraffin blocks, cut into 6 µm sections
and mounted on glass slides. Slides were then stained using standard immunohistochemistry as described below. Slides were de-paraffinized with 2 sequential 5-minute washes in
xylenes, followed by 1-minute washes in a descending series of ethanols: 100%, 100%, 95%,
80%, 70%. Slides were then incubated in deionized water for one minute prior to antigen
retrieval as noted. After antigen retrieval, slides were incubated in 5% hydrogen peroxide
in methanol to quench endogenous peroxidase activity. Slides were washed for 10 minutes
in running tap water, 5 minutes in 0.1 M tris, then blocked in 0.1 M tris/2% fetal bovine
serum (FBS). Slides were incubated in primary antibodies overnight. The following primary
antibodies were used. For misfolded α-synuclein, Syn506 (Duda et al. 2002) was used at 0.4
µg/mL final concentration with microwave antigen retrieval (95◦ C for 15 minutes with citric
acid based antigen unmasking solution (Vector H-3300). For pathologically-phosphorylated
α-synuclein, pS129 α-synuclein (EP1536Y; Abcam ab51253) was used at 1:20,000 with microwave antigen retrieval. To stain midbrain dopaminergic neurons, Tyrosine hydroxylase
(TH-16; Sigma-Aldrich T2928) was used at 1:5,000 with formic acid antigen retrieval.
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Primary antibody was rinsed off with 0.1 M tris for 5 minutes, then incubated with goat
anti-rabbit (Vector BA1000) or horse anti-mouse (Vector BA2000) biotinylated IgG in 0.1
M tris/2% FBS 1:1000 for 1 hour. Biotinylated antibody was rinsed off with 0.1 M tris
for 5 minutes, then incubated with avidin-biotin solution (Vector PK-6100) for 1 hour.
Slides were then rinsed for 5 minutes with 0.1 M tris, then developed with ImmPACT DAB
peroxidase substrate (Vector SK-4105) and counterstained briefly with hematoxylin. Slides
were washed in running tap water for 5 minutes, dehydrated in ascending ethanol for 1
minute each: 70%, 80%, 95%, 100%, 100%, then washed twice in xylenes for 5 minutes and
coversliped in Cytoseal Mounting Media (Fisher 23-244-256).
All mice were initially stained with Syn506 for quantification of pathology. It was noted that
several mice had perfusion artifacts which were recognized by secondary antibody staining
of Syn506 due to the fact that Syn506 is a mouse antibody. Since absolute quantification
relies on no background staining these mice were excluded from analysis. The recently
developed pS129 a-synuclein antibody (EP1536Y) is a rabbit monoclonal antibody, and
using anti-rabbit secondary antibody prevents recognition of endogenous mouse antibodies
present in perfusion artifacts. After direct comparison of EP1536Y staining to Syn506
staining revealed a high correspondence of the two stains, the remaining mice were stained
with EP1536Y. The fact that analyzing mice in iterative groups finds good correspondence
of time constant fitting (Fig. S4.8) also supports the high congruence of the two stains.
Slides were scanned into digital format on a Lamina scanner (Perkin Elmer) at 20x magnification. Digitized slides were then used for quantitative pathology.
Quantitative pathology
All section selection, annotation and quantification was done blinded to genotype. For
quantification of α-synuclein pathology, coronal sections were selected to closely match the
following coordinates, relative to bregma: 2.10 mm, 0.98 mm, -1.22 mm, -2.92 mm and 4.48 mm. The digitized images were imported into HALO software to allow annotation and
quantification of the percentage area occupied by α-synuclein pathology and the number of
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cell body inclusions. Standardized annotations were drawn to allow independent quantification of 172 regions throughout the brain. Each set of annotations was imported onto the
desired section and modified by hand to match the designated brain regions. After annotation, the analysis scripts were applied to the brain to make sure that no non-pathology
signal was detected. After annotation of all brains, analysis algorithms were applied to all
stained sections and data analysis measures for each region were recorded.
Two analysis algorithms were applied to the tissue. The first detects total signal above a
minimum threshold. Specifically, the analysis included all DAB signal that was above a 0.157
optical density threshold, which was empirically determined to not include any background
signal. This signal was then normalized to the total tissue area. A minimal tissue optical
density of 0.02 was used to exclude any areas where tissue was split, and a tissue edge
thickness of 25.2 µm was applied to exclude any edge effect staining. The second analysis
was designed to detect only cell body inclusions. This analysis first classified staining into
two broad classes: thin versus thick pathology based on size and texture inputs. The
analysis used only the class of thick pathology and excluded objects smaller than 40 µm2
and greater than 400 µm2 to remove small inclusions and to separate multiple inclusions
from each other.
Every 10th slide through the midbrain was stained with tyrosine hydroxylase (TH). THstained sections were used to annotate the substantia nigra, and cell counting was performed
manually in a blinded manner for all sections. The sum of all sections was multiplied by 10
to estimate the total count that would be obtained by counting every section.
Computational model
To generate a computational model of pathological spread, we required anatomical connectivity, gene expression and α-synuclein pathology measures that were in the same anatomical
space. We used the previously-generated data set (Oh et al. 2014) for synaptic connectivity
and Snca gene expression (Lein et al. 2007) (brain-map.org). Snca gene expression values
were recorded as 200 µm2 pixel expression energy values (Snca-RP 071218 03 E03 (coro-
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nal)). The mean value for all pixels in a given region was taken as the expression energy
for that region. α-synuclein pathology measures generated for this study were calculated
as described above and reported in Supplementary Table 1. The anatomical regions largely
corresponded between the three data sets, but in cases where they did not, the average for
the regions in the corresponding atlas was taken to create an accumulated score for that
region. For example, the thalamus was broken into several large regions for α-synuclein
pathology analysis due to the fact that there is little pathology there and the several nuclei
that encompass it are difficult to manually demarcate. Therefore, the ventromedial thalamus (VMThal) in the pathology data actually encompasses the following nuclei from the
connectivity data: Ventral anterior-lateral (VAL), ventral posteromedial (VPM), ventral
medial (VM), ventral posterolateral (VPL) and reticular (RT) nuclei of the thalamus. In
the other direction, the piriform area, while only having one connectivity value, actually
spans several of the sections in which pathology was quantified. Therefore, the mean of
all piriform α-synuclein pathology values was used to compare to the connectivity of the
piriform area.
Linear diffusion model of pathological spread
Previous studies have used linear diffusion models to predict patterns of atrophy observed
in various neurodegenerative diseases (Pandya et al. 2017; Raj et al. 2012), supporting a
mechanism of prion-like spread of misfolded proteins along large white matter fibers. In the
present work, we aimed to validate the ability of these linear diffusion models to predict the
spread of misfolded α-synuclein throughout the mouse brain from an injection site in the
right caudate-putamen (iCPu).
We model pathological spread of α-synuclein as a diffusion process on a directed structural
brain network G = {V, E} whose nodes V are N cortical and subcortical grey matter regions
and whose edges eij ∈ E represent an axonal projection initiating in Vi and terminating in
Vj , where eij ≤ 0 for all E. Edge strength was quantified by the Allen Brain Institute using
measures of fluorescence intensity from retrograde viral tract tracing (Oh et al. 2014). We
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define the weighted adjacency matrix of G as A = [Aij ]. Rows and columns of A were
averaged to generate a final parcellation of 116 regions, in accordance with our quantitative
measurements of regional synuclein pathology at time t, which were obtained at t = [1, 3, 6]
months.
We represent the magnitude of observed α-synuclein pathology of all N nodes at time t as
the vector x(t). We compute the predicted regional α-synuclein pathology x̂(t) as a function
of A and seed region s ∈ V :

x̂(t) = e−cLt xo ,

(4.1)
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scale of the system. We selected the time constant c which maximized the model fit f ,
defined as Pearson correlation between log10 (x(t)) and log10 (x̂(t)) for all non-zero values of
x(t), averaged over t = [1, 3, 6]. Note that L is the out-degree Laplacian, a version of the
well-characterized graph Laplacian designed for directed graphs (Hong et al. 2015). This
model posits that the rate of change of in pathology at region i is proportional to a weighted
sum of the pathology at all other regions and the strength of outgoing projections arriving
at those regions from region i, minus the sum of outgoing connections from region i times
the amount of pathology at region i. Notably, as a property of all Laplacian matrices, L has
a single eigenmode with an eigenvalue equal to 0, describing the steady state behavior of
the system as t approaches ∞ (Hong et al. 2015). Asymmetric graphs also have eigenmodes
with complex eigenvalues, such that x̂i (t) oscillates, or in the case of our particular matrix
A, exhibits a single, damped oscillation over time. Thus, the time constant c identifies
where along the damped oscillation curve of the system x̂(t) provides the best fit to the
observed data, with large values of c indicating the best fit lies closer to the static end
behavior. All computations were performed in R (R Core Team (2017). R: A language and
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environment for statistical computing. R Foundation for Statistical Computing, Vienna,
Austria. URL https://www.R-project.org/) and MATLAB.
Model incorporating α-synuclein expression
In addition to the spread of the misfolded protein along anatomical connections, we also
hypothesized that the pathogenicity of misfolded synuclein would be dependent on the
presence of endogenous α-synuclein at each brain region. We observed that the residuals of
x̂(t) as a linear predictor of x(t) were correlated with R, a vector of length N containing
the estimated levels of α-synuclein mRNA at each brain region (brain-map.org). Thus, we
sought a way to explicitly incorporate R into our linear diffusion model as a measure of the
intrinsic vulnerability of each region. To accomplish
this, we modify A such that A = SA,

 Ri for i = j
where S is the diagonal matrix of R such that S =
. This step weights the

 0 otherwise
outgoing connections of each region in A by its level of synuclein expression, and can be
viewed as an “update rate” in the context of linear systems theory (Hong et al. 2015). All
subsequent steps, including generation of the Laplacian, fitting of the time constant c, and
propagation of the model as a continuous linear system, were performed according to the
procedures described above.
Statistical analysis
Quantification of model specificity
After identifying that our connectome-based linear diffusion model could explain substantial
variance in the spread of misfolded α-synuclein from the iCPu over time, we next sought
to test the specificity of this model to the use of iCPu as the seed site s, which defines the
vector xo . To test the model specificity, we fit the time constant c to the observed data
as described above using every region as s except for iCPu, generating a distribution of
non-specific fits for each time points. We assessed the specificity of iCPu as the seed region
s by computing the number alternate seed regions yielding better fist than the fit obtained
using iCPu as a seed.
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While iCPu seed produced nearly the best possible fit at all time points, we observed that
several models utilizing alternate seed regions still fit the observed data relatively well. We
hypothesized that seed regions with similar connectivity profiles to that of iCPu would
perform similarly in explaining the observed data. We computed the similarity of incoming
connectivity to iCPu as the Pearson correlations between the column of Aij where j is
the iCPu, and the columns of Aij where j is all other regions except iCPu. Conversely,
we computed the similarity of outgoing connectivity to iCPu as the Pearson correlations
between the row of Aij where i is the iCPu, and the rows of Aij where i is all other regions
except iCPu.
Because the relationship between alternate seed model fit and similarity of incoming connectivity to iCPu appeared to have a non-linear form, we used a general additive model
(GAM) to fit the relationship using the gam function from the mgcv package in R (Wood
and Clyne 2006). A GAM is a generalized linear model in which the linear predictor is defined by unknown smooth functions of predictor variables (Wood 2004; Wood et al. 2011).
We fit the following non-linear model to predict the fit of the alternate seed model from a
smooth function of the connection similarity:

y = s(C) + ,

(4.2)

where y is the fit of the alternate seed model, C is the connection similarity of the respective
seed region to iCPU (described above), and  is an error term.
Evaluating split-reliability and generalizability of model fit
The data presented in the body of the paper utilize values for the time constant c derived
from data from all mice at every time point (xf ull (t)). To ensure that this approach did
not result in overfitting, we randomly sampled without replacement the available mice at
each time point to generate xtrain (t) and xtest (t) for each time point. The time constant
c was determined on xtrain (t), and the model was evaluated based on its fit with xtest (t).
This process was repeated 100 times, generating a distribution of out-of-sample fits for each
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time point. We computed a non-parametric p-value for the generalizability of the model as
the number of times the fit generated using xf ull (t) exceeded the fit generated by xtest (t),
quantifying the difference between in-sample and out-of-sample performance.
Network null models
To ensure that our results were specific to the retrograde spread of misfolded synuclein
along neuronal processes, we repeated our analyses using several network null models. To
demonstrate a general specificity of the model for the topology of the synaptic connectome
represented by A, we carried out a procedure that rewires the edges of G while exactly
P
P
preserving the out-degree and in-degree sequence, i.e. N
Bij and N
j=1
i=1 Bij , where Bij =


 1 for Aij > 0
. This rewiring approach tests whether the model fit is due to a relatively

 0 otherwise
basic structural property of the graph, i.e. degree, as opposed to unique, higher order
topological features of the synaptic connectome.
Next, we tested whether a model based on anterograde propagation of misfolded protein
along axons might explain the observed spread of pathology. To test this model, we simply
replaced A with its transpose A| and repeated all subsequent steps as described above.
Finally, we tested the null model that spread of misfolded protein occurs simply due to
diffusion through tissue based on closeness in Euclidean space. To test this model, we
reconstructed A = [Aij ] such that the edges represented the Euclidean distance between
region i and region j. All subsequent steps were performed as described above.
Empirical data
For α-synuclein pathology data, a two-way ANOVA was run on each region, and the months
were compared to each other using Tukey’s multiple comparison test, while the genotypes
were compared to each other using Sidak’s multiple comparison test. For TH cell counts
in the midbrain, the side ipsilateral to the injection was compared to the side contralateral
to the injection and the genotypes were compared to each other using a two-way ANOVA
with Sidak’s multiple comparison test. All behavioral data compared both non-injected
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mice to α-synuclein PFF injection and NTG to G2019S cohorts using two-way ANOVA
with Sidak’s multiple comparison test. Data distribution was assumed to be normal, but
this was not formally tested. No statistical methods were used to pre-determine sample
sizes but our sample sizes are similar to those reported in previous publications (Luk et al.
2012; Henderson et al. 2019).
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SUPPLEMENTARY FIGURES
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Figure S4.1: Analyzed Regions. The regions annotated for pathology measures and used
in subsequent analysis are labeled here as a reference.
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Figure S4.2: Heat map of pathological α-synuclein burden by region and time.
Pathology in wildtype mice is shown as a log-scale heat map with age post-injection on
the x-axis, broken down by contralateral and ipsilateral side, and region of analysis on the
y-axis. n (number of mice), 1 MPI=4, 3 MPI=6, 6 MPI=6.
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Figure S4.3: Heat map representing synaptic connectivity measures to the CPu.
Measures of direct connectivity to and from the CPu as reported in ref. (Oh et al. 2014) are
plotted here as a log-scale heatmap. The anterograde connections from the CPu are much
weaker, in general, than the retrograde connections to the CPu. Regions in gray have no
measure connectivity to or from the CPu.
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Figure S4.4: Concept of a network diffusion model based on anatomical connectivity. Network diffusion model paradigm for estimation of pathological protein spread through
an anatomically-connected network. Two anatomically-connected regions (R1 and R2) are
shown for simplicity, though the network model would incorporate all known anatomical
connections. In this case, the amount of pathology in each region (x1 and x2 ) and the
inter-region connectivity strength (c1,2 ) are known. Therefore, the diffusivity constant (β)
can be used to scale the model to empirical data.
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Figure S4.5: Fit of alternate seed regions increases with incoming connection profiles more similar to that of iCPu. We computed the similarity of incoming projections
between iCPu and all other regions as the correlation between their respective columns
in the synaptic connectivity matrix. We observed a non-linear increase in fit to actual
pathological spread from the iCPU when we used alternate seed regions with incoming
connections more similar to that of the iCPu. Generalized additive models (GAMs) with
incoming connection similarity as smooth terms predicting alternate seed fit are shown for
1 MPI (left panel), 3 MPI (center panel), and 6 MPI (right panel). R2 values on the plots
indicate the amount of variance that the GAM was able to explain in alternate seed fit using
in-projection similarity to the iCPu as a predictor variable. The purple line represents the
fitted mean and the shaded area is the 95% confidence interval. n (number of mice), 1
MPI=4, 3 MPI=6, 6 MPI=6.
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Figure S4.6: Connectivity-based predictions of anterograde pathological spread
from right CPu for NTG and G20 mice. (a) A network diffusion model based on
anterograde spread along synaptic connectivity predicts the spread of pathology over time
from a seed in the iCPu. Scatter plots and Pearson correlation coefficients (r) between regional log10 -scaled synuclein pathology values (y-axis) and log10 -scaled predicted pathology
values (x-axis) are shown for 1 MPI (left panel), 3 MPI (center panel), and 6 MPI (right
panel). The green line represents the line of best fit, and the shaded ribbon represents the
95% prediction interval. Notably, the anterograde model does not perform as well as the
retrograde model. n (number of mice), 1 MPI=4, 3 MPI=6, 6 MPI=6.
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Figure S4.7: Distance- and higher-order feature-based predictions of pathological
spread from right CPu for NTG mice. (a) A network diffusion model based on the
Euclidean distances between brain regions poorly explains the observed spread of pathology
over time from a seed in the iCPu. Scatter plots and Pearson correlation coefficients (r)
between regional log10 -scaled synuclein pathology values (y-axis) and log10 -scaled predicted
pathology values (x-axis) are shown for 1 MPI (left panel), 3 MPI (center panel), and 6
MPI (right panel). The green line represents the line of best fit, and the shaded ribbon
represents the 95% prediction interval. (b) We generated a rewired version of the synaptic
connectome that preserved the exact degree sequence while destroying higher order features.
This rewired network poorly explains the observed spread of pathology over time from a seed
in the iCPu, suggesting that higher order topology of the connectome is a key factor in the
model, rather than simple structural properties such as degree. Scatter plots and Pearson
correlation coefficients (r) between regional log10 -scaled synuclein pathology values (y-axis)
and log10 -scaled predicted pathology values (x-axis) are shown for 1 MPI (left panel), 3
MPI (center panel), and 6 MPI (right panel). The green line represents the line of best
fit, and the shaded ribbon represents the 95% prediction interval. n (number of mice), 1
MPI=4, 3 MPI=6, 6 MPI=6.
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Figure S4.8: Split reliability of time constant fit. For each time point, we randomly
sampled half of the mice without replacement and trained the time constant to fit the average of this training sample. Then, we compared the predicted values from the training
sample to an average of the remaining mice. This procedure was repeated 100 times to
generate a distribution of out-of-sample fits, which were all non-overlapping with 0 and
explained considerable amounts of variance (Pearson’s r > 0.5 for all out-of-sample predictions at month 3 and month 6). The fits generated by using an average of all mice were
at or below the 5th percentile of the distribution of out-of-sample fits for all time points.
This percentile can also be interpreted as a p-value from a one-tailed, non-parametric test
of the null hypothesis that our model is not overfitting the data, such we would observe a
fit as high as the fit observed by pooling all the data (black diamond) in a distribution of
out-of-sample fits (purple violin plot, width corresponds to observation frequency). We did
not correct these p-values for multiple comparisons because we expected not to reject the
null hypothesis, and therefore multiple comparisons correction would enforce that finding.
Overall, these results suggest a high degree of split reliability for our model in our sample.
n (number of mice), 1 MPI=4, 3 MPI=6, 6 MPI=6.
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Figure S4.9: Conceptual framework for assessment of the relative vulnerability
of regions. The log predicted pathology vs. log actual pathology graph from 1 MPI is
overlaid here with conceptual groups. Most of the regions here are fill well (green shading) by
a model which considers only anatomical connectivity. However, regions which have more
pathology than expected by connectivity alone are considered relatively vulnerable (red
shading), while the regions that have less pathology than would be expected are relatively
resilient (blue shading) to pathology induction.

197

Figure S4.10: Using model vs. empirical data residuals to understand vulnerability. (a) In order to measure the relative vulnerability of all regions, the residual between
pathology predicted based on anatomical connectivity and empirical pathology measures
were taken at all timepoints and are displayed as a heat map. (b) Some of this differential
vulnerability can be explained by the difference in the ability to fit pathological data at
different timepoints. These differences can be partially abrogated by taking the average
residual across timepoints and is reported as the average of the residuals for each region.
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Figure S4.11 (previous page): Computed intrinsic vulnerability and Snca gene expression. (a) Scale bars for vulnerability and Snca expression measures. (b) Evaluated
regions are ranked here from most to least vulnerable based on the fit to modeled pathological α-synuclein spread as described in the main text. Midbrain and thalamic nuclei
are least vulnerable, while select cortical regions and the amygdala show the highest vulnerability. (c) Snca gene expression data from Allen Brain Atlas in situ hybridization for
the same regions is displayed here from highest expression to lowest expression. The Snca
gene expression has an overall similar pattern to computed vulnerability, with thalamic
and midbrain regions showing the lowest expression, while select cortical regions have the
highest Snca expression. Note that there are more regions with high Snca expression. (d)
Vulnerability and Snca expression values displayed side-by-side and sorted by region such
that vulnerability and Snca expression can be directly compared.

AFTERWORD
The results contained in this section were obtained through follow-up analyses of the same
dataset described in this chapter and are not published in Henderson et al. 2019 or elsewhere.

This chapter demonstrated that retrograde, transsynaptic, linear network spreading dynamics are sufficient to explain the progression of α-synuclein pathology in a mouse model
of Parkinson’s disease (PD). These findings raise three key additional questions that were
not addressed in the main text.
First, it was observed that a model of anterograde spread did not perform as well as the
retrograde model, but nevertheless explained a statistically significant amount of variance
in the empirical pathology data (Fig. S4.6; 1MPI, r = 0.32, p = 0.0015; 3 MPI, r =
0.39, p = 2.3 × 10−5 ; 6 MPI, r = 0.43, p = 2.5 × 10−6 ). Is this observation confounded
by redundancy in anterograde and retrograde connectivity (Bassett and Bullmore 2017),
or does anterograde spread occur alongside retrograde spread? In order to address this
question, we constructed a model in which anterograde and retrograde spread are linearly
superimposed. We fit the parameters of this model by minimizing the error term  in the
equation
x(t) = βo (t) + βr e−cr Lr t + βa e−ca Lr t + (t),
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(4.3)

Figure S4.12: Correlation of Snca expression with α-synuclein pathology in NTG
mice. Scatterplots and Pearson correlation coefficients (r) of Snca expression versus actual
pathology values for each region are plotted for 1 (df = 95, pcorr = 5.92x10-6), 3 (df = 111,
pcorr = 7.49×10−8 ) and 6 (df = 111, t = 8.70, pcorr = 1.03×10−13 ) MPI (two-tailed t-tests).
p-values were Bonferroni-corrected over the 3 time points. The green line represents the
line of best fit, and the shaded ribbon represents the 95% prediction interval. n (number of
mice), 1 MPI=4, 3 MPI=6, 6 MPI=6.
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retrograde spread, ca is a time constant of anterograde spread, βo is an intercept at time
t, and βa and βr are weights for the importance of anterograde and retrograde spread,
respectively, at time t. We found that this model was able to generate good predictions
of pathology at all time points (Fig. A4.1a-c). We also compared the weights on anterograde and retrograde spread (βa (t) and βr (t)) and observed that both were statistically
significant at all time points (Fig. A4.1d; βa (1MPI): p = 0.040, βr (1MPI): p = 5.4 × 10−7 ,
βa (3M P I): p = 0.00019, βr (3M P I): p = 9.9×10−15 , βa (6MPI): p = 1.4×10−11 , βr (6MPI):
p = 0.00033). These findings suggest that both anterograde and retrograde spread co-occur,
though retrograde spread predominates.
Second, in discussing the notion of “network spread,” it is easy to conjure the image of
α-synuclein spreading across multiple synapses over time to create a characteristic spatial
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Figure S4.13: In silico seeding of alternate regions in mouse brain. Heat map
of regions affected with α-synuclein pathology with in silico propagation of α-synuclein
pathology after seeding in either the (a) hippocampus, (b) secondary motor cortex or (c)
caudoputamen. The color scale represents log-transformed mean percentage area occupied
with α-synuclein pathology.
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Figure S4.14: Characterization of G2019S LRRK2 mice. G2019S mice have similar
α-synuclein levels and do not accumulate pS129 α-synuclein without the injection of exogenous α-synuclein PFFs. α-synuclein staining in the primary somatosensory cortex (a) and
caudoputamen (b), is similar between NTG and G2019S mice at 3, 6 and 12 months of age
(n = 3 mice/age/genotype). Pathological pS129 α-synuclein also does not accumulate in
the brains of these mice. Somatosensory cortex (c) and caudoputamen (d) are shown as
compared to mice (n = 3 mice/age/genotype) of the same genotypes 3 months post-injection
with α-synuclein PFFs (bottom). (e) G2019S mice weigh less than their NTG counterparts
on average, and injection with α-synuclein PFFs does not change this difference. (f ) Grip
strength is diminished upon α-synuclein PFF injection in both genotypes (two-way ANOVA,
*** p = 0.0006, **** p < 0.0001), but minimal difference is observed in the response of each
genotype. (g) Non-injected 6-month G2019S mice show an increased latency to fall on the
rotarod (two-way ANOVA, *** p = 0.0006), but this difference is lost by 9 months of age.
In contrast, there is no difference between α-synuclein PFF-injected mice at either 6 months
(3 MPI) or 9 months (6 MPI). Scale bars = 100µm. Plots display mean ± standard error. n
(number of mice), NTG Non-Injected (4M=14, 5M=10, 6M=12, 7M=11, 8M=11, 9M=16),
G2019S Non-injected (4M=12, 5M=15, 6M=15, 7M=16, 8M=15, 9M=17), NTG PFFInjected (4M=11, 5M=11, 6M=11, 7M=6, 8M=6, 9M=6), G2019S PFF-Injected (4M=12,
5M=9, 6M=9, 7M=7, 8M=7, 9M=7).
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Figure S4.15: Network diffusion model based on anatomical connectivity explains
pathological α-synuclein spread in G2019S mice. (a) Scatterplots and Pearson correlation coefficients (r) of log predicted pathology based on anatomical connectivity versus
actual pathology values for each region are shown for 1 (df = 104, pcorr = 1.66 × 10−8 ),
3 (df = 112, pcorr = 1.21 × 10−9 ) and 6 (df = 113, pcorr = 1.04 × 10−11 ) MPI (two-tailed
t-tests). p-values were Bonferroni-corrected over the 3 time points. The green line represents the line of best fit, and the shaded ribbon represents the 95% prediction interval. n
(number of mice), 1 MPI=6, 3 MPI=6, 6 MPI=7.
pattern of pathology. However, the main text did not address the extent to which indirect
and direct connections contribute to model performance. To quantify these contributions,
we compared two models. The first “Full” model was the retrograde spreading model based
on the full set of connections in the brain (Oh et al. 2014), and the second “Direct only”
model consisted of retrograde spreading only along the connections projecting into the iCPu
injection site. We used bootstrap resampling of the pathology data to compare the model
fits (Pearson’s r). This analysis revealed that the “Direct only” model explained most
of the variance in spread patterns, though by 6 MPI incorporating indirect connections
led to a statistically significant increase in model performance (Fig. A4.2a; Direct only,
6 MPI, mean r = 0.51 vs. Full, 6 MPI, mean r = 0.63; pcorr = 0.003, non-parametric).
These findings suggest that misfolded α-synuclein traverses more than one synaptic hop in
spreading throughout the connectome.
Finally, there are two major potential use cases for these models in developing new therapies for PD, by providing a framework for understanding the impact of treatments on
network spread. In the case of a pharmacotherapy or immunotherapy that targets aggre-
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Figure S4.16: Neuron loss estimate is confirmed in the midbrain by tyrosine
hydroxylase counts. (a) One section in between the two sections used for pathology
quantitation was stained with an anti-TH antibody and used for quantification of substantia
nigra neurons in each 3 month post-injection mouse (two-way ANOVA with Sidak’s multiple
comparison test, ** p = 0.0075 for NTG, ** p = 0.0013 for G2019S). (b) The mean estimated
neuron loss between 3 and 6 months from the SN was subtracted from the TH cell counts in 3
MPI mice (two-way ANOVA with Sidak’s multiple comparison test, **** p < 0.0001 for both
NTG and G2019S comparisons, * p = 0.0135 for NTG-G2019S ipsilateral comparisons).
(c) Every 10th section through the SN was stained with an anti-TH antibody and SN
neurons were counted to estimate the total number of neurons present in NTG and G2019S
mice 6 months after injection (two-way ANOVA with Sidak’s multiple comparison test, ***
p = 0.0002, **** p < 0.0001). (d) Representative images of the contralateral and ipsilateral
substantia nigra from NTG and G2019S mice 6 months post-injection (scale bar = 500µm).
Plots display mean ± standard error with individual values plotted. n (number of mice), 3
MPI-NTG=6, 3 MPI-G2019S=6, 6 MPI-NTG=6, 6 MPI-G2019S=7.
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Figure A4.1: Bidirectional spreading models suggest that α-synuclein spreads
retrogradely and anterogradely through the connectome (a-c) Actual pathology (xaxis) versus pathology predicted by a bidirectional spreading model (y-axis) for 1 MPI (panel
a), 3 MPI (panel b), and 6 MPI (panel c). (d) Standardized linear regression β weights for
anterograde and retrograde spread at 1 MPI, 3 MPI, and 6 MPI. The low variance inflation
factor suggests that these regression weights are not biased by multicollinearity between
anterograde and retrograde spreading estimates.

206

a.

*

0.8

Pearson r

0.7

●

0.6

●
●
●
●
●
●
●
●

●
●
●
●
●
●
●
●

0.5

●
●
●
●
●

●

Direct Only
Full

●
●
●
●
●
●
●
●
●

0.4

●
●

0.3

●

●

●

●

●
●

1 MPI

3 MPI

6 MPI
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separately. *, pcorr = 0.003 for a bootstrapped comparison of means, Bonferroni-corrected
over 3 time points.
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gated α-synuclein, it seems likely that the impact on network spread would be global. Here,
a network model may not be necessary to understand the impact of this therapy. In the
treatment of drug-resistant epilepsy, white matter fibers and gray matter around an identified seizure onset zone are resected through a neurosurgical procedure in an attempt to
prevent future seizures (Rosenow and Lüders 2001). Likewise, it has been observed that patients with history of truncal vagotomy have reduced risk for PD (Svensson et al. 2015). Is a
similar form of resection therapy plausible to halt the progression from motor-predominant
PD to PD with dementia, or for PD that is initiated via other cranial nerves besides the
vagus? In order to answer this question, we performed a virtual resection of the projections
from each region into the iCPU injection site one at a time and recomputed the model fit
(Fig. A4.3a). Interestingly, the substantia nigra (SN), which is a known hub of disease in
idiopathic PD, emerged as the region whose connection to the iCPu impacted the fit to the
empirical pathology data the most. The decrement of fit due to deleting this connection
was only r = −0.03, suggesting that the spatial pattern of pathology in this network is
mostly preserved. However, we were interested to know how the absolute levels of simulated pathology changed as well. In order to quantify the absolute levels of pathology,
we computed a finite area under the pathology curve (AUPC), which captures the total
amount of pathology seen by the brain over time in the simulation. This analysis revealed
that deleting the projection from SN to iCPu had a drastic impact on AUPC, beyond what
would be expected from the projection’s strength (Fig. A4.3b) or from the strength of the
projections from the rest of the brain into the SN (Fig. A4.3c). It is important to recognize
that the CPu was chosen as the injection site here due to its strong connectivity with the
SN, but that the SN may not play the same topological role using seed sites that mirror
idiopathic PD. Nevertheless, these findings suggest that in theory, deleting key connections
may slow the spread of pathology sufficiently to halt the development of symptoms, depending on regional thresholds for tolerating pathology without neuronal dysfunction (Fig.
A4.3).
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injection site. The substantia nigra (SN) reveals the greatest decrement in fit. (b-c) The
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Abstract
In current models of neurodegeneration, individual diseases are defined by the presence of
one or two pathogenic protein species. Yet, it is the rule rather than the exception that a
patient meets criteria for more than one disease. This fact often remains hidden until autopsy, when neuropathological evaluation can assign disease labels based on gold-standard
criteria. Ultimately, the prevalence of concomitant diagnoses and the inability to infer
an underlying neuropathological syndrome from clinical variables hinders the identification
of patients who might be good candidates for a particular intervention. Here, by applying a clustering algorithm to post-mortem histopathological data from 895 patients with
degeneration in the central nervous system, we generate 4 non-overlapping, data-driven
disease categories that simultaneously account for tau neurofibrillary tangles, α-synuclein
inclusions, neuritic plaques, TDP-43 inclusions, angiopathy, neuron loss, and gliosis. The
resulting disease clusters are transdiagnostic in the sense that each cluster contains patients
belonging to multiple different existing disease diagnoses, who colocalize in clusters according to the pathogenic protein aggregates known to drive each disease. We show that our
disease clusters, defined solely by histopathology, separate patients in terms of cognitive
phenotypes, cerebrospinal fluid (CSF) protein levels, and genotype in a manner that is not
trivially explained by the representation of individual diseases within each cluster. Finally,
we use cross-validated multiple logistic regression to accurately predict cluster membership
from CSF protein levels and genotype, both accessible in vivo. Broadly, our approach parses
phenotypic and genotypic heterogeneity in neurodegenerative disease, and represents a general framework for identifying otherwise-fuzzy disease subtypes in other areas of medicine,
such as epilepsy, vascular disease, and cancer. In clinical neurology, the statistical models
we generate may be useful for repurposing drugs by comparing efficacy to probabilistic estimates of disease cluster membership, as well as for future trials that could be targeted
towards an algorithmically defined family of diseases.
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INTRODUCTION
Age-related neurodegenerative diseases affect over 7 million Americans (Hebert et al. 2003),
amounting to nearly $1 trillion in healthcare costs annually. This public health issue is projected to worsen (Dorsey et al. 2007; Brookmeyer et al. 1998; Hebert et al. 2003) as life
expectancy increases and the U.S. population continues to skew towards older individuals.
The neurodegenerative disease umbrella includes major clinicopathological entities such as
Alzheimer’s disease (Hyman et al. 2012), Parkinson’s disease (Jankovic 2008), and frontotemporal dementia (Irwin et al. 2015), in addition to less common disease subtypes such
as progressive supranuclear palsy (Irwin et al. 2015), corticobasal degeneration (Irwin et al.
2015), and multiple systems atrophy (Gilman et al. 2008). Neurology is in dire need of translational research that accounts for the heterogeneous presentations of neurodegeneration to
facilitate the development of targeted treatments.
Decades of evidence support the notion that pathological protein aggregation is a primary
disease process in neurodegeneration (Selkoe and Hardy 2016; Thal and Fändrich 2015).
These protein aggregates may spread along large white matter fibers over time, causing
dysfunction in distant regions (Raj et al. 2012; Pandya et al. 2017), and their toxicity is
thought to be mediated in part by the inflammatory system (Wyss-Coray 2006; Akiyama
et al. 2000). Different neurodegenerative syndromes are characterized by aggregation of
specific proteins; classically, Alzheimer’s disease involves both amyloid-β and microtubuleassociated protein tau (tau) (Selkoe and Hardy 2016; Thal and Fändrich 2015), Parkinson’s
disease involves α-synuclein (Jankovic 2008), and frontotemporal dementia can involve tau
(Rademakers et al. 2004; Irwin et al. 2015) or TDP-43 (Neumann et al. 2006).
Despite this apparent specificity, aggregation of amyloid-β, tau, α-synuclein, and TDP43 is found post-mortem in virtually all brains with neurodegenerative disease in addition
to brains from cognitively healthy individuals (Robinson et al. 2018; Higashi et al. 2007;
Nakashima-Yasuda et al. 2007; Takahashi et al. 2010). To complicate matters further,
numerous in vitro and animal studies have demonstrated that these proteins interact to
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produce unique, concomitant dysfunction (Fang et al. 2014; He et al. 2017; Giasson et al.
2003; Clinton et al. 2010). Moreover, there are multiple mechanisms by which molecular
pathology causes cellular dysfunction (Styr and Slutsky 2018) (i.e. angiopathy, gliosis,
neuronal cell death, signaling dysfunction), and cellular dysfunction may be a more specific
marker of cognitive dysfunction than plaque burden alone (Jeong 2017; Yankner and Lu
2009). Additionally, most studies have examined overlap of only 2-3 aggregates at once
or preselect subjects with specific diagnoses. Thus, the latent structure of copathology
that may emerge when all regions, aggregates, and patients are considered simultaneously
remains unknown.
The healthcare system is familiar with the problem of highly complex biology underlying
variable clinical presentations. The ever-decreasing costs of computing hardware and easily
accessible programming libraries for advanced computational approaches, such as machine
learning and network science, provide tools to parse heterogeneity by defining new datadriven disease subtypes. These tools have been applied in multiple contexts in cancer biology
(Li et al. 2009; Liu et al. 2005), epilepsy (Bartolomei et al. 1999; Cragar et al. 2005), and
psychiatry (Xia et al. 2018; Drysdale et al. 2017; Grisanzio et al. 2018). Machine learning
techniques and network approaches have been utilized in speech recordings (König et al.
2015), neuroimaging (Avants et al. 2010; Brier et al. 2016), and clinical data (Khanna et al.
2018) of patients with neurodegenerative diseases, but have thus far been underutilized in
the field of neuropathology, in which multiple forms of pathological protein aggregates with
different morphologies can be measured alongside cellular dysfunction. It is also difficult to
map specific imaging phenotypes or biomarkers to a particular disease due to inaccuracies in
clinical diagnoses (Toledo et al. 2012). Indeed, the gold standard for identifying a particular
neuropathological syndrome is evaluation of proteinopathic burden on autopsy (Hyman
et al. 2012; Irwin et al. 2015; Kansal and Irwin 2015).
Here, instead of honing in on 1-2 diseases or proteins, we simultaneously analyze copathology
between 7 types of pathology (α-synuclein inclusions, tau neurofibrillary tangles, TDP-43
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Figure 5.1: Schematic of data processing. (a) The burden of amyloid-β plaques,
α-synuclein plaques, tau neurofibrillary tangles, TDP-43 inclusions, ubiquitin, neuritic
plaques, angiopathy, gliosis, and neuron loss was evaluated on a 5-tier ordinal scale (0,
Rare, 1+, 2+, 3+) via cerebral autopsy in 895 patients through the Integrated Neurodegenerative Disease Database (Toledo et al. 2014). Evaluation of pathological burden was
performed for all proteins for the listed regions, in addition to the substantia nigra and locus
coeruleus, which are hidden for ease of visualization. Dentate gyrus and CA1/subiculum
were quantified separately but shown together here as the hippocampus for ease of visualization. Abbreviations for brain regions can be found in Table S5.1. (b) We compute a
895 × 895 similarity matrix whose ij th element contains a Spearman correlation between
pathology score vectors for patient i and patient j. Next, we use network community detection by modularity maximization to assign each patient to a data-driven disease cluster.
(c) Using linked data from cerebrospinal fluid (CSF) protein testing and genotyping, we
train statistical models to predict membership to disease clusters.
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inclusions, neuritic plaques, neuronal loss, angiopathy, and gliosis) across 15 brain regions
(98 total features) in a sample of 895 patients evaluated by expert neuropathologists on
autopsy (Fig. 5.1a-b). Next, we used a data-driven clustering approach that assigns each
patient to a single, data-driven, transdiagnostic “disease cluster” while accounting for all
available forms of pathology (Fig. 5.1b). We evaluated this approach alongside the existing
model of neurodegenerative disease, in which diseases are defined by 1-2 protein species
and patients simultaneously meet criteria for multiple diagnoses. The resulting clusters
grouped together diseases known to be driven by the same pathogenic protein, providing
a novel data-driven confirmation of traditional disease classification schemes. Additionally,
we found a separate cluster containing strong copathology between neuritic plaques, Lewy
bodies, and tau neurofibrillary tangles. These disease clusters, which were defined solely by
histopathology, differed in terms of cognitive phenotype, cerebrospinal fluid (CSF) protein
levels, and genotype at the APOE and MAPT loci. Finally, using a random forest classifier,
we achieved accurate identification (AUC = 0.85) of the data-driven tauopathy cluster from
a heterogeneous clinical population using only data available in vivo, which exceeded our
ability to distinguish individual tauopathies (AUC < 0.75). Our findings complement current definitions of neurodegenerative disease syndromes and provide clinicians with greater
explanatory power for parsing disease heterogeneity in the context of existing biomarkers.

RESULTS
Copathology-driven clusters group heterogeneous diseases by underlying proteinopathies
Co-occurring pathology is a common feature of several neurodegenerative disorders (Robinson et al. 2018), complicating the interpretation of diagnoses as uncovering mono- or diproteinopathic disease processes; however, co-pathology has mostly only been studied in a
pairwise or triadic fashion, often in subsets of patients with a specific disease. As a result,
it remains unknown the extent to which individual diagnoses represent well-defined groups
when considering the full space of copathology and patients. To address this problem, we
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sought to identify latent, data-driven clusters of neurodegenerative disease patients that
explicitly account for copathology. Here, using a sample of 895 autopsy cases with various
neurodegenerative diagnoses, we computed the polychoric correlation (Olsson 1979; Revelle 2019) between vectors of pathology scores for each pair of patients as a measure of
pairwise inter-patient similarity across 98 features of molecular and cellular pathology (Fig.
5.2a). These “pathological features” included measurements of different types of proteinopathic features (thioflavin-staining neuritic plaques, tau neurofibrillary tangles, α-synuclein
inclusions, TDP-43 inclusions) or types of histological features (angiopathy, gliosis, neuron
loss) taken from up to 15 brain regions. When patients are ordered by their arbitrary subject number, the resulting matrix of inter-subject polychoric correlations has no obvious
structure (Fig. 5.2a). When patients are ordered by primary histopathological diagnosis, block-like structure becomes evident, indicating similar histopathological findings in
patients with the same primary diagnoses (Fig. 5.2b). However, we also observe large, positive correlation values on the off-diagonal blocks, indicating similarity in histopathological
findings that is unexplained by the primary diagnosis.
To parse the observed overlap between disease entities, we grouped patients according to
their distributions of pathology using an unsupervised clustering algorithm known as kmedoids (Fig. 5.2c, see Methods and Supporting Information, Fig. S5.7 for details, including selection of k and split reliability). Notably, this algorithm was agnostic to histopathologic diagnosis, yet consistently grouped histopathologic diagnoses together by their underlying molecular drivers. This fact became evident when we constructed a representative
patient for each cluster by calculating the average pathology scores across all patients in
that cluster. Specifically, we saw clusters characterized by tau (Cluster 1), amyloid-β and
tau (Cluster 2), TDP-43 (Cluster 3), and α-synuclein (Cluster 4) (Fig. 5.2d). Indeed, the
subjects belonging to Cluster 1 were composed of primary tauopathies (Irwin et al. 2015),
such as Pick’s Disease, progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) (Fig. 5.2e). Cluster 2 was composed primarily of patients with high levels
of Alzheimer’s disease neuropathologic change (ADNC) (Montine et al. 2012) (Fig. 5.2e).
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Figure 5.2: Unsupervised clustering of copathology groups disease entities into
proteinopathy families. (a) We computed a matrix of polychoric correlations between
vectors of pathology scores for each pair of subjects across all available pathological features to quantify the similarity in distributions of pathology. (b) The same matrix as in
panel (a) where rows and columns are ordered by primary histopathologic diagnosis. Black
lines along the diagonal mark blocks of patients with the same diagnosis. (c) The same
matrix as in panel (a) where rows and columns are ordered by a partition detected through
k-medoids clustering. Black lines along the diagonal mark blocks of patients grouped into
the same cluster. (d) Representative vector of pathology scores for each cluster (cluster
centroids) demonstrate distinct profiles of pathology that map to underlying molecular
drivers of disease, including tau, amyloid-β, TDP-43, and α-synuclein. (e) Composition
of each cluster in terms of primary histopathologic diagnoses (see Methods, Sample Construction). Each cluster is comprised of disease entities that are putatively caused by the
protein most highly represented in the cluster’s centroid. Counts placed above stacked bars
indicate the number of patients in each cluster. (f ) In a subset of patients, all of which
have a primary diagnosis of Alzheimer’s disease, we show the composition of each cluster
in terms of secondary histopathologic diagnosis. Counts placed above stacked bars indicate
the number of patients with Alzheimer’s disease in each cluster. ADNC = Alzheimer’s disease neuropathologic change identified through ABC staging (Montine et al. 2012), CBD =
corticobasal degeneration, FTLD = frontotemporal lobar dementia with TDP-43 inclusions,
LBD = Lewy body disease, PSP = progressive supranuclear palsy. See Methods, Sample
Construction for definition of Tau-Other and Other.
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Cluster 3 exhibited strong representation of TDP-43 proteinopathies, namely FTLD-TDP
and amyotrophic lateral sclerosis (ALS) (Fig. 5.2e). Cluster 4 contained primarily synucleinopathies, housing patients with a spectrum of Lewy body disease and Multiple Systems
Atrophy (Fig. 5.2e). Cluster 5 contained strong copathology between α-synuclein and
ADNC, while Cluster 6 contained individuals with minimal cerebral pathology (Fig. 5.2d)
that mostly met criteria for low ADNC and/or ALS. We did not find any differences in
the prevalence of early onset AD between clusters. When we plotted the mean pathology
scores for each cluster on spatial maps of the brain (Fig. S5.8a) using neuroimaging tools
(Jenkinson et al. 2012; Cammoun et al. 2012), it became apparent that the amygdala and
hippocampus tended to have relatively high pathology scores across all clusters. These findings suggest that the solution of our clustering algorithm respects the known hierarchy of
neurodegenerative diseases, which is driven by aggregation of specific pathogenic proteins,
and captures a known pattern of prominent copathology (Beach et al. 2012; Robinson et al.
2018; Higashi et al. 2007; Irwin et al. 2017) as a distinct group. We also employed an
alternative approach called exploratory factor analysis (Revelle 2019; Holgado–Tello et al.
2010), which independently confirmed the finding that each pathological protein contributes
a large amount of latent structure to the 98-dimensional pathology space (Fig. S5.10a).
Targeted investigation of α-synuclein and Alzheimer’s disease co-pathology
After establishing the similarity between our clustering solution and existing schema for
categorizing neurodegenerative disease, we next explored how our clustering approach might
expand upon these schema by its explicit treatment of copathology. A previous study found
distinct spatial patterns of α-synuclein pathology in patients with ADNC and LBD (Toledo
et al. 2016), but the patterns of copathology between ADNC (tau and amyloid-β) and
α-synucleinopathy remain unstudied. As a first step towards measuring copathology, we
visualized the distribution of secondary diagnoses in each cluster given to all patients with
intermediate (iAD) or high (hAD) levels of ADNC. In Clusters 1 and 3, individuals with
iAD had secondary diagnoses of tauopathies and TDP-43 proteinopathies, respectively (Fig.
5.2e-f), suggesting that moderate ADNC is within the histopathological bounds of these
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latent disease groups. Interestingly, in Clusters 2, 4, and 5, we found secondary diagnoses
of Lewy body disease in individuals with iAD and hAD (Fig. 5.2e-f), suggesting that
the algorithm identified 3 subgroups of patients with concomitant ADNC and α-synuclein
pathology.
To probe these subgroups further, we performed a targeted investigation of the pathology
scores found in patients with both AD and LBD in Clusters 2, 4, and 5 (Fig. 5.3). First, we
isolated patients in Cluster 2, 4, and 5 with both Lewy body disease and intermediate (iAD)
to high (hAD) levels of Alzheimer’s disease neuropathologic change (ADNC) (Montine et al.
2012). Next, we calculated the median score of each pathological feature across subjects with
LBD and iAD or hAD (Fig. 5.3a-c), which revealed 3 visually different patterns of cerebral
copathology. Interestingly, we found that Cluster 5 represents a strong AD-α-synuclein
neocortical copathology subgroup, Cluster 2 represents a “pure” AD subgroup with a mild
amygdalar synucleinopathy, and Cluster 4 represents a “pure” α-synuclein subgroup with
a mild, limbic predominant tauopathy and little neuritic plaque pathology.
Next, we used pairwise Wilcoxon rank-sum tests at every one of the 98 pathological features
to quantify the differences in median pathology scores between the three groups (Fig. 5.3df). Compared to Cluster 2, Cluster 5 has stronger widespread α-synuclein pathology (Fig.
5.3e, pFDR < 0.05 for all regions except amygdala and cerebellum), weaker cortical tau
pathology (Fig. 5.3e, pFDR < 0.05 for anterior cingulate, superior middle temporal lobe,
mid-frontal cortex, and angular gyrus), and similar neuritic plaque pathology (Fig. 5.3e,
pFDR > 0.05 except for in CA1/subiculum). Additionally, the downstream effects of this
pathology, as measured by neuron loss and gliosis, also differed between these two groups.
Despite having a similar cortical neuritic plaque burden and increased cortical α-synuclein
pathology, the downstream effects of that pathology Cluster 5 had less cortical gliosis and
neuron loss than Cluster 2 (Fig. 5.3e, pFDR < 0.05 for superior middle temporal lobe, midfrontal cortex, and angular gyrus), suggesting that cortical gliosis and neuron loss are more
tightly linked to tau pathology than α-synuclein pathology. Importantly, these two groups
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Figure 5.3: Comparison of ADNC and Lewy body copathology clusters. (a-c)
Median pathology scores for patients with intermediate to high ADNC and Lewy body
diseases in Cluster 2 (panel a), Cluster 4 (panel b), and Cluster 5 (panel c), represented as
a region × type matrix of pathological features. (d-f ) Matrix of pairwise comparisons of
median pathology scores for each pathological feature, whose color axis reflects the indicated
difference in pathology. *, pFDR < 0.05. ADNC, Alzheimer’s disease neuropathologic
change. Abbreviations for brain regions can be found in Table S5.1.
do not differ in their age at death (Fig. S5.5a) or onset of disease (Fig. S5.5b), suggesting
that pathological differences are not explained by differing time courses of disease. These
findings suggest that in the presence of α-synuclein co-pathology, an alternative pattern of
ADNC with decreased cortical tau and similar amyloid-β may occur.
Disease clusters exhibit unique in vivo phenotypes
After generating new disease categories based solely on post-mortem pathology, we sought
to characterize patients within each cluster in terms of in vivo phenotypes. First, we
evaluated cognition in an n = 159 subsample of patients with available data from the
Montreal Cognitive Assessment (MoCA) (Nasreddine et al. 2005). To compare MoCA
scores between clusters, we defined Mi−j as the median difference between scores from
patients in cluster i and scores from patients in cluster j. Because scores were not all
normally distributed, we used the Wilcoxon rank-sum test to evaluate the null hypothesis
that Mi−j = 0 for each MoCA score and all unique pairs ij where i 6= j. We found
significant differences in the overall MoCA scores between clusters (Fig. S5.4a), with Cluster
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2 harboring the lowest scores (median MoCA = 11, pFDR < 0.05 with Cluster 1, 4, and
6), and Cluster 5 (M5−6 = −7.00, n = 52, pFDR = 0.0016) and Cluster 4 (M4−6 = −6.00,
n = 66, pFDR = 0.0050) containing lower scores than Cluster 6, which was characterized
by minimal pathology (Fig. 5.2d). Interestingly, overall MoCA scores did not significantly
differ between Cluster 5 and Cluster 2 or Cluster 4 (Fig. S5.4a; M5−2 = 4.00, n = 76,
pFDR = 0.077; M5−4 = −1.00, n = 72, pFDR = 0.56). These findings suggest that our
data-driven clusters capture cognitive differences, and that the identified subtype of ADNCα-synuclein copathology is not characterized by globally worse cognition, contrary to what
has previously been shown in more general investigations of AD-α-synuclein copathology
(J. Irwin and I. Hurtig 2018; Robinson et al. 2018).
Next, we wanted to confirm whether these differences in overall MoCA score were harbored
in specific MoCA items, or found throughout all items in the assessment. We compared
MoCA subscores between clusters and corrected for multiple comparisons across all 15
unique pairwise comparisons for all 6 MoCA subscores (90 total comparisons) by adjusting
the false discovery rate (q < 0.05). We found no significant differences between clusters
for digit attention and naming items. For repetition, orientation, and delayed recall items,
Cluster 2 had lower median scores than at least one other cluster, with the largest differences
found for orientation testing (Fig. 5.4a, all pFDR < 0.05). However, the visuospatial
subsection produced better separation in performance across multiple clusters, with Cluster
4 (median: 1, 3rd quartile: 3) and Cluster 5 (median: 2, 3rd quartile: 2) exhibiting the
lowest scores (Fig. 5.4a; M5−6 = −2.00, n = 52, pFDR = 0.00051; M5−1 = −2, n = 39,
pFDR = 0.013; M4−6 = −2, n = 66, pFDR = 0.0011). For this section, the Cluster 2 median
was lower than the Cluster 1 median (Fig. 5.4a, n = 60, M2−1 = −2.00, pFDR < 0.01)
and than the Cluster 3 median (Fig. 5.4a, n = 58, M2−3 = −2.30, pFDR < 0.05). The
Cluster 1 median and Cluster 3 median visuospatial scores were higher than the Cluster
4 median scores (Fig. 5.4a; M1−4 = 1.21, n = 89, pFDR < 0.05; M3−4 = 1.50, n = 87,
pFDR < 0.05). These results suggest that testing of visuospatial cognition may be more
sensitive to α-synuclein pathology or AD-α-synuclein copathology than orientation, which
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Figure 5.4: Cognitive deficits and CSF protein levels in disease clusters. (a) Pairwise intercluster comparisons of median Montreal Cognitive Assessment (MoCA) subscores
(Nasreddine et al. 2005) using the Wilcoxon rank-sum test, FDR-corrected for multiple
comparisons (q < 0.05) over all pairwise tests for 6 subscores. (b) Pairwise intercluster
comparisons of median CSF protein levels for amyloid-β1−42 , phosphorylated tau, and total
tau using the Wilcoxon rank-sum test, FDR-corrected for multiple comparisons (q < 0.05)
over all pairwise tests for all 3 proteins. Plots were constructed using code from R package
ggpubr (Kassambara 2018). ns, pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***,
pFDR < 0.001. ****, pFDR < 10−6 . CSF, cerebrospinal fluid.
is primarily sensitive to a group of Alzheimer’s disease patients with minimal copathology
(Fig. 5.2d,f). Importantly, this trend, although not statistically significant due to a large
reduction in power, was still present when we either isolated (Fig. S5.13b) or excluded (Fig.
S5.13a) patients with intermediate to high ADNC from Clusters 2, 4, and 5, suggesting that
our finding crosses the boundaries of neuropathologically defined Alzheimer’s disease and
is characteristic of the data-driven disease cluster.
In order to probe the apparent item-dependent differences in MoCA scores, we next examined how pathology at individual regions could explain cognitive scores compared with
summaries of whole brain pathology, such as our clusters or ADNC staging. Here, we
examined the visuospatial sub-item, the orientation sub-item, and the total MMSE score
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as cognitive measurements. We computed the set of Spearman correlations between each
pathological feature (i.e. scores for a specific type of pathology in each region) and each
cognitive measure (Fig. S5.11a-c). This analysis revealed that corticolimbic α-synuclein
pathology and neuritic plaques were most strongly negatively related to visuospatial subscores (Fig. S5.11a; amygdalar α-synuclein, ρ = −0.36, pFDR = 3.9 × 10−4 ; middle frontal
gyrus neuritic plaques, ρ = −0.22, pFDR = 0.034). On the other hand, corticolimbic tau,
neuritic plaques, gliosis, and neuron loss were negatively related to orientation subscores
(Fig. S5.11b; middle frontal gyrus tau, ρ = −0.42, pFDR = 1.4 × 10−6 ) and overall MMSE
(Fig. S5.11c; angular gyrus neuron loss ρ = −0.47, pFDR = 4.5 × 10−25 ). However, these
findings are potentially non-specific due to the covariance between regional pathology scores.
To address this covariance, we trained random forest models to predict each cognitive measure from different transformations of the pathology matrix and evaluated the performance
of these models in multiple held out samples. In doing so, we found that knowledge of each
patient’s cluster assignment explained nearly as much variance in visuospatial and orientation subscores (Fig. S5.11g-h; mean visuospatial R2 = 0.18, mean orientation R2 = 0.20)
as did the entire matrix (Fig. S5.9a) of pathology scores (Fig. S5.11g-h; mean visuospatial
R2 = 0.23, mean orientation R2 = 0.26) and explained more variance than simple regional
averages (Fig. S5.11g-h; mean visuospatial R2 = 0.14, mean orientation R2 = 0.18), pathological feature type averages for visuospatial (Fig. S5.11g-h; mean visuospatial R2 = 0.16,
mean orientation R2 = 0.23), ADNC level (Montine et al. 2012) (Fig. S5.11g-h; mean
visuospatial R2 = 0.06, mean orientation R2 = 0.20), or LBD classification (McKeith et al.
2017) (Fig. S5.11g-h; mean visuospatial R2 = 0.13, mean orientation R2 = 0.05). These
findings suggest that these data-driven clusters capture cognitively relevant spatial patterns
of pathology, which may separate global deficits captured through orientation from more
specific deficits in visuospatial tasks.
In addition to cognitive biomarkers of disease, we were also interested to know how our
pathology-defined clusters separated patients with respect to the levels of proteins found in
cerebrospinal fluid (CSF), a diagnostic test primarily used to identify Alzheimer’s disease
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(Tapiola et al. 2009; Kang et al. 2013; Perneczky et al. 2011; Irwin et al. 2018; Kansal and
Irwin 2015) with mixed success in FTLD (Toledo et al. 2012). Specifically, we assessed CSF
amyloid-β1−42 , phosphorylated tau, and total tau in an n = 214 subsample of patients with
available data. Again, we used the Wilcoxon rank-sum test to evaluate the null hypothesis
that the median sample difference between every unique pairwise combination of clusters is
equal to 0 for each CSF protein, correcting for multiple comparisons over 15 unique tests
for 3 CSF proteins by adjusting the false discovery rate (q < 0.05). We found that median
CSF amyloid-β1−42 , phosphorylated tau, and total tau in Cluster 2 and Cluster 5 differed
significantly from Clusters 1, 3, 4, and 6 (all pFDR < 0.01), except for Cluster 5 and Cluster
3 with respect to total tau (M5−3 = 15.43, n = 46, pFDR = 0.33). However, we did not find
statistically significant differences in median amyloid-β1−42 , phosphorylated tau, or total
tau levels between Cluster 2 and Cluster 5 (all pFDR > 0.05). This finding is consistent
with CSF amyloid-β and tau markers demonstrating copathology-independent associations
with AD pathology (Tapiola et al. 2009; Toledo et al. 2012), though here we include more
patients with tauopathies in our sample. As expected, these findings were driven by the
large constituents of AD patients in Clusters 2 and 5 (Fig. S5.14a); however, the small
subset of patients in Cluster 2 with no or low ADNC (Montine et al. 2012) tended to have
lower CSF amyloid-β1−42 and high phosphorylated and total tau, those these trends were
not statistically significant due to the large reduction in power.
Genotypic signatures of disease clusters
Genetic factors play an important role in determining risk for development of neurodegenerative disease. The 4 allele at the apolipoprotein E (APOE ) gene locus is a strong risk
factor for Alzheimer’s disease, while the 2 allele is thought to be protective (Liu et al.
2013). Interestingly, the H1 haplotype at the gene locus encoding tau (MAPT ) has been
associated with progressive supranuclear palsy (PSP) (Baker et al. 1999), Parkinson’s disease (Tobin et al. 2008), and Alzheimer’s disease (Myers et al. 2005), three diseases with
putatively distinct etiologies. We sought to understand how these genetic risk factors might
be represented within our pathology-based disease clusters. Using a subsample of 861 pa-
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tients with genotyping at the APOE and MAPT loci, we measured the representation of
genotypes within each cluster (Fig. 5.5a-b). Next, using multiple logistic regression, we
measured the odds of cluster membership given the presence of risk alleles.
First, we used this approach to investigate how APOE alleles were distributed across our
disease clusters. We found that subjects carrying an APOE -4 allele had higher odds of
belonging to Cluster 2 than to any other cluster (Fig. 5.5f; Cluster 1, β = 1.9, df = 356,
pFDR = 1.4 × 10−7 ; Cluster 3, β = 1.4, df = 346, pFDR = 2.8 × 10−6 ; Cluster 4, β = 0.96,
df = 380, pFDR = 1.1 × 10−5 ; Cluster 6, β = 1.2, df = 495, pFDR = 1.0 × 10−10 ) except
for Cluster 5 (β = 0.12, df = 361, pFDR = 0.66). Similarly, subjects carrying an APOE -4
allele had higher odds of belonging to Cluster 5 than to any other cluster (Fig. 5.5f; Cluster
1,
beta = 2, df = 174, pFDR = 1.5 × 10−6 ; Cluster 3, β = 1.4, df = 164, pFDR = 5.2 × 10−5 ;
Cluster 4, β = 0.98, df = 198, pFDR = 0.00062; Cluster 6, β = 1.2, df = 313, pFDR =
1.4 × 10−6 ) besides Cluster 2. These results align with previous findings that APOE 4 is associated with ADNC, even amidst α-synuclein copathology (Tsuang et al. 2013).
Also, subjects carrying an APOE -2 allele had higher odds of belonging to Cluster 1 (Fig.
5.5e; β = 1.2, df = 356, pFDR = 0.0043) or Cluster 6 (Fig. 5.5e; β = 1.3, df = 495,
pFDR = 0.00042) than to Cluster 2. These findings suggest that APOE-2 is protective
against ADNC, which is less prevalent in Cluster 1 and Cluster 6 than in Cluster 2 and
Cluster 5.
Next, we used the same regression-based approach to examine how MAPT alleles were
distributed across our disease clusters. We found that the presence of two H2 alleles portended lower odds of Cluster 1 membership relative to other clusters (Fig. 5.5g; Cluster 2,
β = −2.4, df = 357, pFDR = 1.5 × 10−5 ; Cluster 4, β = −1.3, df = 194, pFDR = 0.037; Cluster 6, β = −2.4, df = 309, pFDR = 2.3 × 10−5 ). Similarly, the odds of Cluster 1 membership
were higher given the presence of an H1 allele relative to Cluster 2 (Fig. 5.5c; β = 0.72,
df = 357, pFDR = 0.023) and Cluster 6 (Fig. 5.5c; β = 0.84, df = 309, pFDR = 0.0091).
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PSP is known to be associated with the MAPT H1 haplotype and was primarily found in
Cluster 1. Therefore, we repeated the above analysis while excluding PSP patients from
Cluster 1 to test whether the associations between Cluster 1 membership and MAPT haplotypes could be simply explained by the sequestration of PSP patients in Cluster 1. When
excluding PSP from Cluster 1, the relationship between the odds of Cluster 1 membership and the presence of an H2 allele was still present (Fig. S5.16a; Cluster 2, β = −2.3,
df = 312, pFDR = 0.00018; Cluster 6, β = −2.3, df = 264, pFDR = 0.00033), although the
relationship between Cluster 1 odds and H1 allele presence was weakened and not statistically significant (Fig. S5.16a; Cluster 2, β = 0.25, df = 312, pFDR = 0.62; Cluster 6,
β = 0.35, df = 264, pFDR = 0.47). Overall, these findings suggest that our pathology-based
clusters automatically produced categories whose genotypic compositions cross boundaries
drawn by existing disease labels.
Multivariate classification of disease labels from in vivo biomarkers
Clinicians currently utilize CSF protein analysis and genotyping in diagnosing neurodegenerative disease (Kang et al. 2013; Irwin et al. 2015; Kansal and Irwin 2015). However,
non-concordant clinical diagnosis (Toledo et al. 2012; Beach et al. 2012) and heterogeneous
co-pathology within existing disease categories hinders the use of these tests to accurately
infer a specific disease process afflicting a patient with putative dementia (Toledo et al.
2012). Previous studies have demonstrated utility of CSF testing in predicting histopathologically confirmed AD (Tapiola et al. 2009; Toledo et al. 2012; Perneczky et al. 2011),
FTLD (Toledo et al. 2012), or concurrent synucleinopathy in AD patients (Irwin et al.
2018). Here, we were interested in quantifying the utility of multiple in vivo biomarkers
in explicitly predicting data-driven groupings of patients with copathology (Fig. 5.2) compared with labels from existing disease definitions. In 287 patients (194 patients with both
pathology and CSF data and 93 additional clinically normal controls with CSF data only),
we trained multiple logistic regression and random forest decision tree models to identify a
single class of disease label out of the remaining heterogeneous group of patients using CSF
amyloid-β1−42 , phosphorylated tau, total tau protein levels, and mini-mental status exam
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(MMSE) scores. In this way, we convert a multi-class prediction problem to a one-vs.-all
scenario to increase the available sample size for model training. Additionally, compared
to a pairwise comparison between two disease entities (Irwin et al. 2018; Perneczky et al.
2011), a one-vs.-all prediction requires no clinical priors or narrowing of problem scope to
a particular syndrome, which may be unrealistic given the weak correspondence between
clinical diagnosis and underlying neuropathology (Beach et al. 2012; Toledo et al. 2012).
Importantly, compared to previous studies (Irwin et al. 2018; Tapiola et al. 2009; Perneczky
et al. 2011) that predict histopathologically confirmed diagnoses from CSF, we did not
preselect or exclude certain diagnoses from our heterogeneous sample; we tested non-linear
models; we utilized cognitive and genetic data; and we report only cross-validated algorithm
performance in data not used to train our models.
Interestingly, we found that the out-of-sample area under the receiver-operater characteristic
curve (AUC) values were largely similar with the inclusion of genotype data (Fig. S5.17)
and use of non-linear random forest decision tree models (Liaw et al. 2018) (Fig. S5.18),
suggesting that CSF protein levels and APOE /MAPT genotype explain common variance
in disease status. However, both genetic data and random forest models boosted AUC
values for predicting primary tauopathies (PSP and CBD) and our primary tauopathydriven Cluster 1 (Fig. S5.17, Fig. S5.18). Notably, disease labels could still be predicted
from genotype alone with above-chance accuracy (Fig. S5.19).
Here, we present the out-of-sample performance of a multiple logistic regression model
using only CSF protein levels as features, but results with inclusion of genotypic data
and use of random forest models are presented in the Supplementary Information (Fig.
S5.17, Fig. S5.18). Confirming previous findings (Tapiola et al. 2009; Toledo et al. 2012),
the model was able to identify intermediate to high ADNC with mean AUC = 0.91 and
clinically normal patients with mean AUC = 0.90 (Fig. 5.6a). Performance in identifying
neuropathologic diagnoses of Lewy body disease (LBD) or FTLD-TDP was weaker yet
still above chance, with mean AUC of 0.66 and 0.78, respectively (Fig. 5.6a). PSP and
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CBD could be identified by general linear models with AUCs of 0.6 and 0.72 (Fig. 5.6a),
respectively, but random forest models could identify each these diseases with an AUC
of 0.75 (Fig. S5.18) Collectively, these findings suggest that CSF protein can be used to
distinguish patients with a particular traditional neuropathologic diagnosis from a group of
patients with a heterogeneous mix of neurodegenerative diseases.
After demonstrating that we could predict existing disease labels with high accuracy from
CSF protein levels, we next asked whether the disease cluster we identified could improve
our ability to infer histopathologic syndromes from clinical data by comparing the AUC
for identifying each data-driven cluster to the AUCs for identifying the individual diseases
that constitute each cluster (Fig. 5.2e-f). With the same group of patients, we carried out
the same identification procedure using disease cluster membership as class labels instead
of existing disease definitions. We achieved mean AUCs of 0.79, 0.88, 0.82, 0.72, 0.74, 0.61
for each cluster, respectively (Fig. 5.6c). While the AUC for identifying intermediate to
high ADNC (0.91) was higher than the AUC for identifying Cluster 2 (Fig. 5.6a,c), our
data-driven tauopathy and TDP-43 proteinopathy clusters appeared to be easier to identify
than their constituent diseases. Interestingly, we were able to identify Cluster 1 with a mean
AUC of 0.86 using a random forest algorithm and genetic data, which was better than the
AUCs for PSP and CBD by 0.11 with the same approach (Fig. S5.18; AUC= 0.86 vs. 0.75).
Using linear models, we also identified Cluster 3 with a higher AUC by 0.04 than FTLDTDP (AUC= 0.82 vs. AUC= 0.78). The feature weights of these models were similar when
predicting a cluster or its constituent diseases (Fig. 5.6b,d; Fig. S5.18b,d), suggesting that
the cluster-predicting models are more accurate due to the grouping together of multiple
diseases with similar biomarker patterns. We also confirmed that our ability to diagnose
non-AD pathology was not trivially due to our ability to accurately identify AD pathology
by demonstrating similarly accurate classification of Cluster 1 (AUC= 0.79) and Cluster
3 (AUC= 0.84) in an n = 181 subsample of patients with no intermediate to high ADNC
in Clusters 2, 4, and 5 (Fig. S5.20). These findings suggest that groups of tauopathies
can be better resolved than individual tauopathies using CSF amyloid-β1−42 and tau, while
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Figure 5.6: Identifying disease labels from initial testing of CSF protein. (a, c)
Characteristics of prediction of existing diagnoses (panel a) or disease clusters (panel c) in
held-out testing data using multiple logistic regression to predict disease labels from CSF
protein levels. Sub-panels i and ii show the test-set sensitivity and specificity, respectively,
using a threshold value of 0.5. Sub-panel iii shows the area under the curve (AUC) on the
test-set, reflecting performance over a range of threshold values. Bar length represents mean
performance, and error bars indicate 95% confidence intervals over 100 repetitions of k-fold
cross-validation at k = 5. Sub-panel iv shows representative receiver-operator characteristic
curves for test-set predictions of existing diagnoses (panel a) or disease clusters (panel c).
(b, d) Mean standardized multiple logistic regression β across 100 repetitions of k-fold crossvalidation at k = 5 in the prediction task for existing disease labels (panel e) or disease
clusters (panel f ). The β weights can be interpreted as the increase in log-odds ratio for
a one standard deviation increase in the value of the predictor. TPR, true positive rate.
FPR, false positive rate. Total Tau, total CSF tau protein. Phosph. Tau, total CSF
phosphorylated tau. Amyloid-β1−42 , total CSF amyloid-β1−42 . MMSE, total Mini-Mental
Status Exam score.
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ADNC may be better identified as currently defined by ABC staging (Montine et al. 2012),
regardless of copathology (Tapiola et al. 2009).

DISCUSSION
Neurodegenerative diseases are typically defined by the increased burden of one or two
pathogenic protein species. However, it is the rule rather than the exception that individual patients meet criteria for multiple diseases and exhibit several pathogenic protein
aggregates. In the present work, we analyzed a large post-mortem sample of patients with
a diverse representation of neurodegenerative diseases. Using a disease-blind approach, we
assigned each patient to a new disease cluster by simultaneously accounting for the levels
of 4 key aggregated protein species and 3 histological features across 15 regions. The resulting clusters, defined only from pathology data, differed in terms of cognition, genetics,
and CSF protein levels. Finally, we trained statistical models that were able to classify
cluster membership with above-chance accuracy from in vivo measurements. This work
represents an advance in our understanding of the clinical and neuropathologic heterogeneity among neurodegenerative diseases. Furthermore, our methods and approach provide a
general framework that could be applied to various clinical populations outside of patients
with neurodegeneration.
Accounting for copathology produces transdiagnostic categories of neurodegenerative disease
Existing definitions of neurodegenerative disease typically require the presence of one or
two pathological proteins and reflect decades of clinical and scientific consensus (Irwin
et al. 2015; Hyman et al. 2012; Gilman et al. 2008). As a result of this partial treatment of
copathology, it remains unknown the extent to which individual diagnoses represent welldefined groups. In the present work, we define 6 non-overlapping disease categories using
an unsupervised approach that simultaneously considers 98 pathological features (Fig. 5.2).
These categories appear to be primarily driven by global levels of 4 proteins (Fig. S5.8; Cluster 1: tau, Cluster 2: amyloid-β, Cluster 3: TDP-43, and Cluster 4: α-synuclein), rather
than their regional distributions. Cluster 5 contained individuals with strong amyloid237

β, tau, and α-synuclein copathology, and Cluster 6 contained individuals with minimal
cerebral pathology. We found that our clustering approach groups together existing disease entities caused by each pathological protein, while simultaneously parsing copathology
between different proteinopathies. Patients with Alzheimer’s disease were found in all 6
clusters, though primarily in Cluster 2, consistent with known pairwise measures of copathology between ADNC, α-synuclein, or TDP-43 (Robinson et al. 2018; Higashi et al.
2007; Nakashima-Yasuda et al. 2007; Takahashi et al. 2010). Overall, these results provide
a data-driven confirmation of existing models of neurodegenerative disease.
Interestingly, Clusters 2, 4, and 5 all contained individuals with both intermediate to high
ADNC and evidence of Lewy body disease in various regional distributions (McKeith et al.
2017). We compared regional pathology scores between patients with intermediate to high
ADNC and LBD in each group and found strikingly different patterns of ADNC-α-synuclein
copathology. Cluster 2 had strong neocortical AD pathology with amygdalar synucleinopathy, Cluster 4 had strong neocortical and limbic synucleinopathy with limbic-predominant
tauopathy and minimal neuritic plaque pathology, and Cluster 5 had strong cortical AD
pathology and synucleinopathy. The separation of patients with concomitant amyloid-β,
tau, and α-synuclein pathology into Cluster 2, Cluster 4, and Cluster 5 suggests that there
may exist a pathophysiologically separate form of strong AD-syn co-pathology, while limbic
tauopathy and synucleinopathy may be a normal finding alongside intermediate to high
ADNC (Uchikado et al. 2006). Alternatively, this separation could reflect the existence of
multiple strains of α-synuclein (Covell et al. 2017), which may differentially interact with
tau (Guo and Lee 2014).
Despite being defined solely from pathology data, our clusters separated patients phenotypically and genotypically. We found that individual CSF analyte levels and APOE -4 allele
representation in Cluster 2 and Cluster 5 differed from all other clusters, but not between
Cluster 2 and Cluster 5 (Fig. 5.4 and 5.5). Cluster 2 trended towards a more pathological
biomarker profile than Cluster 5, consistent with previous studies using manually selected
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“pure” AD and AD-α-synuclein copathology groups (Irwin et al. 2018; Toledo et al. 2012).
The fact that our data-driven “pure” AD cluster (Cluster 2) still contained small amounts
of limbic synucleinopathy may reflect a pathophysiological link between AD and α-synuclein
pathology (Guo et al. 2013; Masliah et al. 2001). Interestingly, we found that the orientation and visuospatial MoCA items differentially separated the clusters from one another.
While orientation scores were lower in Cluster 2 than in other clusters, including Cluster 5,
the visuospatial scores were lowest in Cluster 4 and Cluster 5 (Fig. 5.4). These trends were
still apparent even when we excluded or isolated patients from Clusters 2, 4, and 5 with
intermediate to high ADNC, suggesting that visuospatial deficits and intact orientation
may distinguish “pure” AD from AD-α-synuclein copathology. Indeed, performance on a
pentagon-copying task was predictive of the development of clinical dementia in Parkinson’s
disease patients (Williams-Gray et al. 2009). Importantly, the cluster assignments alone explained more variance in the visuospatial MoCA item than LBD subtype, ADNC level,
regional average pathology, or average amounts of each type of pathology (Fig. S5.11), suggesting that multiple forms of cognitive impairment may be captured by this classification
system.
Statistical models expand the utility of CSF protein analysis
An ideal route towards targeted therapies generally involves the identification of a sufficiently homogeneous clinical population whose biological characteristics motivate the use of
a targeted treatment. In the case of neurodegenerative disease, phenotypic and genotypic
heterogeneity, along with discordance between clinical diagnoses and gold-standard neuropathological diagnoses (Toledo et al. 2012), limit a clinician’s ability to map biomarkers
to specific neurodegenerative processes. To address this problem, we trained generalized
linear models and random forest decision trees to predict histopathologic disease class membership based on CSF protein levels, MMSE scores, and genotype at the APOE and MAPT
loci. Notably, for all predictive modeling, we included all available patients regardless of
diagnosis, incorporated additional cognitively normal controls, used the chronologically earliest available CSF sample, and reported model performance on a distribution of held-out
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samples in order to mirror a realistic clinical scenario. Consistent with previous studies
(Tapiola et al. 2009; Toledo et al. 2012; Perneczky et al. 2011), we were able to identify
intermediate to high ADNC (AUC = 0.91) and Cluster 2 membership (AUC = 0.88) from
a heterogeneous clinical population of patients with neurodegenerative disease using CSF
protein levels (Fig. 5.6a,c). Interestingly, incorporation of genetic data and use of a nonlinear random forest model allowed us to distinguish our tauopathy cluster (Cluster 1) from
all other patients with an AUC of 0.86, compared with AUCs of 0.75 for classifying PSP
and CBD, two major constituent diseases of Cluster 1. Similarly, we were able to classify
Cluster 3 with an AUC of 0.82 compared to an AUC of 0.78 for FTLD-TDP. Finally, we
demonstrated above chance accuracy in disease class identification based solely on genotype
at two loci.
All in all, these findings suggest an untapped utility in genotyping and CSF protein analysis
for identifying subgroups of patients within flexibly defined histopathologic boundaries,
using simple statistical models to generate predictions. Such models may be valuable for
designing and repurposing pharmaceuticals, immunotherapies, or combination therapies
(Perry et al. 2015) by allowing their efficacy to be compared against probabilistic estimates
of membership to a particular histopathologic disease class. Moreover, predictions based
on genotype would be stable throughout an individual’s life span, allowing for prospective
evaluation of treatments designed to intervene early in the disease course.
Limitations
We acknowledge a number of limitations in the present study. First, the semiquantitative
assessment of the degree of each pathological feature precludes the use of statistical methods
relying on interval or continuous data and is subject to issues of inter-rater reliability. More
granularity in the levels of pathology might be obtained through quantitative, automated
image analysis (Neltner et al. 2012; Irwin et al. 2016). Continuous pathology data would lend
itself well to principal component analysis, which might identify dimensions of covarying
neuropathological features. The loadings on these dimensions could then be correlated with
phenotype in a continuous fashion, rather than generating a hard partition and performing
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comparisons of means, as in the present work. However, such approaches for quantitative
mapping are still being validated and the large sample size of manually labeled data vastly
outweighs the benefit of using smaller amounts of automatically labeled data. We took a first
step towards this endeavor by performing an exploratory factor analysis (Fig. S5.10) and
principal component analysis (Fig. S5.12) using polychoric correlations. These methods
provided complementary rather than redundant information when viewed alongside the
k-medoids clusters that were primarily studied. The fact that we were able to generate
meaningful disease categories consistent with prior work argues that the use of ordinal data
is not a drastic limitation, and may inspire others to use similar approaches on datasets
that have remained incompletely explored due to their discrete nature.
Another caveat is that the cluster definitions depend on the sample composition and the set
of available features. Application of the same approach to samples with different compositions might yield independently interesting results by relative subtyping. Nevertheless, a
new observation (from any new patient) could be assigned to one of the clusters analyzed in
this paper by simply taking the maximum polychoric correlation with each cluster centroid.
Adding more pathological features would likely increase the number of stable clusters. In
our sample, different morphologies of tau were quantified together, but could give rise to
new clusters if quantified separately. We also excluded amyloid-β antibody staining from
the clustering procedure due to missing data, which precluded us from detecting diffuse
amyloid-β plaques. It is also important to acknowledge that our sample consisted primarily
of Caucasian patients (Table S5.2, 89.6% overall), unlike the population of patients with
dementia in the U.S. (Association 2019; Demirovic et al. 2003). Therefore, these findings
may not generalize to non-white subjects, nor will they help to explain the increased prevalence of dementia in non-white populations (Association 2019). Future studies that include
additional features and subjects might identify novel subclusters of those studied here, while
studies that hone in on a smaller subset of features might glean insights about the structure
of the data at a different scale.
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Finally, the availability of phenotypic measurements (MoCA and CSF protein analysis)
are biased by clinical decision making. One can imagine that lumbar puncture followed
by CSF protein analysis and detailed cognitive phenotyping were not routinely performed
on patients primarily exhibiting motor symptoms. However, our sample size was large
enough that we were able to validate our model in a distribution of held-out samples, unlike
prior applications of CSF-based predictive models which report training set accuracy in
smaller samples with well-circumscribed disease boundaries (Perneczky et al. 2011; Irwin
et al. 2018). This validation procedure increases confidence in the external validity of
our model. Additionally, the diagnostic composition of our CSF sample closely matched
the diagnostic composition of the entire sample, suggesting that such biases had minimal
impact. Nevertheless, the true model performance “in the wild” cannot be accurately
estimated without external validation in an independent sample.
Future directions
The utility of the statistical models in the present work are limited by sample size, but
also in the availability of relevant features. Incorporation of quantitative data on clinical
symptomatology, along with more complete genomic data, would likely also enhance the
predictive value of these models. Several of the disorders studied in the present work have
unique clinical attributes, and are associated with multiple genetic variants (Irwin et al.
2015; Van Cauwenberghe et al. 2016; Kalinderi et al. 2016). Clinical symptomatology and
genotype can be obtained non-invasively, and might be applied more easily as well as explain additional variance in disease. In particular, a model based purely on genotype could
theoretically provide an estimate of disease risk at birth, which would allow for the development of preventative therapies targeting early, preclinical disease. Incorporation of addition
pathology features would likely produce further granulation of a truly hierarchical disease
scheme, only one level of which has been studied in depth here. While we demonstrate how
individuals cluster together with respect to neuritic plaques, tau, α-synuclein, and TDP43, other features, such as the type of gliosis found in each region, different morphological
strains of tau and α-synuclein, and characteristics of the local inflammatory response to pro-
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tein aggregates, would likely split the clusters identified here into more granular subtypes.
Similarly, incorporation of additional biomarkers emphasized in the AT(N) framework (Jack
et al. 2018), such as PET imaging for amyloid-β or tau, would enhance the biological interpretation of these clusters and likely improve classification accuracy. Unlike CSF protein
markers used here, PET imaging directly quantifies the spatial distributions of tau and
amyloid-β. CSF amyloid-β is asymptotically related to PET amyloid-β (Jack et al. 2018;
Landau et al. 2013), which may partly explain the smaller regression weights we observed
for CSF amyloid-β compared with CSF tau.
Furthermore, the general approach we utilized in the present work is neither specific nor
limited to neurodegenerative disease. Unsupervised learning can be applied to similarity
matrices based upon any set of features pertinent to a disease with overlapping pathophysiologic modes, as in multifactorial disorders such as epilepsy, vascular disease, or cancer.
Crucial to this endeavor is the compilation of large multimodal and multisite datasets that
capture a broad range of diagnoses, phenotypes, and genotypes. In addition to the potential
clinical utility of biomarker-based forecasting of histopathological syndromes, the present
work may serve as a model for the use of unsupervised methods to identify data-driven,
transdiagnostic disease subtypes in any field.

METHODS
Sample construction
All data were obtained through the Integrated Neurodegenerative Disease Database (INDD)
(Xie et al. 2011; Toledo et al. 2014), hosted by the Center for Neurodegenerative Disease
Research at the Hospital of the University of Pennsylvania. A team of expert neuropathologists assessed the extent of 6 molecular pathological features (amyloid-β, neuritic plaques,
tau, α-synuclein, TDP-43, and ubiquitin) and 3 cellular pathological features (angiopathy,
neuron loss, and gliosis) for 15-20 brain regions during autopsy for 1659 patients as previously described (Toledo et al. 2014; Xie et al. 2011), totaling 172 pathological features. All
patients gave informed consent. Semiquantitative pathology scores (0, Rare, 1+, 2+, 3+)
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were converted to integers from 1 to 5 and treated as ordinal data except when computing
mean regional pathology scores to visualize cluster centroids. Here, we studied a subset of
895 patients (age at death: mean 73.2 years, standard deviation 11.58 years; sex: 43.8%
female, 56.2% male) over 98 pathological features. See supplementary Information, Treatment of missing data, for a discussion of how these pathological features and subjects were
selected (Fig. S5.1)..
Expert neuropathologists assigned up to 5 histopathologic diagnoses to each patient according to well-accepted disease definitions codified in the neuropathology literature; namely,
Alzheimer’s disease (Montine et al. 2012; Hyman et al. 2012), amyotrophic lateral sclerosis
(ALS) (Irwin et al. 2015), argyrophilic grain disease (Irwin et al. 2015), cerebral amyloid angiopathy (CAA) (Hyman et al. 2012), cerebrovascular disease (CVD) (Hyman et al. 2012),
corticobasal degeneration (CBD) (Irwin et al. 2015), frontotemporal lobar dementia with
TDP-43 inclusions (FTLD-TDP) (Irwin et al. 2015), frontotemporal lobar dementia without
TDP-43 inclusions (FTLD-Other) (Irwin et al. 2015), dementia with Lewy bodies (McKeith
et al. 2017), Parkinson’s disease with and without dementia (McKeith et al. 2017), multiple system atrophy (Gilman et al. 2008), primary age-related tauopathy (PART) (Irwin
et al. 2015; Crary et al. 2014), Pick’s disease (Irwin et al. 2015), and progressive supranuclear palsy (PSP) (Irwin et al. 2015). Counts of primary histopathologic diagnoses in the
full sample, along with counts of infrequent diagnoses we classified as “Other” or “Tau
Other,” are shown in Figure S5.2. We defined Alzheimer’s disease using the ABC staging
system defined in Table 3 of ref. (Montine et al. 2012), which describes Alzheimer’s disease
as a spectrum of low, intermediate, and high levels of Alzheimer’s disease neuropathologic
change (ADNC). Throughout the paper, we note where we observe low levels of ADNC, but
consider “Alzheimer’s disease” to be intermediate to high levels of ADNC, which is generally
considered sufficient to explain symptoms of dementia (Montine et al. 2012). We combined
dementia with Lewy bodes, Parkinson’s disease, and Parkinson’s disease with dementia into
Lewy body disease (LBD), because these entities can only be reliably distinguished based
upon clinical features. We stratified LBD into subtypes occurring in brainstem (bLBD),
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limbic (lLBD), amygdala-only (aLBD), or neocortical (nLBD) distributions, as described
in ref. (McKeith et al. 2017). If LBD subtype was not available for a patient with an entry
for LBD, we classified these patients as LBD not otherwise specified (LBD-NOS). The presence of tau pick bodies, synuclein in glia, tau-tufted astrocytes, and astrocytic plaques and
tau-positive oligodendrocytes was used to diagnose Pick’s disease (Irwin et al. 2015), MSA
(Gilman et al. 2008), PSP (Irwin et al. 2015), and CBD (Irwin et al. 2015), respectively, but
were not included in the clustering because they were not measured at the regional level.
FTLD-TDP and ALS were diagnosed neuropathologically as described in Ref. (Irwin et al.
2015). All patients were also given a clinical diagnosis by their physician prior to autopsy.
Cerebrospinal fluid (CSF) analyte levels were measured using a Luminex assay (Shaw et al.
2009).
Unsupervised clustering of patients by molecular pathology
Traditional definitions of neurodegenerative diseases typically only account for 1-2 species
of protein aggregate. Here, we sought to group patients into clusters in an unsupervised
manner (Kaufman and Rousseeuw 1990; Hastie et al. 2009) in the space defined by the
N × p matrix P, where p is the 98 available pathological features and N is the 895 subjects
in our sample. To perform clustering of the ordinal semiquantitative pathology scores, we
constructed a matrix R whose elements Rij equal the polychoric correlation (Olsson 1979;
Revelle 2019) between the ith and j th columns of P, corresponding to the vector of pathology
scores for patient i and patient j. Next, we performed k-medoids clustering (Kaufman and
Rousseeuw 1990) on the dissimilarity matrix D = 1 - R. We used a bootstrapping procedure
to select k = 6 based on maximizing the silhouette score and minimizing the area of the
curve of the cumulative distribution function of the Jaccard similarity between bootstrapped
samples (Kerr and Churchill 2001; Hastie et al. 2009; Von Luxburg 2010; Ben-Hur et al.
2001) (for detailed discussion, see Supplementary Information, Optimization and validation
of clustering procedure).
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Group comparisons of phenotypic measurements
We used non-parametric testing to compare phenotypes between disease clusters. Using
pairwise Wilcoxon rank-sum tests, we compared mean scores in 6 subdomains of the Montreal Cognitive Assessment (Nasreddine et al. 2005) (MoCA) between all unique combinations of clusters. All p-values were FDR-corrected (q < 0.05) over all comparisons for
all 6 subdomains. The abstraction score was excluded due to missing data. We also used
pairwise Wilcoxon rank-sum tests to compare CSF protein levels between all unique combinations of clusters. For patients that underwent multiple CSF studies, we only considered
their earliest measurement in order to control for disease progression as much as possible.
All p-values were FDR-corrected (q < 0.05) over all comparisons for the 3 CSF proteins
that we assessed.
Logistic regression of cluster membership on allele counts
Assuming a multiplicative genomics model (Clarke et al. 2011), we used multiple logistic
regression to perform pairwise comparisons of allele distributions between disease cluster
membership as binary phenotypes (Cook et al. 2016). First, for each pair of clusters i =
1, .., k and j = 1, .., k, we constructed a Nij × 1 binary outcome vector Yij , where Nij is the
number of patients belonging to cluster i or cluster j. The elements of Yij indicate whether
a patient belongs to cluster i or cluster j. A value of 1 indicates membership to cluster i
and a value of 0 indicates membership to cluster j. Next, we construct a corresponding
Nij × ng allele table A, where ng is the number of non-wild type alleles for a given gene g.
The table A consists of ng column vectors, Aa , where a = 1, .., ng , and the elements of each
column vector Aa indicate how many copies of allele a of gene g are present in each of the
Nij patients belonging to cluster i or cluster j. Next, we assumed additive genetic effects
and used logistic regression (Cook et al. 2016) to fit the following model to predict Yij from
an allele table Ag for each gene g:

ln

p
1−p

!
= β0 +

ng
X
a=1
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βa Aa +  ,

(5.1)

where p is the probability that a patient belongs to cluster i, β0 and βa are parameters
obtained by fitting the model, ln is the natural logarithmic function, and  is an error term.
We fit this model for all unique pairwise comparisons of clusters, such that ij correspond
to k C2 . In this model, β0 is interpreted as the log odds that a patient belongs to cluster
i given that the patient has two wild-type alleles. The parameter βa is the change in log
odds that a patient belongs to cluster i given the presence of 1 copy of allele a. We adjusted
p-values over all comparisons for all genes and all alleles to control the false discovery rate
at q < 0.05.
Supervised learning of disease labels
In order to demonstrate a practical clinical use for multivariate models of biomarkers,
we used data available in vivo to predict whether a patient met criteria for a specific
neurodegenerative disease or was classified into a particular data-driven disease cluster.
We converted this multi-class prediction scenario into a one-versus-all binary prediction
scenario, in which we attempted to predict a N × 1 binary disease label vector Di , whose
elements equal 1 for patients positive for the ith disease label and equal 0 for patients
negative for the ith disease label. Here, the disease labels were Alzheimer’s disease, LBD,
FTLD-TDP, and the four clusters, indexed by i = 1, .., 7, and N is the number of patients
with available data, either CSF protein levels, allele counts, or both. We used multiple
p 
, where p is the probability that a patient is positive
logistic regression to predict ln 1−p
for the ith disease label, from a feature matrix X, whose dimensions are N × q, where N
is the number of patients with available data and q is the number of features. Depending
on the analysis, X contained allele counts for non-wild-type alleles of 2 genes (N = 1312,
q = 3), levels of 3 CSF proteins at initial evaluation (N = 268, q = 3), or both allele count
and CSF protein levels (N = 262, q = 6).
When evaluating the performance of a model in predicting the ith disease label, we wanted
to ensure that our results were robust across multiple patient samples and consistent in a
held-out sample of patients that were not involved in training the model. Therefore, we used
100 repetitions of k-fold cross validation (Kohavi 1995) to obtain estimates and confidence
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intervals for the out-of-sample performance of each model. For each repetition, we randomly
split X and Di along their rows into k = 10 subsets Xj and Dj for j = 1, .., k. When the
j th subset was used as the held-out testing dataset, Xj and Dj were the independent and
dependent variables, respectively. The remaining k −1 subsets were compiled into a training
dataset, whose independent and dependent variables we refer to as Xr and Dr . In order
to aid the training process, we ensured class balance in Xr and Dr by randomly undersampling their rows (Drummond and Holte 2003; Mani and Zhang 2003), such that 50%
of patients in Xr and Dr were positive for disease label i prior to training. Using multiple
logistic regression, we fit the following equation with the training data:

ln

p
1−p

!
= β0 + βr Xr +  ,

(5.2)

where p is a vector of probabilities that each patient is positive for the ith disease label, β0
is an intercept vector, βr is a vector of feature weights obtained through model fitting, ln
is the natural logarithmic function, and  is a vector of random error terms. Next, we used
the intercept β0 and feature weights βr obtained by fitting our model to the training data
to evaluate the out-of-sample performance of our model. We used the held-out testing data
Xj to compute Dp = β0 +βr Xj , where Dp is a vector of predicted log odds that each patient
is positive for the ith disease label. We converted Dp from a vector of log odds to a vector
of probabilities and evaluated the performance of Dp in predicting Dj . We repeated this
procedure for j = 1, .., k until each subset Dj and Xj was used as the held-out data exactly
one time. The entire k-fold cross-validation procedure was repeated 100 times for the ith
disease label to generate a distribution of test-set performance metrics (sensitivity, specificity, area under the curve). Reported sensitivity, specificity, and accuracy were obtained
using a classification threshold value of 0.5 for Dp , although prediction characteristics for
a range of threshold values from 0 to 1 can be found in the receiver-operator characteristic
curves.
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SUPPORTING INFORMATION
Treatment of missing data
We examined the representation of missing values within the data in order to determine
which features and subjects to exclude. We began with a sample of pathology data from
1659 subjects on 172 pathological features (9 types of pathology for 15-20 regions each). We
computed the number of missing features per subject and plotted this quantity as a function
of autopsy date (Fig. S5.1a), and noticed that a sharp decline in missing features occurred at
the start of 2007, corresponding to the introduction of TDP-43 to autopsy protocols, which
was accompanied by additional standardization of protocols. Accordingly, we excluded
724 cases autopsied prior to January 1st , 2007. Next, in order to ascertain whether certain
groups of features should be excluded on the basis of missing data, we plotted the percentage
of the remaining 935 subjects with missing data for each pathological feature (Fig. S5.1b).
We observed that a set of regions and feature types were outliers with respect to missing
data. Ubiquitin and amyloid-β antibody staining showed increased missingness ubiquitously
across all regions (Fig. S5.1b). The occipital cortex (OC), the dentate gyrus (DG), and the
locus coeruleus (LC) showed increased missingness ubiquitously across feature types (Fig.
S5.1b). All features involving these regions, ubiquitin, or amyloid-β antibody staining were
removed, in addition to cerebellar angiopathy (CB), which also had a high percentage of
missing data. We did not expect that the removal of ubiquitin and amyloid-β antibody
staining would greatly impact our study, because ubiquitin non-specifically tags protein
aggregates and the “Thio” feature category quantifies neuritic plaques, a subset of amyloidβ antibody-staining plaques that are more relevant to Alzheimer’s disease (Montine et al.
2012). After removal of these 74 features, we were left with the final 98 features studied in
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the main text (Fig. S5.1c). Note that the color axis in (Fig. S5.1c) has its maximum near
7%, while the general consensus is that 5% to 10% of missing data per feature or subject is
inconsequential (Dong and Peng 2013).
Abbreviation
Cing
SMT
MF
Ang
CS
EC
Amyg
TS
CP
GP
SN
Med
CB
Pons
MB

Region
Anterior cingulate cortex
Superior-middle temporal cortex
Middle frontal cortex
Angular gyrus
CA1/Subiculum
Entorhinal cortex
Amygdala
Thalamus
Caudate-Putamen
Globus pallidus
Substantia nigra
Medulla
Cerebellum
Pons
Midbrain

Table S5.1: Definition of brain region abbreviations.
In order to maximize our sample size while excluding any remaining outlying subjects with
respect to missing data, we examined the distribution of data missingness for each subject
by plotting the percentage of subjects (Fig. S5.1d, y-axis) with less than some threshold
value (Fig. S5.1d, x-axis) of features missing. This analysis revealed a steep drop off in
the availability of subjects if subjects with missing data for 15% or less of the features; in
order to lean towards inclusion of more subjects, we set a threshold of 20% for missing data,
excluding 29 subjects with missing data for more than 20% of the 98 features. 5 additional
subjects of the remaining 906 subjects were excluded because they were missing diagnostic
evaluation. Finally, 6 of the remaining 901 subjects were excluded from clustering because
they had no variance in pathology, and therefore a correlation across pathological features
could not be computed, which left us with our final sample of 895 subjects.
Next, we used multiple imputation with chained equations (MICE) with a random forest
algorithm (Shah et al. 2014) in order to impute and replace missing values in the pathology
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Figure S5.2: Counts of primary histopathologic diagnoses in full sample and
“Other” subcategories. (a) Counts of patients assigned to a set of primary histopathologic diagnoses. If a patient had intermediate to high Alzheimer’s disease neuropathologic
change (ADNC) (Montine et al. 2012), we automatically assigned AD as the primary diagnosis. (b-c) Counts of primary histopathologic diagnoses in subsets patients with infrequent
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Figure S5.3: Missing data by pathological feature and cluster. (a-i) Jitter plots of
the percentage (y-axis) of missing features, prior to imputation, for every subject within
each cluster (x-axis) for angiopathy (a), gliosis (b), neuritic plaques (c), neuron loss (d),
α-synuclein (e), tau (f ), and TDP-43 (g). ns, puncorr > 0.05. *, puncorr < 0.05. **,
puncorr < 0.01. ***, puncorr < 0.001. ****, puncorr < 10−6 .
score matrix based on the multivariate structure within the data. We then performed kmedoids clustering on this matrix to generate the partition studied in the main text of
this manuscript (Fig. 5.2c-f). In order to confirm whether biases in missing data could
be driving the clustering partition that we identified from the imputed data matrix, we
compared the amount of previously missing data entries by cluster stratified by the type of
pathological feature (Fig. S5.3a-g). We then compared the median amounts of previously
missing data entries between each cluster using the Wilcoxon rank-sum test, and found no
statistically significant differences between any two pairs of clusters for any set of features.
Importantly, we did not adjust for multiple comparisons in this analysis in order to be
sensitive to any small differences in missing data that might have introduced bias into
clustering assignments.
Sample characteristics
In this section, we present a number of clinical, cognitive, and demographic characteristics
of the patients in our sample, along with information about the timing of the clinical
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measures studied in the main text relative to autopsy. Global cognitive impairment differed
between patients in each of our data driven clusters, which can be seen from the boxplots
of overall MoCA (Nasreddine et al. 2005) scores in Figure S5.4a. In this analysis, we used
the MoCA administered closest to death so that the state of the brain during measurement
of cognition most closely aligns with the quantification of proteinopathy for each patient.
Due to the retrospective nature of the study, we could not ensure that all analyzed MoCAs
were administered at the same time relative to death in all patients. In order to ensure
that these differences were not driving cognitive differences between clusters, by virtue of
certain clusters representing cognitive assessments that do not reflect the neuropathology we
observed, we compared the difference in time between death and the MoCA administration
date closest to death using the Wilcoxon rank-sum test (Fig. S5.4b). We found individuals
in Clusters 1, 4, 5, and 6 largely had MoCAs administered within 5 years of death, with no
significant differences in MoCA administration dates except between Cluster 4 and Cluster
6, which differed such that Cluster 4 patients tended to have MoCAs administered closer to
death. Cluster 2 and Cluster 3 patients tended to have their last MoCAs taken further away
from death (Fig. S5.4b; Cluster 2 vs. Cluster 1, Cluster 4, and Cluster 5, all pFDR < 0.05;
Cluster 3 vs. Cluster 5, pFDR < 0.05). However, patients in Cluster 2 had lower MoCA
scores, suggesting that these low scores can not be explained by the MoCAs having been
administered at a more advanced stage of disease. Finally, in a larger subset of n = 459
patients with available data, we compared Mini-Mental Status Exam (MMSE) scores closest
to the time of death between clusters, and found that Cluster 2 and Cluster 3 had the lowest
MMSE scores (Fig. S5.4c; Cluster 2 vs. Cluster 1, Cluster 4, Cluster 5, and Cluster 6, all
pFDR < 0.01; Cluster 3 vs. Cluster 1, Cluster 4, Cluster 5, and Cluster 6, all pFDR < 0.05)
but did not differ from each other (Fig. S5.4c; Cluster 2 vs. Cluster 3, pFDR > 0.05).
Cluster 2 MMSEs tended to be administered further away from the time of death than
other clusters (Fig. S5.4d; all pFDR < 0.05), possibly due to the tendency of providers to
avoid unnecessary assessments in patients with advanced dementia. These findings suggest
that MMSE may distinguish TDP-43 proteinopathy and ADNC from synucleinopathy and
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Figure S5.4: Overall MoCA and MMSE scores differ between clusters. (a-b) Pairwise inter-cluster comparisons of median overall Montreal Cognitive Assessment (MoCA)
scores (Nasreddine et al. 2005) (a), time in years between the analyzed MoCA and death
(b), (c) Mini-Mental Status Exam (MMSE) scores closest to the time of death, and (d) time
in years between the analyzed MMSE score and death using the Wilcoxon rank-sum test,
FDR-corrected for multiple comparisons (q < 0.05) over all pairwise tests for 6 clusters. ns,
pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001. ****, pFDR < 10−6 .
even the concurrent ADNC and synucleinopathy in Cluster 5.
Next, we compared patients in each of our data-driven clusters with regards to several key
demographic characteristics using the Wilcoxon rank-sum test. We found that the median
age at death differed between clusters, such that Cluster 2 and Cluster 5, which have high
proportions of Alzheimer’s disease (Fig. 5.2e), had higher median ages at death than most
other clusters (Fig. S5.5a; Cluster 2 vs. Cluster 1, Cluster 3, Cluster 4, Cluster 6, all
pFDR < 0.01; Cluster 5 vs. Cluster 1, Cluster 3, Cluster 4, Cluster 6, all pFDR < 0.01).
Next, we assessed whether the age of disease onset differed by cluster. We found that Cluster
3 and Cluster 4, which contain diseases known to have early onsets, such as FTLD-TDP,
ALS, PD, and DLB, had lower median ages of onset compared to Cluster 2 and Cluster 5,
which largely contain individuals with Alzheimer’s disease (Fig. S5.5b; Cluster 3 vs. Cluster
2 and Cluster 5, all pFDR < 0.01; Cluster 4 vs. Cluster 2 and Cluster 5, all pFDR < 0.01). We
separately considered age of onset in the subset of patients with intermediate to high ADNC,
because AD is often divided into early onset cases (EOAD) with genetic determinants and
idiopathic late onset cases (LOAD) (Koedam et al. 2010). This analysis revealed that
age of onset of patients with intermediate to high ADNC did not differ between clusters
(Fig. S5.6a, all pFDR > 0.05). Similarly, when we defined EOAD as onset before age 65
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(Koedam et al. 2010), we did not detect any statistically significant differences between
the proportions of AD patients in each cluster with EOAD using bootstrapping to generate
confidence intervals around the observed proportions (Fig. S5.6b, all pFDR > 0.05). We
also sought to determine whether there was any bias towards certain pathological features
based on autopsy date. In order to test for this bias, we compared the median autopsy
dates between all pairs of clusters, and we found no statistically significant differences (Fig.
S5.5c, all pFDR > 0.05). These findings suggest that the wide range of autopsy dates did not
introduce bias into our clustering approach. Similarly, we wanted to assess for any biases
introduced by the the timing of CSF sampling relative to disease onset. For all analysis
of CSF data in this manuscript (Figures 5.4, S5.14, 5.6, S5.17, S5.18, S5.20), we used
the chronologically earliest sample available for each patient in order to utilize the earliest
possible biomarker of disease. Here, we computed the period of time in years between the
onset of disease and the acquisition of the earliest CSF sample (Fig. S5.5d, y-axis) and
compared the median of this time period between each pair of clusters (Fig. S5.5d). We
found that patients in Cluster 4 tended to have their first CSF samples acquired much
later than disease onset (Fig. S5.5d; Cluster 4 vs. every other cluster, all pFDR < 0.001),
while patients in other clusters tended to have their first CSF samples acquired within 5
years of disease onset. The delayed CSF sampling in Cluster 4 might correspond to the
delayed onset of dementia in patients who initially presented with motor symptoms due to
a synucleinopathy. However, we found strong inter-cluster differences and predictive value
of CSF biomarkers with Cluster 1, 2, and 3, none of whom differed signficantly in their
delay to initial CSF testing. Finally, we characterized the distribution of binary sex and
reported race of patients within each cluster (Table S5.2). As expected, the clusters with
the lowest percentages of females were Cluster 4 and Cluster 5, which contained individuals
with synucleinopathies that are known to predominantly affect males. We also found that
our sample was largely comprised of Caucasian patients (89.6% overall), which likely does
not reflect the true U.S. population of individuals living with dementia, nor can it be used to
adequately characterize the increased risk of dementia in non-white individuals (Association
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Figure S5.5: Demographic characteristics of data-driven clusters. (a-c) Pairwise
inter-cluster comparisons of age at death (a), age of disease onset (b), date of autopsy (c),
and time between chronologically earliest CSF sample (used throughout the paper) and disease onset (d), using the Wilcoxon rank-sum test, FDR-corrected for multiple comparisons
(q < 0.05) over all pairwise tests for 6 clusters. (d) Percentage of female subjects within
each cluster. ns, pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001. ****,
pFDR < 10−6 .
2019; Demirovic et al. 2003).
Optimization and validation of clustering procedure
In order to group patients into disease categories that simultaneously account for all measured forms of molecular and cellular pathology, we employed a data-driven clustering approach in the space defined by the N × p matrix P, where p is the 98 available pathological
features and N is the 895 subjects in our sample. First, we defined the similarity matrix
R, whose ij th element contains the polychoric correlation (Olsson 1979; Revelle 2019) between the ith and j th columns of P, for every pair of subjects i and j. We then defined
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Female
White
Black or African American
Unknown or Not Reported
More than One Race
Asian

Cluster 1
46.10
88.80
3.37
4.49
2.25
1.12

(%)
(%)
(%)
(%)
(%)
(%)

Cluster 2
48.80
90.50
3.51
3.16
2.81
0.00

Cluster 3
42.90
89.60
1.30
6.49
1.30
1.30

Cluster 4
20.70
87.90
0.86
6.03
3.45
1.72

Cluster 5
36.60
96.80
1.08
0.00
2.15
0.00

Cluster 6
40.00
86.80
10.20
2.55
0.43
0.00

Overall
40.80
89.60
4.47
3.46
2.01
0.45

Table S5.2: Sex and race by cluster and in overall sample.
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Figure S5.6: Prevalence of early onset Alzheimer’s disease in each cluster. (a)
Pairwise inter-cluster comparisons of age of disease onset in patients with intermediate to
high ADNC, using the Wilcoxon rank-sum test, FDR-corrected for multiple comparisons
(q < 0.05) over all pairwise tests for 6 clusters. (b) Pairwise inter-cluster comparison of the
proportion of AD patients with AD onset before age 65 using non-parametric bootstrapping,
FDR-corrected for multiple comparisons (q < 0.05) over all pairwise tests for 6 clusters. ns,
pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001. ****, pFDR < 10−6 .
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the dissimilarity matrix D between as D = 1 − R. Next, we used k-medoids clustering to
identify k representative observations (medoids) and partition all other observations into
clusters around those medoids, such that sum of distances Dij over all subjects within each
cluster is minimimized. Two free parameters in this clustering approach are the number
of clusters k and the lower threshold t for the similarity matrix R, such that all elements
of R < t were set to 0. In order to identify the optimal and most generalizable values
for k and t, we evaluated two criteria over 1000 bootstrapped samples (Kerr and Churchill
2001; Hastie et al. 2009; Von Luxburg 2010) of D relative to a null model: the silhouette
score and the area under the curve (AUC) of cumulative distribution function (CDF) of the
Jaccard similarity between bootstrapped partitions (Ben-Hur et al. 2001). The silhouette
score measures how close points are to other points in their cluster relative to points in
other clusters, and the AUC of the Jaccard CDF evaluates the stability of the clustering
given randomnesss in the data (Kerr and Churchill 2001; Hastie et al. 2009; Von Luxburg
2010; Ben-Hur et al. 2001).
First, we selected the optimal threshold for the similarity matrix R by generating 1000
bootstrapped samples of R. On each bootstrapped sample, we performed k-medoids clustering for each combination of k = 1, ..., 10 and t = 0, 0.1, ..., 0.5 and then computed the
mean silhouette score over k clusters (Fig. S5.7a-c, e-g; light blue boxplots). This analysis
revealed that the highest mean silhouette scores across bootstrapped samples and values
of k were found at a threshold value of 0.3 (Fig. S5.7d). Therefore, we proceeded with
a threshold value of t = 0.3. Next, for each value of k with t = 0.3, we computed the
AUC of the CDF of the Jaccard similarity on shared elements between each pair of the
1000 bootstrapped partitions (hereafter referred to as AUC of the Jaccard CDF). As a null
model, we shuffled the columns of P independently at random 10 times and generated 10
null dissimilarity matrices (Dnull ), then computed the silhouette scores (Fig. S5.7a-c, e-g;
grey boxplots) and AUC of the Jaccard CDF on 100 bootstrapped samples for each of the
10 Dnull matrices and pooled them together to generate a null distribution of 1000 bootstrapped samples for each value of k and t. We only computed Dnull 10 times because the
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polychoric correlation is a computationally intensive operation.
Finally, we evaluated the sihouette scores and AUC of the Jaccard CDF to select a value of
k. We plotted 1 - the AUC of the Jaccard CDF as a function of k at t = 0.3, normalized by
1 - the AUC of the Jaccard CDF observed for each value of k in the null data, in order to
control for trivial decreases in stability as the number of clusters increases (Von Luxburg
2010) (Fig. S5.7h). We observed plateaus in the AUC of the Jaccard CDF at k = 6 and
k = 10, suggesting that clustering at k = 6 and k = 10 is robust to randomness in the data.
However, we also observed a drop off in the median silhouette score after k = 6 for t = 0.3
(Fig. S5.7e). Thus, we proceeded to analyze the k = 6 partition of the full 895 subject
sample. Interestingly, we observe outlier bootstrap samples in which the silhouette scores
at k = 10 are as high as those observed at k = 6 (Fig. S5.7e), but the median silhouette
score was far lower, suggesting that some combinations of subjects yield stable partitions
at k = 10. Future studies should examine this partition in detail with more data in order
to increase stability.

Factor analysis and principal component analysis of pathology data
In addition to using k-medoids clustering to partition subjects into groups, we also employed exploratory factor analysis (Revelle 2019; Holgado–Tello et al. 2010) using the polychoric correlation (Olsson 1979) to identify oblique latent factors that drive weighted linear
combinations of pathological features to different extents in different patients. This factor
analysis revealed that the factor loadings explaining the most variance in the pathology data
(Fig. S5.10c) had strong weights on entire types of pathological features (Fig. S5.10a; all
regions for α-synuclein pathology (Factor 1), TDP-43 pathology (Factor 2), etc.). Interestingly, neuron loss and gliosis of the substantia nigra loaded onto the α-synuclein factor (Fig.
S5.10a). Because the exploratory factor analysis did not enforce an orthogonality constrain,
factor scores (the contribution of each factor loading to each subject) were correlated across
subjects (Fig. S5.10b). The covariance matrix between factor scores revealed positive cor-
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Figure S5.7: Choosing k for k-medoids clustering. (a-c, e-g) We performed k-medoids
clustering for each combination of k = 1, .., 10 and lower threshold t = 0, 0.1, ..., 0.5 on each
of 1000 bootstrapped samples of the dissimilarity matrix D, and plotted the mean silhouette
score over k clusters for each value of k and t. Light blue, actual data D. Grey/black, null
data Dnull . (d) Mean silhouette scores over all values of k for each value of t. (h) 1 Area under the curve (AUC) of the cumulative distribution function (CDF) of the Jaccard
similarity between each pair of 1000 bootstrapped samples for each value of k at t = 0.3,
normalized by the values obtained from the null data. This analysis revealed plateaus in
the AUC of the Jaccard CDF at k = 6 and k = 10, while panel e revealed a drop off in the
median silhouette score over bootstraps at k > 6.
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Figure S5.8: Spatial maps of representative disease cluster members. (a) We
plotted mean regional pathology scores onto a surface rendering of a standard structural
image (Jenkinson et al. 2012) using an anatomical parcellation (Cammoun et al. 2012) to
map autopsy sample sites (Toledo et al. 2014). Color-scaled mean pathology scores for
each region and each pathological feature are shown for each disease cluster. In general,
pathology was quantified for only one hemisphere, chosen at random, and therefore only one
cortical hemisphere is shown and subcortical structures are plotted symmetrically for ease
of visualization. Pathology scores from the substantia nigra was included in the data-driven
clustering procedure, but is not visualized here. Additionally, CA1/subiculum is plotted
here as the entire hippocampus. Caudate and putamen are shown as separate structures
but were quantified jointly. See Fig. 5.1a for schematic of region labels.

262

Cluster 2

Cluster 1

a.

Cluster 4 Cluster 3

3+
2+
1+

Cluster 5

Rare

Amyg_NeuronLoss
CS_NeuronLoss
EC_NeuronLoss
MF_NeuronLoss
Ang_NeuronLoss
SMT_NeuronLoss
Cing_NeuronLoss
CP_NeuronLoss
GP_NeuronLoss
TS_NeuronLoss
MB_NeuronLoss
SN_NeuronLoss
Med_NeuronLoss
CB_NeuronLoss
Amyg_Gliosis
CS_Gliosis
EC_Gliosis
MF_Gliosis
Ang_Gliosis
SMT_Gliosis
Cing_Gliosis
CP_Gliosis
GP_Gliosis
TS_Gliosis
MB_Gliosis
SN_Gliosis
Med_Gliosis
CB_Gliosis
Amyg_Angiopathy
CS_Angiopathy
EC_Angiopathy
MF_Angiopathy
Ang_Angiopathy
SMT_Angiopathy
Cing_Angiopathy
CP_Angiopathy
GP_Angiopathy
TS_Angiopathy
Amyg_Thio
CS_Thio
EC_Thio
MF_Thio
Ang_Thio
SMT_Thio
Cing_Thio
CP_Thio
GP_Thio
TS_Thio
MB_Thio
SN_Thio
Pons_Thio
Med_Thio
CB_Thio
Amyg_TDP43
CS_TDP43
EC_TDP43
MF_TDP43
Ang_TDP43
SMT_TDP43
Cing_TDP43
CP_TDP43
GP_TDP43
TS_TDP43
MB_TDP43
SN_TDP43
Pons_TDP43
Med_TDP43
CB_TDP43
Amyg_Tau
CS_Tau
EC_Tau
MF_Tau
Ang_Tau
SMT_Tau
Cing_Tau
CP_Tau
GP_Tau
TS_Tau
MB_Tau
SN_Tau
Pons_Tau
Med_Tau
CB_Tau
Amyg_Syn
CS_Syn
EC_Syn
MF_Syn
Ang_Syn
SMT_Syn
Cing_Syn
CP_Syn
GP_Syn
TS_Syn
MB_Syn
SN_Syn
Pons_Syn
Med_Syn
CB_Syn

Cluster 6

0

Figure S5.9: Pathology score matrix organized by cluster assignments. (a) 895 ×
98 matrix of pathology scores (Methods, P) ordered by cluster assignment.
relations between atrophy, tau, and neuritic plaque factors, and weak negative correlations
between α-synuclein and TDP-43 factors (Fig. S5.10b). However, this approach did not
reveal the multiple forms of α-synuclein copathology that were identified by our clustering
approach (Fig. 5.2d-e; Fig. 5.3). Finally, we tested whether these continuous pathological
factor scores could be explained by CSF biomarkers by implementing linear regression models that predict subject factor scores from subject CSF amyloid-β1−42 , phosphorylated tau,
and total tau levels. These models were able to explain statistically significant amounts
of variance in scores of multiple factors (Fig. S5.10d), including the neuritic plaque factor
(Thio, R2 = 0.33, pFDR < 10−6 , F -test), the TDP-43 factor (R2 = 0.070, pFDR < 0.01.
F -test), the angiopathy factor (R2 = 0.21, pFDR < 10−6 , F -test), and the limbic atrophy
factor (R2 = 0.17, pFDR < 10−6 , F -test). These findings suggest that CSF analyte levels
can also explain continuous weights on combinations of pathological features; however, the
interpretation is made difficult by the shared variance between factors, such that explained
variance in scores for one factor may not be specific to that factor.
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To overcome the limitation of shared variance between factors, we employed principal component analysis (PCA) on a 98×98 matrix of pairwise polychoric correlations between each
pathological feature across all 895 patients. In this context, PCA identifies orthogonal
latent factors that drive weighted linear combinations of pathological features to different
extents in different patients. The weights on each pathological feature are called “loadings,”
and the extent to which these loadings are represented in each patient is called a “score.”
The loadings on each principal component did not obviously correspond to one or more
types of pathology to the extent that we observed with our k-medoids clusters. Next, we
compared the distributions of scores of each principal component between patients with
different neuropathological diagnoses (Fig. S5.12). This analysis revealed that PC1 loaded
positively onto AD patients, but negatively onto ALS and MSA, separating patients with
cortical tau and neuritic plaque pathology from those with primarily subcortical TDP-43
pathology (Fig. S5.12a,d). PC2 loaded positively onto FTLD patients and negatively onto
LBD patients, separating cortical synuclein pathology from cortical TDP-43 pathology. Interestingly, PC3 loaded positively onto both FTLD and LBD patients, possibly reflecting
covariance between synucleinopathy and TDP-43 proteinopathy.
After characterizing the principal components of the pathology matrix, we took a subsample
of 192 patients with MMSE, genotypes, and CSF biomarkers and used a random forest
algorithm to forecast each patient’s score on the first 3 principal components. We report
the out-of-sample performance averaged over 10 repeats of 5 cross-validation folds. These
findings revealed that the first principal component can be predicted well (Fig. S5.12g;
mean R2 = 0.39, mean AUC= 0.77), and PC2 and PC3 could be predicted moderately
well (Fig. S5.12h-i; PC1 mean R2 = 0.11; PC2 mean R2 = 0.10). Overall, the principal
components themselves provided a substantially different and complementary interpretation
of the pathology data compared to the clustering approach, which may be useful to explore
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Figure S5.10: Exploratory factor analysis of pathology scores. (a) Loadings (color
axis) of a 15 factor solution (y-axis) onto each of the 98 input pathology scores (x-axis).
Factors were named based on their concentrated loading onto specific combinations of pathological features. (b) Pairwise inter-factor Pearson correlations between vectors of subjectspecific scores for each factor. Due to the lack of orthogonality constraint in this implementation of exploratory factor analysis, there are non-zero correlations in the off-diagonal
of this matrix. (c) Variance explained in pathology data by each factor, either individually
(light blue line) or cumulatively (light red line). (d) Variance explained in each factor score
by a linear regression whose predictor variables were CSF amyloid-β1−42 , phosphorylated
tau, and total tau levels. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001. ****,
pFDR < 10−6 .
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Figure S5.11: Clusters capture the relationship between cognitive measures and
pathology scores. (a-c) Pairwise Spearman correlations between each pathology score
and the MoCA visuospatial subscore (panel a), the MoCA orientation subscore (panel b),
or total MMSE score (panel c) thresholded at pFDR < 0.05, corrected within each subpanel.
(d-f ) Relative node purity index, a measure of feature importance (Imp. on color axis labels)
for random forest models trained to use all pathology scores to predict MoCA visuospatial
subscores (panel d ), the MoCA orientation subscores (panel e), or total MMSE scores
(panel f ). Titles indicate the average model R2 in held out data over 50 repetitions of
5-fold cross-validation. (g-i) Distributions of R2 values for predicting MoCA visuospatial
subscores (panel g), the MoCA orientation subscores (panel h), or total MMSE scores
(panel i ) in held-out data over 50 repetitions of 5-fold cross-validation, using different sets
of predictors: All Pathology, entire matrix in Fig. S5.9; Path Type Average, average score
collapsed over regions for each type of pathological feature, i.e. synuclein, TDP-43, etc.;
Regional Pathology Average, average pathology score for each region collapsed over types of
pathology; Clusters, binary indicators of cluster membership; ADNC, binary indicators of
level of ADNC (Montine et al. 2012); LBD, binary indicators of LBD distribution (McKeith
et al. 2017); PCA, first 6 principal components of polychoric correlations of pathology matrix
(Fig. S5.12); EFA, first 6 exploratory factors from Fig. S5.10.
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Figure S5.12: Predicting principal components of pathology. (a-c) Principal component (PC) loadings obtained from decomposing the 98×98 matrix of polychoric correlations
between each feature over 895 subjects. Component loadings are shown for PC1 (panel a),
PC2 (panel b), and PC3 (panel c), along with the variance explained by each component.
(d-f ) Comparison of the distributions of PC scores between major diseases, with one-sample
Wilcoxon rank-sum tests comparing the sample medians to 0 for PC1 (panel d ), PC2 (panel
e), and PC3 (panel f ). (g-i) Predicting PC scores from MMSE, CSF proteins, and genotypes
in n = 192 patients. Main panel shows out-of-sample ROC curves and AUC for classifying
subjects with scores > 1 standard deviation in the overall sample for PC1 (panel g), PC2
(panel h), and PC3 (panel i ). Insets show out-of-sample prediction for one representative
cross-validation fold, with title showing the mean over 10 repeated folds, of R2 values for
predicting PC scores as a continuous variable for PC1 (panel g), PC2 (panel h), and PC3
(panel i ). ns, pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001. ****,
pFDR < 10−6 .
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in the future using quantitative measures of pathology.
Disease clusters separate phenotypes and genotypes independent of existing
disease labels
In order to probe the transdiagnostic nature of our disease clusters, we repeated the analyses
in Fig. 5.4b and Fig. 5.5 while excluding or isolating certain existing disease entities. In
this way, we examine how our disease cluster system parses heterogeneity both across and
within existing disease boundaries.
First, we compared MoCA items in a n = 82 subsample of patients with no intermediate
to high ADNC in Clusters 2, 4, and 5, which were the clusters containing large amounts of
such patients (Fig. 5.2e). In the full sample (Fig. 5.4a), we found that patients in Cluster
2 showed low scores on the orientation items of the MoCA, while patients in Cluster 2,
4, and 5 showed poor performance on the visuospatial cognition items. When we either
excluded (Fig. S5.13a) or isolated (Fig. S5.13b) patients with intermediate to high ADNC,
these trends were still apparent, though were no longer statistically significant after multiple
comparisons correction, likely due to the large reduction in statistical power (all pFDR >
0.05). These findings suggest that the differences in orientation deficits and visuospatial
cognition between clusters are present both in patients with and without intermediate to
high ADNC.
Next, we compared CSF protein levels in an n = 101 subsample of patients with no intermediate to high ADNC in Clusters 2, 4, and 5. Here, we found that the trend of Cluster 2
exhibiting lower CSF amyloid-β1−42 disappear (Fig. S5.14a), yet the trend of increased CSF
phosphorylated and total tau in Cluster 2 remained despite not being statistically significant (Fig. S5.14a, all pFDR > 0.05). When we isolated n=125 patients with intermediate to
high ADNC, we did observe the trend of lower CSF amyloid-β, higher phosphorylated tau,
and higher total tau in Cluster 2, though it was not statistically significant (Fig. S5.14a).
These results suggest that inter-cluster differences in individual CSF analytes are primarily
driven by levels of ADNC, though patients with low or no ADNC in Cluster 2 may be
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Figure S5.13: Trends of differences in MoCA item scores between clusters remain
with and without Alzheimer’s disease. (a-b) Pairwise intercluster comparisons of
median Montreal Cognitive Assessment (MoCA) subscores (Nasreddine et al. 2005) using
the Wilcoxon rank-sum test, FDR-corrected for multiple comparisons (q < 0.05) over all
pairwise tests for 6 subscores. In panel a, analysis is performed on an n = 82 subsample of
patients with intermediate to high ADNC excluded from Cluster 2. In panel b, analysis is
performed on an n = 86 subsample of patients, all of whom met ABC criteria intermediate to
high ADNC. Cluster 1 was excluded because it contained only 2 patients with intermediate
to high ADNC. ns, pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001.
****, pFDR < 10−6 . CSF, cerebrospinal fluid.
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Figure S5.14: Differences in CSF protein levels between clusters are primarily
driven by Alzheimer’s disease. (a-b) Pairwise intercluster comparisons of median CSF
protein levels for amyloid-β1−42 , phosphorylated tau, and total tau using Wilcoxon ranksum test, FDR-corrected for multiple comparisons (q < 0.05) over all 3 proteins. In panel
a, analysis is performed on an n = 101 subsample of patients with intermediate to high
Alzheimer’s disease neuropathologic change (ADNC) from Cluster 2, 4, and 5. In panel b,
analysis is performed on an n = 125 subsample of patients, all of whom had intermediate
to high ADNC. ns, pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001.
****, pFDR < 10−6 . CSF, cerebrospinal fluid.
phenotypically similar to the rest of Cluster 2 with respect to CSF phosphorylated tau and
total tau.
Next, we performed a similar analysis with respect to genotype. Specifically, we excluded
patients with no intermediate to high ADNC in Clusters 2, 4, and 5, yielding an n = 504
sample, and quantified the distribution of APOE and MAPT genotypes across each cluster
(Fig. S5.15a-b). Using pairwise multiple logistic regression, we estimated the increase in
log odds ratio of cluster membership given the presence of APOE alleles (Fig. S5.15c-e). In
this sample, we did not find any significant relationships between APOE allele presence and
cluster membership, though there was a trend towards increased presence of an APOE -4
allele in Cluster 2 relative to Cluster 1 and Cluster 3, and in Cluster 5 relative to Cluster 1,
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Figure S5.15: Genotypic differences between clusters at the APOE locus are
primarily driven by Alzheimer’s disease. Using an n = 504 sample excluding patients
with intermediate to high Alzheimer’s disease neuropathologic change (ADNC) from Cluster
2, 4, and 5, we assessed the prevalence of APOE genotypes across clusters. (a-b) Within
each cluster, we calculated the proportion of each genotype for APOE (panel a) and MAPT
(panel b). (c-e) Matrix of logistic regression β-weights, whose ij th element reflects the
increase in log odds ratio for membership to cluster i relative to cluster j given the presence
of APOE -2 (panel c), APOE -3 (panel d), APOE -4 (panel e). ns, pFDR > 0.05. *,
pFDR < 0.05. **, pFDR < 0.01. ***, pFDR < 0.001. ****, pFDR < 10−6 .
3, and 4 (Fig. S5.15e, both pFDR > 0.05). These findings suggest that differences in APOE
allele presence between clusters is primarily driven by localization of Alzheimer’s disease to
Cluster 2 and Cluster 5.
We also analyzed the extent to which progressive supranuclear palsy (PSP) was driving the
genotypic associations involving Cluster 1. To answer this question, we excluded patients
with PSP from Cluster 1, generating an n = 816 sample, and then we used multiple logistic
regression to compare the representation of MAPT alleles across clusters. We found that
the log odds ratio of Cluster 1 membership was reduced given the presence of two H2 alleles
at the H2 locus relative to Cluster 2 (Fig. S5.16a, pFDR < 0.001) and Cluster 6 (Fig. S5.16a,
pFDR < 0.001), though this trend was present for Cluster 1 relative to Cluster 1, 3, and 4 as
well (Fig. S5.16a, pFDR > 0.05). We did not find statistically significant regression weights
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for H1 alleles as a predictor of Cluster 1 membership relative to any cluster, though the
estimates were all greater than 0 (Fig. S5.16b, pFDR > 0.05).
Variations on disease label prediction task
In the main text, we present prediction of cluster membership using an unpenalized multiple
logistic regression classifier trained only on CSF protein levels. However, we attempted 3
variations on this approach in the experimental process. Conversion to a one-versus-all
prediction, class-balancing, splitting of training and testing samples, and evaluation of outof-sample performance was performed here exactly as in the main text (see Methods for
details).
First, we trained an unpenalized multiple logistic regression model to predict membership
to existing disease labels and disease clusters using both CSF protein and genotype at the
APOE and MAPT loci. Compared to the out-of-sample accuracy and AUC achieved in
Fig. 5.6 using only CSF protein, the performance of these models was virtually identical
or slightly worse. Mean AUC in predicting Alzheimer’s disease was similar to Fig. 5.6 at
0.91 (Fig. S5.17a 95% CI, 0.91-0.92; Fig. 5.6a 95% CI, 0.91-0.91). Mean AUC in predicting
FTLD decreased from 0.78 to 0.74 (Fig. S5.17a 95% CI, 0.74-0.75; Fig. 5.6a 95% CI, 0.780.79). Mean AUC in predicting Cluster 1 improved slightly from 0.79 to 0.81 (Fig. S5.17b
95% CI, 0.80-0.82; Fig. 5.6c 95% CI, 0.79-0.80). These findings suggest that genotype at
the APOE and MAPT loci largely do not explain meaningful unique variance in disease
class membership, under the traditional system of disease labels or our system of disease
clusters, with the exception of Cluster 1.
We also used a random forest algorithm to predict disease class labels from both CSF protein
and genotype at the APOE and MAPT loci, in case there were non-linear relationships or
interactions between genes, CSF, and class labels. This approach further enhanced the
ability to distinguish Cluster 1 from other clusters from a mean AUC of 0.81 (Fig. S5.17b)
to 0.86 (Fig. S5.18c 95% CI, 0.86-0.87; Fig. 5.6c 95% CI, 0.79-0.80). The AUC for
identifying other tauopathies also increased (PSP: mean AUC of 0.75 (95% CI, 0.74-0.76)
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in Fig. S5.18a vs. mean AUC of 0.66 (95% CI, 0.65-0.67) in Fig. S5.17a; CBD: mean AUC
of 0.75 (95% CI, 0.73-0.76) in Fig. S5.18a vs. mean AUC of 0.64 (95% CI, 0.62-0.65) in Fig.
S5.17a), but still remained inferior to the prediction of Clustedr 1. Prediction of Cluster 3
became less accurate, decreasing from a mean AUC of 0.82 in a linear model based on CSF
and MMSE (Fig. 5.6b; 95% CI, 0.81-0.83) to a mean AUC of 0.77 (Fig. S5.18c; 95% CI,
0.77-0.78). These findings suggest that accounting for non-linearities and interactions can
improve the ability to map phenotype and genotype to disease labels (in the case of Cluster
1), but using such models also has the potential to reduce generalizability (in the case of
Cluster 3).
However, the fact that the genotypes we studied do not improve prediction in a model that
already contains CSF protein data does not mean that prediction based on genotype is not
potentially useful. In fact, prediction based on genotype may be more useful in that it is
less invasive and could provide an estimate of risk for a particularly disease class before
the onset of subclinical neurodegeneration. To assess this possibility, we trained a multiple
logistic regression classifier to predict disease labels based on APOE and MAPT genotype
and MMSE score. The classifier was able to predict PSP, Multiple System Atrophy, LBD,
FTLD, corticobasal degeneration, amyotrophic lateral sclerosis, and Alzheimer’s disease
with above-chance out-of-sample accuracy. Additionally, Cluster 1, Cluster 2, and Cluster
3 could be predicted out-of-sample with above-chance accuracy. Prediction of Alzheimer’s
disease (Fig. S5.19a; 95% CI 0.79-0.80) and Cluster 2 (Fig. S5.19c; 95% CI 0.79-0.80)
were very similar, consistent with the fact that these histopathologically defined groups
overlap genetically (Fig. S5.15c-e and Fig. 5.5d-f). Prediction of Cluster 1 was also fairly
accurate, with a mean AUC of 0.79 (Fig. S5.19c; 95% CI 0.78-0.79) that performed better
than prediction of PSP (Fig. S5.19c; mean AUC =0.71, 95% CI 0.70-0.72) or CBD (Fig.
S5.19c; mean AUC =0.70, 95% CI 0.69-0.71), two major constituent diseases of Cluster 1
(Fig. 5.2e).
Finally, we wished to assess the extent to which the strong representation of Alzheimer’s

273

disease in the sample was driving the high classification accuracy of Cluster 1, Cluster 2,
and Cluster 3. We trained multiple logistic regression classifiers (Fig. S5.20a) and random
forest classifiers (Fig. S5.20c) to predict membership to disease clusters from CSF protein
levels, genotype at the APOE and MAPT loci, and MMSE score in an n = 87 sample after
excluding patients with intermediate to high Alzheimer’s disease neuropathologic change
(ADNC) from Cluster 2, 4, and 5. We found that out-of-sample accuracy was diminished
for all clusters relative to their best performance in other models, likely due in part to
reduced sample size and the elimination of intermediate to high ADNC, which represents
a population of phenotypically distinct individuals. Nevertheless, we were able to identify
Cluster 2 with AUC of 0.76 (Fig. S5.20c), Cluster 1 with AUC of 0.79 (Fig. S5.20c),
and Cluster 3 with AUC of 0.84 (Fig. S5.20a). Overall, these results suggest that our
data-driven disease clusters are sufficiently phenotypically distinct from one another to be
distinguished by multivariate models even in a sample with minimal ADNC.
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Figure S5.16: Genotypic differences between clusters at the MAPT locus persist
when excluding progressive supranuclear palsy. In panels a-b, we analyze an n =
816 sample excluding all patients with progressive supranuclear palsy. (a-b) Matrices of
logistic regression β-weights, whose ij th element reflects the increase in log odds ratio for
membership to cluster i relative to cluster j given the presence of MAPT -H2 (panel a)
or MAPT -H1 (panel b). ns, pFDR > 0.05. *, pFDR < 0.05. **, pFDR < 0.01. ***,
pFDR < 0.001. ****, pFDR < 10−6 .
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Figure S5.17: Genotype adds minimally to identification of disease labels when
using CSF protein data. (a-b) Characteristics of prediction of existing diagnoses (panel
a) or disease clusters (panel b) in held-out testing data using multiple logistic regression to
predict disease labels from CSF protein levels and genotype. Sub-panels i, and ii show the
test-set sensitivity and specificity, respectively, using a threshold value of 0.5. Sub-panel iii
shows the area under the curve (AUC) on the test-set, reflecting performance over a range
of threshold values. Bar length represents mean performance, and error bars indicate 95%
confidence intervals over 100 repetitions of k-fold cross-validation at k = 5. Sub-panel iv
shows representative receiver-operator characteristic curves for test-set predictions of existing diagnoses (panel a) or disease clusters (panel b). (c-d) Mean standardized multiple
logistic regression β across 100 repetitions of k-fold cross-validation at k = 5 in the prediction task for existing disease labels (panel c) or in the prediction task for disease clusters
(panel d). The β weights can be interpreted as the increase in log-odds ratio for a one standard deviation increase in the value of the predictor in the case of continuous predictors, or
for a one unit increase in allele count in the case of interval predictors. TPR, true positive
rate. FPR, false positive rate. Total Tau, total CSF tau protein. Phosph. Tau, total CSF
phosphorylated tau. Amyloid-β1−42 , total CSF amyloid-β1−42 . E2 and E4, 2 and 4 alleles
at the APOE locus. H1, MAPT haplotype. MMSE, Mini-Mental Status Exam.

276

Random forest
0.91
0.91−0.92

PSP

0.78
0.75−0.8

0.61
0.61−0.62

0.75
0.74−0.76

LBD

0.64
0.63−0.65

0.6
0.59−0.6

0.65
0.64−0.65

FTLD

0.72
0.7−0.73

0.7
0.69−0.71

0.77
0.77−0.78

CBD

0.71
0.69−0.74

0.63
0.62−0.64

0.75
0.73−0.76

AD

0.79
0.78−0.8

0.83
0.83−0.84

0.89
0.88−0.89

Cluster 5
Cluster 4
Cluster 3
Cluster 2
Cluster 1
0.00

0.75

1.00 0.00

Test Specificity

i

Cluster 6

0.50

0.25

Test AUC

ii

0.62
0.6−0.64
0.7
0.67−0.72
0.67
0.64−0.69
0.7
0.68−0.72
0.81
0.8−0.82
0.82
0.8−0.84
0.25

0.75

1.00 0.00

Test Sensitivity

e.

0.25

0.50

0.75

1.00 0.00

Test Specificity

0.25

δ

LBD
CBD

0.05

Cluster 2

MMSETotal

E4

H1

1.00

0.75

1.00

iv

0.50
0.25
0.00

Test AUC

0.75

1.00

0.00

0.25

0.50

FPR

δ
0.125
0.100

Cluster 4
Cluster 3

E2

0.75

0.75

Cluster 5

0.10

0.00

0.50

FPR

Feature Weights

FTLD
AD

0.25

1.00

Cluster 6
0.15

LuminexAbeta42

0.00

d.

0.50

f.

Feature Weights

LuminexTTau

1.00

0.65
0.64−0.66
0.71
0.7−0.72
0.72
0.71−0.73
0.77
0.77−0.78
0.87
0.86−0.87
0.86
0.86−0.87

Normal

LuminexPTau

0.75

iii

0.58
0.57−0.58
0.63
0.62−0.64
0.64
0.63−0.65
0.71
0.7−0.72
0.81
0.8−0.81
0.75
0.74−0.75
0.50

0.00
0.50

TPR

Test Sensitivity

0.25

0.075
0.050
0.025

Cluster 1

0.000
E4

1.00 0.00

0.25

H1

0.75

0.50

E2

0.50

0.75

LuminexTTau

c.

0.25

iv

1.00

TPR

Normal

0.83
0.83−0.84

0.00

b.

iii

0.86
0.85−0.86

MMSETotal

ii

LuminexAbeta42

i

LuminexPTau

a.

Figure S5.18: Random-forest algorithm exhibits similar performance to multiple
logistic regression in identifying disease labels. (a, c) Characteristics of prediction
of existing diagnoses (panel a) or disease clusters (panel c) in held-out testing data using a
random forest classifier to predict disease labels from CSF protein levels. Sub-panels i and ii
show the test-set sensitivity and specificity, respectively, using a threshold value of 0.5. Subpanel iii shows the area under the curve (AUC) on the test-set, reflecting performance over a
range of threshold values. Bar length represents mean performance, and error bars indicate
95% confidence intervals over 100 repetitions of k-fold cross-validation at k = 5. Sub-panel
iv shows representative receiver-operator characteristic curves for test-set predictions of
existing diagnoses (panel a) or disease clusters (panel c). (b, d) Representative decrease
in accuracy δ when removing each predictor individually in the prediction task for existing
disease labels (panel e) or in the prediction task for disease clusters (panel f ). A larger
decrease in accuracy indicates that a feature was more important for a particular prediction
task. TPR, true positive rate. FPR, false positive rate. Total Tau, total CSF tau protein.
Phosph. Tau, total CSF phosphorylated tau. Amyloid-β1−42 , total CSF amyloid-β1−42 . E2
and E4, 2 and 4 alleles at the APOE locus. H1, MAPT haplotype. MMSE, Mini-Mental
Status Exam.
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Figure S5.19: Disease labels can be predicted with above-chance accuracy from
APOE and MAPT genotype. (a, c) Characteristics of prediction of existing diagnoses
(panel a) or disease clusters (panel c) in held-out testing data using multiple logistic regression to predict disease labels from genotype. Sub-panels i and ii show the test-set sensitivity
and specificity, respectively, using a threshold value of 0.5. Sub-panel iii shows the area
under the curve (AUC) on the test-set, reflecting performance over a range of threshold
values. Bar length represents mean performance, and error bars indicate 95% confidence
intervals over 100 repetitions of k-fold cross-validation at k = 5. Sub-panel iv shows representative receiver-operator characteristic curves for test-set predictions of existing diagnoses
(panel b) or disease clusters (panel d). (e, f ) Mean standardized multiple logistic regression
β across 100 repetitions of k-fold cross-validation at k = 5 in prediction task for existing
disease labels (panel e) or disease clusters (panel f ). The β weights can be interpreted as
the increase in log-odds ratio for a one unit increase in allele count. TPR, true positive
rate. FPR, false positive rate. E2 and E4, 2 and 4 alleles at the APOE locus. H1, MAPT
haplotype. MMSE, Mini-Mental Status Exam.
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Figure S5.20: Non-Alzheimer’s disease patients in Cluster 2 can be identified with
accuracy above chance. (a, c) Characteristics of test set prediction of disease clusters
in an n = 87 sample with Braak-CERAD Alzheimer’s disease excluded from Cluster 2, 4,
and 5, using multiple logistic regression on CSF protein and MMSE (panel a), or random
forest on CSF protein, genotype, and MMSE (panel c). Sub-panels i and ii show the test-set
sensitivity and specificity, respectively, using a threshold value of 0.5. Sub-panel iv shows the
area under the curve (AUC) on the test-set, reflecting performance over a range of threshold
values. Bar length represents mean performance, and error bars indicate 95% confidence
intervals over 100 repetitions of k-fold cross-validation at k = 5. (b, d) Representative
receiver-operator characteristic curves for test-set prediction of disease clusters using logistic
regression (GLM, panel b) or random forest (panel d ). TPR, true positive rate. FPR, false
positive rate. Total Tau, total CSF tau protein. Phosph. Tau, total CSF phosphorylated
tau. Amyloid-β1−42 , total CSF amyloid-β1−42 . E2 and E4, 2 and 4 alleles at the APOE
locus. H1, MAPT haplotype. MMSE, Mini-Mental Status Exam.
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Abstract

The development of next-generation therapies for neuropsychiatric illness
will likely rely on a precise and accurate understanding of human brain dynamics. Toward this end, researchers have focused on collecting large quantities of
neuroimaging data. For simplicity, we will refer to large cross-sectional neuroimaging studies as broad studies and to intensive longitudinal studies as deep
studies. Recent progress in identifying illness subtypes and predicting treatment
response in neuropsychiatry has been supported by these study designs, along
with methods bridging machine learning and network science. Such methods
combine analytic power, interpretability, and direct connection to underlying
theory in cognitive neuroscience. Ultimately, we propose a general framework
for the treatment of neuropsychiatric illness relying on the findings from broad
and deep studies combined with basic cognitive and physiologic measurements.

291

INTRODUCTION
Neuropsychiatric illness has widespread and devastating effects on populations around the
world, affecting approximately 20% of individuals in the U.S. alone (Substance Abuse and
Mental Health Services Administration 2017). Converging evidence from genetic, behavioral, and neuroimaging (Goodkind et al. 2015; Kaczkurkin et al. 2017) studies has demonstrated overlapping pathological features in these disorders, suggesting that both common
and unique pathophysiological mechanisms underlie clinical symptoms such as anxiety, depression and psychosis. Accordingly, the classic notion of discrete psychiatric syndromes
defined by clinical symptoms (APA A.A.P. 2013) is being challenged by more biologically
and empirically driven models that link brains and behavior (Insel 2014). High rates of comorbidity between disorders hamper the identification of generalizable pathophysiological
principles, similar to those that allow us to understand dysfunction of less complex internal
organs. The dearth of such principles may partially explain the fact that a large cohort of
patients do not respond to psychotherapy, psychopharmacologics (Gaynes et al. 2009), and
brain stimulation protocols (Rachid 2018). Indeed, a marked consequence of the brain’s
vast complexity is the existence of many distinct and overlapping pathways for cognitive
function and dysfunction, constituting a major challenge in developing accurate diagnoses
and predicting individual responses to treatment.
How, if ever, can we elucidate and intervene on these overlapping pathophysiological mechanisms that underlie neuropsychiatric illness? Recent efforts toward this aim have focused on
the acquisition of human neuroimaging data sets with samples of unprecedented size (Miller
et al. 2016; Van Essen et al. 2013; Thompson et al. 2014; Satterthwaite et al. 2014). These
so-called broad studies provide an excellent picture of between-individual or population-level
variance, allowing the prediction of treatment response from high-dimensional neuroimaging and affective phenotypes based on methods from network neuroscience and machine
learning (Drysdale et al. 2017). The widespread application of such methods has been facilitated by advances in computer processing power and repurposing of graphics processing
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units (GPUs) for machine learning. In complementary efforts, researchers have also collected data with repeated measures on a small cohort or single individual. These so-called
deep studies have generated insights into the substantial within-individual variation in neuroimaging phenotypes that occurs on the scale of days, weeks, and months (Poldrack et al.
2015; Laumann et al. 2015; Finn et al. 2015). Daily changes in neuroimaging phenotypes
have also been linked to variability in behavioral and affective profiles (Betzel et al. 2017),
suggesting that temporal derivatives of neuroimaging phenotypes may contain unique, neuropsychiatrically relevant information. As such, both broad and deep studies have uniquely
contributed to our understanding of healthy neurophysiology and neuropsychopathology.
While initial progress has been made through these unique forms of big data, neuropsychiatry still remains far from the goal of using generalizable principles to develop and deliver
treatment. In this review, we begin by describing the results of broad and deep studies
in more detail, along with methods well-suited for each study type. Next, we describe a
framework to maximize the clinical translatability of broad and deep neuroimaging studies.
Specifically, we posit that broad studies can inform models that identify who would benefit
from intervention and how to intervene, while deep studies can inform models that suggest
when to intervene. Network science and machine learning serve as the foundations for these
models and will undoubtedly play a critical role in the coming generation of neuropsychiatric
care.

INFORMING DIAGNOSIS AND TREATMENT THROUGH LARGE
POPULATION-LEVEL STUDIES
Within the past decade, the neuroimaging community has seen the emergence of broad neuroimaging studies with historically large sample sizes (Fig. 6.1). The Human Connectome
Project (Van Essen et al. 2013), the UK Biobank (Miller et al. 2016), the Philadelphia Neurodevelopmental Cohort (Satterthwaite et al. 2014), and Enhancing Neuroimaging Genetics
through Meta-Analysis (ENIGMA) (Thompson et al. 2014) have each generated valuable
insights into the relationship between brain structure, brain function, and behavior. Impor-
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tantly, analyses of these data have increasingly relied on methods from network neuroscience
(Bassett and Sporns 2017), an emerging field that provides elegant approaches for the quantitative description of complex multivariable phenotypes in brain anatomy and physiology.
In large-scale brain networks, one can succinctly capture the collective role of several regions
simultaneously through node-level metrics, such as the participation coefficient (Sporns and
Betzel 2016; Bertolero et al. 2018), controllability (Gu et al. 2015a), hubness, nodal efficiency (Latora and Marchiori 2001), and weighted degree (Sporns and Betzel 2016) (Box
1). These metrics can be readily computed using freely available code (Rubinov and Sporns
2010; Gu et al. 2015b). Notably, these statistics are influenced by the topology of the entire
network, changes dynamically over time in functional networks (Shine et al. 2016), and is
altered in neuropsychiatric disease (Jeganathan et al. 2018; Van Den Heuvel et al. 2013; Li
et al. 2012). To combine brain network models with clinical, behavioral, and cognitive data
requires the use of multivariate statistical approaches that acknowledge the complexity of
brains, behavior, and genetics by accounting for the covariance structure in each of these
data types (Smith et al. 2015; Miller et al. 2016). Sparse canonical correlation analysis
(sCCA) (Avants et al. 2010) and partial least squares (PLS) (Krishnan et al. 2011) are two
examples of such multivariate statistical methods that are well-suited to identify covariance
patterns between brain networks and high dimensional behavioral, clinical, and genetic data
(Fig. 6.1).
Modularity
Complex networks often contain non-trivial clustering in the form of modularity, in
which groups of nodes exist that are more densely connected with each other than
with nodes in other modules (Sporns 2014; Sporns and Betzel 2016).
Network density
A fully dense network is one in which a connection exists between every possible pair
of nodes. The density of a network is the number of existing connections divided by
the number of possible connections.
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Participation coefficient
Participation coefficient quantifies the extent to which a node sits on the boundary
of multiple modules (Sporns 2014; Sporns and Betzel 2016; Bertolero et al. 2017,
2018), poised to coordinate activity between functional systems of the brain (Yeo
et al. 2011).
Weighted degree
The weighted degree, or strength, of a node is the sum of its connection weights.
Weighted degree can be further broken down into within- and between-module degree,
referring to the strength of a node’s connections to nodes in the same module or in
other modules.
Hubs
Hubs are brain regions with unique roles in structural and functional networks due
to their many, and often divrse, connections with other brain regions. Hubs are
often disrupted in neuropsychiatric illenss (Van Den Heuvel et al. 2013; Buckner
et al. 2009). Hubs can be defined in several ways (van den Heuvel and Sporns 2011;
Gordon et al. 2018; Sporns and Betzel 2016; Bertolero et al. 2017, 2018), often relying
on a balance between participation coefficient and within-module degree.
Nodal efficiency
Nodal efficiency is a measure related to the average number of nodes that must be
traversed to go from a given node to all other nodes (Hilger et al. 2017; Latora and
Marchiori 2001). This quantifies how an individual node contributes to the small
world properties of brain networks (Bassett and Bullmore 2006).
Controllability
Unlike the above metrics, which quantify the static topological role of nodes in a
network, network control theory (Bassett and Sporns 2017; Gu et al. 2015b) uses
a dynamical systems perspective to quantify the ability of each node to support
transitions between states of activity. Two common metrics are average and modal
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controllability, which capture the ability of regional input to drive nearby or distant
state transitions (Gu et al. 2015b; Pasqualetti et al. 2014). These principles have
been explored in neuropsychiatric illness (Jeganathan et al. 2018; Khambhati et al.
2016), over development (Tang et al. 2017), and across species (Kim et al. 2017).

Machine learning classifiers have demonstrated clear promise for neuropsychiatric diagnosis
(Arbabshirani et al. 2017), even with unimodal neuroimaging data. In a multisite study
(n = 941), the ENIGMA schizophrenia working group utilized consensus-based classifiers to
distinguish individuals with schizophrenia from healthy controls with 76% accuracy using
structural MRI alone (Rozycki et al. 2017). However, the clinical utility of such classifiers
may not be realized until they are able to distinguish a particular disorder from a heterogeneous clinical population rather than healthy controls. Results from studies based on
multivariate statistics suggest that the inclusion of clinical and behavioral data may help
classifiers resolve this heterogeneity. In a large multisite study (n = 1188), CCA was used to
define biotypes of major depressive disorder (MDD) based on resting state functional connectivity and clinical symptoms, allowing for diagnosis of depression with 85-90% accuracy
in a replication set and prediction of positive response to transcranial magnetic stimulation (TMS) (Drysdale et al. 2017). The model was also able to distinguish MDD from
schizophrenia more easily than from generalized anxiety disorder, reflecting the varying degrees of overlap in neurobehavioral phenotypes between different forms of mental illness.
Importantly, individual patient data from independent samples can be fed into these models to generate priors for clinicians. In the near future, these models are likely to become
increasingly powerful as open data sharing practices facilitate the growth of training data
sets (Poldrack and Gorgolewski 2014). Such efforts will be critical for generating low dimensional representations of clinical symptoms and network measures of brain structure and
function that are useful in the diagnosis and sub-diagnosis of disease, and in the selection
of interventions and treatments (Fig. 6.1).
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Transcriptome
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Behavior
Brain

Time

Multivariate Statistics
Deep learning classifiers

Time-varying multilayer network models

Automated neurobehaviorial diagnoses
Prediction of treatment response

Variability of individual networks over time
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Figure 6.1: Broad and deep neuroimaging studies. The neuroimaging community has
seen the rise of studies with increasingly large sample sizes (broad studies) and increasingly
intensive sampling (deep studies). Broad studies (left) typically involve cross-sectional sampling of a specific population. Multivariate statistics and deep neural-network classifiers are
two examples of methods that are well-suited to identify high-dimensional patterns between
brain network, behavioral, clinical, and genetic phenotypes. Ultimately, such models might
lead to the automated classification of neuropsychiatric illness based on neurobehavioral
phenotypes, along with predictions of responses to various treatment options. Deep studies (right) typically involve intensive, repeated sampling of a small number of individuals
longitudinally over days, months, or years. Multilayer network models can capture how the
interaction between different components of brain networks, transcriptomes, metabolomes,
or behavioral networks changes over time. Such models could prove particularly powerful
for delineating how variability in individual networks over time affects treatment response.

HARNESSING INDIVIDUAL DIFFERENCES AND WITHIN-SUBJECT
DYNAMICS
In contrast to broad studies, which leverage large sample sizes to make inferences about
individuals in a defined population, deep studies are particularly suited for investigating
the interdependencies between a diverse range of phenotypes that might vary meaningfully
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over time in single individuals (Fig. 6.1). Perhaps the most impressive deep study is the
MyConnectome project (Poldrack et al. 2015), which is the first to describe the existence
and nature of a complex interactome between resting state functional connectivity, transcriptomics, metabolomics, food intake, and behavior over the course of 532 days. It is
interesting to consider the potential for such an interactome to inform the development of
targeted neuromodulatory interventions that depend on the state of the brain at the time
of stimulation (Silvanto and Pascual-Leone 2008). Indeed, daily variation in brain network
connectivity could confound the effects of stimulation, leading to mixed responses to such
treatments for depression (Rachid 2018). To better understand these temporal variations,
one can consider using multilayer network models, which can identify changes in network
structure over time by taking into account the interactions between network components
and the interactions within each network component with time (Muldoon and Bassett 2016)
(Fig. 1). One can also use linear autoregressive models, Hidden Markov Models, or Long
Short-Term Memory recurrent neural networks (Längkvist et al. 2014) to predict how a
complex, interacting system evolves over time. While the level of depth reported in the
MyConnectome project is currently impractical for patient care, it illustrates the complex
origins of day-to-day individual variation and – alongside other intensive sampling studies
– offers useful benchmarks to inform future data collection (Anderson et al. 2011; Laumann
et al. 2015; Gordon et al. 2017; Poldrack 2017).
Typical approaches for “parcellation,” to obtain representative signals within anatomically
(Cammoun et al. 2012) or functionally (Yeo et al. 2011) similar regions or “parcels”, tend to
rely on registering brain images to a common template space. However, performing targeted
manipulations of distributed cognitive systems that exhibit dysfunction in neuropsychiatric
illness demands exceptional precision in mapping brain network architecture and function.
Thus, the growing focus on subject-specific parcellation to define these parcels independently for each participant or patient is a critical complement to the intensive sampling
of deep studies (Fig. 2) (Finn et al. 2015; Laumann et al. 2015; Chong et al. 2017; Honnorat et al. 2017). Constructing subject-specific parcellations builds on historical work in
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tumor resection, where neurosurgeons and anesthesiologists perform patient-specific functional mapping of language and motor circuits with fMRI, pharmacology, and electrical
stimulation (Weng et al. 2017; Dierker et al. 2017). When seeking to map all circuits across
the entire brain, one would focus on mapping individual differences in functional topography that might hold diagnostic and prognostic value, with methods that do not depend on
warping subject-level volumes to an average brain (Kong et al. 2018; Gordon et al. 2017).
Recently, such individualized parcellation techniques have been combined with resting state
fMRI to identify novel subnetworks within the default mode network (DMN) (Braga and
Buckner 2017), a system that has been broadly implicated in virtually every neuropsychiatric illness (Anticevic et al. 2013; Posner et al. 2017; Coutinho et al. 2016; Padmanabhan
et al. 2017). These observations motivate further studies of individual differences in the
distribution of cortical real estate between particular functional networks (Satterthwaite
and Davatzikos 2015) and their finer subdivisions in the context of neuropsychiatric illness
(Fig. 6.2). In these efforts, deep neuroimaging studies will be particularly important, by
providing sufficient data to use subject-specific parcellations. This approach will account
for – rather than average over – individual network topographies (Fig. 6.2). Resolving
individual differences in spatial topography will facilitate an accurate study of the neural
basis of temporal fluctuations in individual symptoms. The richly sampled temporal dimension of deep studies adds a layer of complexity untouched by most broad studies and
the individual-oriented methodology improves the accuracy of patient-specific predictions.
Ultimately, meta-analysis of deep studies might inform a generalizable approach, if not
pathophysiological principles, for making individual predictions of the optimal treatment as
a function of time and a more easily measurable subset of variables.

USING NETWORK MODELS TO LINK INTENSIVE BEHAVIORAL
ASSESSMENT WITH NEUROIMAGING FINDINGS
A key counterpart to accurately interpreting changes in functional brain dynamics over
time in a patient cohort is the ability to concurrently measure changes in behavior, emotions, and mood – core symptoms of neuropsychiatric illness, which are typically assessed
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Group Level
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Individual

Figure 6.2: Subject-specific parcellation uncovers individualized topography of
functional networks. (a) Sample depiction of the default mode network in a group-level
parcellation, which warps subject volumes to standard space, potentially averaging over
important differences in functional network topography. Yellow overlay indicates activity,
while colored lines indicate parcel boundaries. (b) Sample depiction of subject-specific activation map (yellow overlay) with group-level parcellation borders (colored lines) overlayed,
illustrating the possible variation in subject-specific functional topography.
retrospectively in the clinical setting. Experience-sampling (ES) encompasses the measurement of these factors, in addition to physiology, in real time through the use of personal
data recording tools (Hektner et al. 2007). Subject-specific symptom networks can be constructed by computing cross-correlations between measures of different emotions over time,
quantifying the cofluctuation of psychiatric symptoms (Borsboom 2017; Borsboom et al.
2011; Costantini et al. 2017) (Fig. 6.3). Additionally, directed networks can be constructed
using pairwise regression between time-lagged measures, capturing the temporal precedence
of symptom fluctuations (Bringmann et al. 2016). Higher order features of these symptom
graphs (Borsboom 2017), such as network density (Box 1), are greater in individuals with
MDD than in healthy controls (Pe et al. 2015), suggesting that the temporally dynamic
interplay between symptoms may be altered by disease processes. ES also lends itself well
to the study of substance use disorders, in which daily emotional variability can trigger
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relapse (Jones et al. 2018).
Major limitations of ES are the burden of repeated assessment on participants and the
potential for the process of ES itself to influence symptoms (i.e. reactivity (Rowan et al.
2007)). Nevertheless, commonly used forms (Beck, A. T., Steer, R. A., & Brown 1966;
Kroenke and Spitzer 2002; Kay et al. 1987) for evaluating mental health utilize retrospective
reporting, assuming stationarity in these dynamic phenotypes (Schwarz 2007) (Fig. 6.3).
Schizophrenia, for example, is characterized by a lack of insight and poor working memory,
and therefore real-time assessment may be more likely to accurately capture cognitive and
emotional state than single-shot clinical evaluations or self-report measures. Thus, ES
is a highly promising approach for identifying neural correlates of symptom dynamics in
complex, overlapping neuropsychiatric pathologies.
The use of ES has begun to enter into neuroimaging studies, though not with the same
force as the machine learning techniques described above. In schizophrenia patients, corticostriatal task activation and reduced motor activity were found to predict negative symptoms (Kluge et al. 2017). Similarly, physiological signs of autonomic dysfunction acquired
through wearable technology were associated with positive symptom severity (Cella et al.
2017). In a study of patients with anorexia nervosa, reward circuit activity was related
to longitudinal body-mass index measurements and body-related rumination (Seidel et al.
2018). Notably, this particular study used group-level parcellation techniques, indicative of
a common disconnect between the use of cutting edge methods in social science and those
in neuroscience.
Despite these intriguing findings, no parallels have yet been drawn between basic ES measures, network models of psychiatric symptoms, and structural or functional brain networks.
Functional brain network dynamics have been extensively characterized (Shine et al. 2016;
Preti et al. 2017), and there are likely rich relationships with behavioral and symptom
dynamics, as suggested by the MyConnectome project. One could gain traction on these
relationships using multilayer network construction with subsequent community detection
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Figure 6.3: Measuring mood dynamics with experience sampling. (a) Illustration
of symptom measurement by retrospective report, demonstrating how scales of mood symptoms that ask for retrospective reporting average over rich mood dynamics and are subject
to recall bias (Beck, A. T., Steer, R. A., & Brown 1966; Kroenke and Spitzer 2002; Kay
et al. 1987). (b) Example time series of mood measurements from the Profile of Mood
States (Terry et al. 2003). Spikes in the time series indicate rapid changes in mood induced
by brief events. The numbering on the x-axis indicates windowing for network construction.
(c) Illustration of multilayer emotional network construction from subsequent windows of
time series shown in panel (b). Nodes represent mood features, with the letter label corresponding to features in (b), solid gray edges represent the correlation between mood features
within a particular time window, and dashed black edges link mood features together across
time. Constructing such a network facilitates the application of numerous methods for analyzing the temporal dynamics of multivariate relationships (Muldoon and Bassett 2016).

(Muldoon and Bassett 2016) to draw parallels between dynamic functional networks and
symptom networks. Brain regions with high inter-scan variability in functional connectivity and high within-scan community change, i.e. flexibility (Betzel et al. 2017), may
confer similar variability onto behavior phenotypes. The use of advanced machine learning
techniques for time series analysis, such as recurrent neural networks and Hidden Markov
Models, as well as unsupervised multivariate statistical methods, are promising underexplored avenues for finding covariance between complex neural and behavioral phenotypes
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in neuropsychatric illness. Furthermore, ES could explain temporal variance in cortical excitability (Rogasch et al. 2014; Bestmann and Krakauer 2015), an important factor in TMS
response (Sun et al. 2018), and allow for its targeted control. While targeted neuromodulatory treatment paradigms are currently being refined, with the aid of findings from broad
studies, ES provides us with useful methods that will help to identify the optimal time in
a disease course to deliver these treatments.

CONCLUSION
Across many academic disciplines, the use of machine learning techniques, often informed
by network theory, has skyrocketed in the last decade, concordant with the collection of
data with larger (broad ) and more intensive (deep) samples. Both broad and deep studies
provide the neuroscience commmunity with unique opportunities to advance the diagnosis and treatment of neuropsychiatric illness, with the aid of network science and machine
learning. Broad studies allow for network analysis followed by dimensionality reduction
and classification for identifying meaningful symptom-neuropathology correspondence and
predicting treatment responses. Deep studies demonstrate the importance of individual variability and provide a framework for understanding and manipulating complex, individual
phenomes. Experience sampling provides the tools for acquiring intensive repeated physiologic and behavioral measures, the network models of which may have critical unexplored
neural correlates. Ultimately, a model using priors derived from broad studies, patientspecific neuroimaging data, and symptom networks might predict the optimal timing and
type of treatment for individual patients in real time based on a subset of measurements
captured through a personal device. The merger of these techniques has the potential to
usher in a next-generation approach to psychiatric care and contribute to our fundamental
understanding of the complex relationship between mind, body, and behavior.
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CHAPTER 7: General discussion
SYNTHESIS OF RESULTS AND OVERALL DISCUSSION
Macroscale network interactions are fundamental to human cognition and neuropsychopathology. Personalized treatments for disorders of brain networks have lagged behind other fields
of medicine, in part due to an incomplete understanding of how distributed neuronal populations influence one another and respond to inputs. Dynamical systems models aim to
provide an explanation of fluctuations in neuronal population activity that links activity,
static functional connectivity (Fox and Raichle 2007), and time-varying functional connectivity (Preti et al. 2017). Indeed, the network architecture of the brain underlies the
heterogeneity of many neuropsychiatric disorders (Boes et al. 2015; Darby et al. 2019; Seeley et al. 2009), requiring data-driven approaches to arrive at more parsimonious groupings
(Drysdale et al. 2017; Xia et al. 2018; Cornblath et al. 2019).
The body of work in this thesis centers around using dynamical systems models and datadriven tools to explain macroscale network processes in the brain. We applied these approaches to generate novel insights into neurophysiology, development, aging, and the pathophysiology of neurodegenerative disease. Specifically, we used linear network spreading models, a subset of dynamical systems models, to describe how both brain activity and protein
pathogens spread along structural connections in the brain. The findings presented here
help to inform accurate models of the brain’s intrinsic dynamics and responses to external
inputs, which will be critical for identifying dysfunctional neural circuitry and developing
principled interventions for neuropsychiatric illness.
In the first study, we characterized age- and sex-associations of average and modal controllability, regional measures of the influence that one brain area has over the rest of the
brain in the context of a linear dynamical system defined by white matter connectivity. We
found that frontoparietal control properties differ by sex and explain variance in behavioral
impulsivity. These findings suggest that variation in the ability to control brain networks
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is linked to variation in the control of behavior, which may explain increased impulsivity
observed in male subjects (Cross et al. 2011).
In the second study, we directly tested the ability of dynamical systems models based on
white matter connectivity to explain how brain activity changes over time. First, we used
time-resolved methods to identify brain activity states occurring at single BOLD fMRI
time points during resting state and a working memory task. We simulated linear diffusion
of brain activity along white matter tracts and solved for the minimum input needed to
transition between each pair of states. This analysis revealed that brain state transitions at
rest occurred less frequently if they required larger inputs to oppose the spreading of brain
activity along white matter. During the working memory task, we found that a temporal
sequence of default mode system activity immediately followed by frontoparietal system
activity was positively associated with working memory performance. Interestingly, the
prevalence of this sequence increased with age, implicating this temporal pattern in normal
cognitive development.
In the third study, we used linear diffusion models to explain the spread of misfolded αsynuclein in a mouse model of Parkinson’s disease. By injecting misfolded α-synuclein into a
pre-selected site and evaluating whole brain α-synuclein pathology at specific time points, we
addressed several key limitations of previous studies that implicated axonal spread in neurodegenerative disease pathogenesis (Raj et al. 2012; Pandya et al. 2017, 2019). We showed
that retrograde diffusion models explained spatial patterns of pathology better than anterograde models, suggesting that α-synuclein primarily travels from axon to soma to dendrite.
Regional levels of endogenous α-synuclein conferred additional vulnerability to pathology,
likely due to the available pool of molecules that can be converted to pathological Lewy
bodies. These findings further elucidated the network mechanisms of Parkinson’s disease
as a primarily retrograde spreading process that dynamically interacts with endogenous
protein levels.
In the fourth study, we performed a data-driven analysis of co-occurrence of multiple forms
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of neurodegenerative pathology using a large dataset of cerebral autopsy cases. We found 6
statistically robust clusters of patients, each of which was characterized by a different pattern
of copathology. Interestingly, limbic tauopathy was ubiquitous across clusters, including the
“minimal pathology” cluster, suggesting that this autopsy finding may reflect normal aging.
One cluster contained strong α-synuclein and Alzheimer’s disease copathology in different
spatial patterns than the clusters for which either type of pathology was primary. These
findings suggest that α-synuclein and tau may modify one another when they co-occur,
reflecting a unique pathophysiology. Finally, we showed that logistic regression and random
forest could predict membership to clusters on autopsy using only data available to clinicians
in vivo, suggesting that these models may be useful for inferring copathology for clinical
trials that target one or more specific proteins.
In the fifth study, we provide an overview of techniques used to draw inferences about
psychopathology and individual patient trajectories. We discuss how to integrate these
insights in constructing personalized medicine approaches to the management of mood
disorders and psychosis.

GENERAL LIMITATIONS
In discussing the promise of the research presented here, some critical limitations should
be noted. BOLD fMRI signals are thought to reflect low frequency fluctuations in local
field potentials (Mateo et al. 2017; Pan et al. 2013), but this link may be state-dependent
(Ekstrom 2010). However, the use of electrocorticography, which has higher temporal resolution, is limited by poor spatial coverage and the necessity of studying clinical populations
due to its invasiveness. Diffusion tractography is known to produce false positives (Zalesky
et al. 2016), which we address by studying consensus networks (Betzel et al. 2019) obtained
by combining data from over 800 subjects.
Another limitation is the use of linear models in studying the brain, which frequently
exhibits non-linear responses to inputs of varying strengths. However, linear models can
provide a good approximation of a non-linear system at short distances about a fixed point
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(Kim and Bassett 2019), consistent with our use of linear control models to study brain
state transitions at the shortest possible time scale afforded by fMRI. Additionally, initial
evidence suggests that linear network controllability metrics can be used to predict how
non-linear models respond to inputs (Muldoon and Bassett 2016). Empirically, BOLD
fMRI functional connectivity patterns can be captured by data-driven (Liégeois et al. 2017)
or white matter-based linear models (Abdelnour et al. 2014, 2018), suggesting that linear
models are sufficient to capture important aspects of brain function.
Finally, there are practical limitations to the integration of advanced computational tools
into clinical neurology and psychiatry. First, the outputs of complicated models can be
difficult to understand and interpret. For example, even straightforward regression models
(e.g. CHA2 DS2 (Gage et al. 2001)) with continuous probabilistic output are commonly
discretized in practice, with estimated probabilties of adverse events summarized as “low,”
“medium,” or “high” risk. Convincing demonstration of the value of complex models requires comparisons with trivial cases, such as guessing a patient’s future outcome to be a
recent average, a practice which is not frequently adopted (DeMasi et al. 2017). In our
work, we compared our ability to predict data-driven groupings of patients with prediction
of traditional diagnostic labels, and ensured that our findings were not driven by the representation of traditional diagnoses within our data-driven groups. In any case, all models
should be rigorously compared to other candidate models across a number of contexts and
patient populations to build confidence in their generalizability and utility.

FUTURE DIRECTIONS
There are several clear next steps in studying the transsynaptic spread of pathogenic proteins that have potential impact for the development of therapeutic interventions for neurodegenerative disease. It appears that with α-synuclein injections, retrograde spread predominates early in the disease process while the contribution of anterograde spread increases
later on (Mezias et al. 2020). Our ongoing work is focusing on validating the linear spread
of misfolded tau and exploring the contributions of anterograde and retrograde spread. Our
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initial findings suggest that retrograde and anterograde both contribute independently to
spread, with retrograde contributing more at all time points. Future studies will investigate
whether the concurrent spreading of these proteins produces patterns of pathology that differ from those observed when proteins are injected independently. These analyses will shed
light on the disease processes that occur in concurrent tauopathy and α-synucleinopathy
that are potentially unique from either monoproteinopathy. Perhaps the most promising
application of these linear spread models of neurodegeneration is the ability to characterize
whether potential immunologic or small molecule pharmacotherapies interfere with network spreading or globally suppress transmission or aggregation. Simulations using these
well-validated spreading models may also reveal key connections or hubs, the severance of
which may halt the progression of disease, similar to the resection surgeries used to manage
drug-resistant epilepsies (Rosenow and Lüders 2001).
In the field of functional neuroimaging, a trend towards personalized approaches is likely
to yield novel, reliable insights into brain-behavior relationships. Functional neuroimaging studies frequently quantify differences in activity or connectivity using divisions of the
cerebral cortex extracted from group average data (Yeo et al. 2011; Schaefer et al. 2017).
However, individual differences in the spatial boundaries of these divisions contains additional information about behavior (Kong et al. 2018; Cui et al. 2020). Dense temporal
sampling is required to estimate these divisions in single individuals (Gordon et al. 2017).
Many clinical studies use short scan times, suggesting that additional insights into functional
alterations can be obtained by applying these individual-specific approaches.
Network control models are highly promising for clinical applications, but several additional
steps need to be taken to demonstrate their predictive value and expand their utility. The
allure of network control models and optimal control techniques is the ability to design
stimulation paradigms that bring the brain into a target state under specified physiological
constraints, which has relevance for the management of treatment-resistant depression,
epilepsy, and movement disorders (Krook-Magnuson et al. 2015; Tang and Bassett 2018;
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Delaloye and Holtzheimer 2014). An initial step towards this goal would be to train a
network control model on a time series of brain activity containing known timing, locations,
and intensities of external stimulation, and assess whether the model accurately predicts
spontaneous and evoked activity out of sample and in a parameter space not used to train
the model. Initial applications show that accurate out-of-sample prediction can be achieved
with linear control models of local field potentials in humans (Chang et al. 2012), but
it is increasingly common to define target states by functional connectivity (Sani et al.
2018; Kramer and Cash 2012; Helm et al. 2018). Further investigation into how repeated
modulation of activity leads to persistent changes in functional connectivity is needed, which
may be achieved by treating time varying connectivity metrics as state space variables
(Khambhati et al. 2018).
Finally, a critical feature of macroscale brain organization is the existence of ascending neuromodulatory systems, which project from brainstem and basal forebrain nuclei and release
metabotropic neurotransmitters onto cortical and subcortical targets (Avery and Krichmar
2017; Shine 2019). Serotonin and norepinephrine are two neuromodulators that are frequent
pharmacologic targets in mood, anxiety, and attention disorders. Neuromodulation has a
pronounced effect on interactions between neurons (Nusbaum and Beenhakker 2002) and
macroscale functional connectivity (Shine et al. 2016, 2017). One recent study suggests that
neuromodulators control spatial modes of task-relevant brain activity (Shine et al. 2019).
Incorporating and validating the effects of neuromodulatory influences in macroscale models
of brain activity (Deco et al. 2018; Shine and Poldrack 2018) may help characterize abnormal neuromodulatory signaling in clinical populations and prove useful for interpreting the
effects of non-invasive genetic manipulations (Vasan et al. 2019; Rezai et al. 2020) as they
are developed.

CONCLUSIONS
This work is unified by the application of network spreading models and other computational tools to characterize healthy brain function as well as pathologies that affect the brain.
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In applying these tools, we gained new insights about macroscale structure-function relationships in the context of the development of executive functioning. We resolved a critical
debate about the role of regional vulnerability and network spread in Parkinson’s disease
pathogenesis, and quantitatively tested the delineation between different neurodegenerative
diseases. In the future, these approaches may prove useful for understanding phenotypic
heterogeneity and network mechanisms in stroke, epilepsy, and neuropsychiatric illness.
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